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ABSTRACT 
 Non-viral nucleic acid delivery systems must condense nucleic acids into small 
particles, confer protection from degrading factors in serum and in cells, achieve uptake 
to targeted cells, direct nucleic acids to appropriate intracellular destinations, release this 
cargo to permit its action, and exhibit minimal toxicity.  The nature of synthetic vectors 
allows for facile addition of new features, but these modifications can affect performance 
in unanticipated ways.  The effective combination of functional components necessitates 
a systems approach, where the materials design simultaneously considers the functional 
environment of and the various barriers to delivery.  This thesis facilitates and promotes a 
systems approach by undertaking development of an improved mechanistic 
understanding of non-viral gene transfer in vitro, emphasizing elucidation of delivery 
vehicles’ interactions with and behavior within cells.  Special attention is given to the 
gene delivery behavior of cyclodextrin-containing polycations. 
Simple modifications to delivery systems can have unanticipated consequences.  
In Chapter 2, it is shown that greater distance between toxicity-reducing cyclodextrin 
moieties and amidine charge centers increases both the transfection efficiency and 
toxicity of a polycationic vector.  Chapter 3 shows data demonstrating that modification 
with poly(ethylene glycol) for extracellular salt-stabilization alters non-viral gene 
delivery particles’ intracellular trafficking and resulting gene expression.  Taken together, 
the results reveal that non-viral gene delivery vehicles behave as assembled, 
multifunctional systems. 
pH-buffering components exhibit complex behavior in non-viral gene delivery.  
In Chapter 4, the intracellular activity of such components is quantified using confocal 
 vi
microscopy.  Analysis of chloroquine and its chemical analogues demonstrates in Chapter 
5 that chloroquine improves non-viral gene transfer through pH-buffering as well as 
through enhanced nucleic acid unpackaging and its own interactions with nucleic acids.  
Chapter 6 gives results that characterize delivery behavior of analogous vectors with and 
without pH-buffering capacity and show that factors beyond buffering activity contribute 
to improved transfection efficiency.  Collectively, these results emphasize consideration 
of new system components’ effects on all functions of a non-viral gene delivery system. 
A systems approach requires comprehensive consideration of the gene delivery 
process.  Chapter 7 reviews current understanding of intracellular barriers to non-viral 
gene delivery, and Chapter 8 offers recommendations for future work. 
 vii
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CHAPTER 1: INTRODUCTION 
 
1.1 Introduction 
 Molecular conjugates are nanometer-sized entities consisting of synthetic 
materials (lipids, polycations, targeting agents, etc.) and nucleic acids.  These composites 
are delivery vehicles that function to transport nucleic acids to sites of action.  Such 
systems can avoid the DNA-size limitations and immunogenicity that are possible with 
some viral delivery vectors, and their straightforward formulation with easily-
manufactured, relatively low-cost materials could be useful in preparing large-scale 
therapeutics at acceptable costs.  If their therapeutic indices can be improved, non-viral 
gene delivery vectors will likely be used in a wide range of medical applications. 
 Non-viral gene delivery vectors must exhibit a variety of properties to achieve 
their function.  First, they must condense nucleic acids into small particles (ca. 100 nm or 
less) and confer protection from degrading factors that exist in serum and in cells.  The 
gene delivery particles must be taken up by cells that have been targeted, direct the 
nucleic acids to an appropriate intracellular destination (cytoplasm for small interfering 
RNA (siRNA) and nucleus for plasmid DNA (pDNA)), release the nucleic acids to allow 
for their action, and exhibit minimal toxicity (Figure 1.1).  Although the limiting 
intracellular barrier(s) to non-viral gene delivery remain(s) poorly defined, many recent 
approaches have sought to better understand and enhance: (i.) escape from the endocytic 
pathway, (ii.) vector unpackaging, (iii.) cytoplasmic persistence of nucleic acids, and (iv.) 
nuclear delivery.  A further intracellular barrier that has not been extensively addressed is 
the poor cytoplasmic mobility of large nucleic acids. 
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Figure 1.1  Functions of molecular conjugates 
Molecular conjugates must bind and condense nucleic acid payloads, protect nucleic 
acids from nuclease degradation, allow for cellular uptake, facilitate escape from 
endocytic vesicles, and release the nucleic acids to permit their function.  It remains 
unclear if pDNA must be released from the vector prior to nuclear entry or should be 
directed to the cell nucleus within intact vector-pDNA complexes. 
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 The development of molecular conjugates has followed an additive process where 
the perceived challenges are addressed by a variety of modifications, the most successful 
of which are then incorporated into existing systems.  Initially, existing materials were 
evaluated for their ability to bind and condense nucleic acids and mediate transfection of 
cultured cells [1-3].  These early non-viral systems showed little in vivo applicability due 
to shortcomings such as high toxicity, instability to physiological salt and serum, and 
poor transfection efficiency.  However, the synthetic nature of non-viral systems allows 
for facile, well-defined modification, facilitating incorporation of new components to 
address specific barriers to delivery.  Early attempts to improve transfection efficiency 
included addition of cell-targeting ligands such as transferrin [4-6] or saccharides [7-9], 
or addition of membrane-destabilizing peptides [2,7,10].  In an effort to boost 
transfection efficiency of non-viral vectors, some researchers began incorporating viral 
peptides [11-15] or transfecting cells in the presence of chemical agents [16-18].  To 
facilitate escape from the endocytic pathway, various researchers have added buffering 
moieties such as histidine [19-21]. 
 These modified systems have not displayed sufficient improvements in 
performance, prompting synthesis of new materials designed to overcome the 
shortcomings of their predecessors.  Various groups have sought to build vectors with 
fusogenic properties [22] or buffering moieties [23-24].  Other groups have constructed 
materials with an emphasis on reduced toxicity [25-27].  When novel materials have been 
found inadequate, researchers have reverted to an additive approach, modifying the new 
materials with functionalities similar to those that had previously been added to the first 
generation of materials [28]. 
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 A considerable challenge in the field of molecular conjugates is building a 
workable system that exploits the combined attributes of the components without 
suffering losses due to the assembly of the system.  Modifications of existing systems, as 
described above, have brightened the prospects for effective in vivo gene delivery.  
However, these alterations, often involving changes to the chemical structure of the 
delivery vectors or nucleic acids, have also affected gene delivery performance in 
unanticipated ways.  For example, we have demonstrated that conferring salt stability to 
polyethylenimine-DNA complexes with a poly(ethylene glycol) coating dramatically 
changes the morphology of the endocytosed entities and significantly reduces the 
resulting gene expression in vitro [29]. 
 As molecular conjugates are designed to contain a combination of functional 
components, it is likely that engineered systems for non-viral gene delivery will 
eventually be constructed.  The additive approach to vector development is giving way to 
a systems approach where the functional environment of and the various barriers to 
delivery are simultaneously considered in the materials design.  For example, the initial 
emphasis on identifying materials that bind and condense nucleic acids may have 
underappreciated the importance of their subsequent intracellular release [30]; attention 
has now turned to vectors with a weaker binding strength [31] or whose chemical 
structure or nucleic acid condensation is disrupted following cellular uptake [32-38].  The 
need for a systems approach extends to in vitro investigations, as modifications intended 
for in vivo applicability can significantly affect both in vitro and in vivo performance 
[29]. 
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The objective of this thesis is to develop a more comprehensive understanding of 
non-viral gene delivery particles’ interaction with and behavior within cells.  This work 
facilitates and promotes a systems approach to vector development by providing an 
improved mechanistic understanding of the process of non-viral gene transfer in vitro. 
Weaknesses of an additive approach to vector development are apparent in the 
next two chapters, which describe multiple, correlated effects of simple modifications to 
delivery systems.  Chapter 2 demonstrates that subtle modifications to the chemical 
structure of non-viral vectors can have significant and possibly inseparable effects on 
both transfection efficiency and toxicity.  In Chapter 3, it is shown that PEGylation for 
extracellular salt-stabilization of non-viral gene delivery particles has a significant impact 
on the uptake and intracellular trafficking of these particles. 
The subsequent three chapters demonstrate the value of a systems approach by 
characterizing the complex function of pH-buffering components in non-viral gene 
delivery.  Incorporation of such components has been a popular strategy in the additive 
approach to vector development, motivated largely by examples of improved transfection 
efficiencies from non-viral vectors with pH-buffering capacity and by the enhanced 
transfection efficiency of many non-viral vectors in the presence of chloroquine.  Chapter 
4 of this thesis evaluates and quantifies the function of pH-buffering components in non-
viral gene delivery vectors, and in Chapter 5, chloroquine and a number of its chemical 
analogues are studied in an effort to define its effects on transfection and to further 
describe the role of pH buffering.  Chapter 6 further explores the role of pH-buffering 
components by examining delivery behavior of analogous vectors with and without 
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intracellular pH-buffering capacity: a cyclodextrin-containing polymer and its imidazole-
terminated variant. 
Chapter 7 reviews current understanding of intracellular barriers to non-viral gene 
delivery in the context of this report’s emphasis on a systems approach to vector 
development.  Chapter 8 offers recommendations for future work. 
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CHAPTER 2: STRUCTURAL EFFECTS OF CARBOHYDRATE-CONTAINING 
POLYCATIONS ON GENE DELIVERY: CYCLODEXTRIN TYPE AND 
FUNCTIONALIZATION† 
 
2.1 Abstract 
 Linear cationic β-cyclodextrin (β-CD)-based polymers can form polyplexes with 
plasmid DNA and transfect cultured cells.  The effectiveness of the gene delivery and the 
cellular toxicity has been related to structural features in these polycations.  Previous β-
CD polycations were prepared from the cocondensation of 6A,6D-dideoxy-6A,6D-diamino-
β-CD monomers with other difunctionalized monomers such as dimethyl suberimidate 
(DMS).  Here, the type of CD and its functionalization are varied by synthesizing 
numerous 3A,3B-dideoxy-3A,3B-diamino-β-and γ-CD monomers.  Both alkyl-and alkoxy-
diamines are prepared in order to vary the nature of the spacing between the CD and the 
primary amines in the monomers.  These diamino-CD-monomers are polymerized with 
DMS to yield amidine-based polycations.  The nature of the spacer between the CD-ring 
and the primary amines of each monomer is found to influence both molecular weight 
and polydispersity of the polycations. When these polycations are used to form 
polyplexes with plasmid DNA, longer alkyl regions between the CD and the charge 
centers in the polycation backbone increase transfection efficiency and toxicity in BHK-
21 cells, while increasing hydrophilicity of the spacer (alkoxy versus alkyl) provides for 
lower toxicity. Further, γ-CD-based polycations are shown to be less toxic than otherwise 
identical β-CD-based polycations.   
                                                 
† Reprinted with permission from Bioconjug. Chem. 2003, 14, 672-678. Copyright 2003 
American Chemical Society. 
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2.2 Introduction 
 Numerous nonviral gene delivery studies are involved in elucidating the 
relationships between vector structure and transfection efficiency by modifying 
promising systems and assaying their performance. This ongoing research has 
demonstrated the significant influence of polycation structure on efficiency of gene 
delivery. Poly-(ethyleneimine)s (PEIs) are a widely studied class of polycations for gene 
delivery. PEI molecular weight has been shown to affect both cytotoxicity and 
transfection efficiency [1,2]. The charge density [1] and degree of branching [3] in the 
PEI backbone also significantly alter transfection efficiency in vitro. Furthermore, 
substituents grafted onto PEI affect the interaction of PEI with DNA as well as PEI/DNA 
polyplex interactions with cells [4-6 and references therein]. Ionenes are another class of 
gene delivery vehicles whose structure has been related to stability of interaction with 
DNA [7] and to transfection efficiency [8]. Structure-function studies have also been 
undertaken with systems based on chitosan [9], polylysine [10], linear 
poly(amidoamine)s [11], polysaccharide-oligoamine conjugates [12], and other vectors. It 
is clear from these reports that minor changes in structure of the gene delivery vehicle 
can have dramatic effects on the gene delivery efficiency and toxicity of the vector.  
 We have prepared families of linear, β-cyclodextrin-containing polycations 
(βCDPs) and have shown that these polymers can be used as gene delivery vectors [13, 
14].  Cyclodextrins (CDs) are cup-shaped molecules formed of cyclic oligomers of 
glucose.  Cyclodextrins comprised of 6, 7, and 8 glucopyranose units are called α-, β-, 
and γ-CD, respectively (β-CD is represented in Figure 2.1).  There are three distinct 
hydroxyls per glucopyranose unit; two secondary carbons and one primary carbon bear 
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these hydroxyls and are labeled C(2), C(3), and C(6), respectively (Figure 2.1). The 
glucopyranose units are denoted alphabetically starting with “A” and proceeding around 
the cyclodextrin ring (Figure 2.1). 
 
 
 
 
Figure 2.1  Representations and labeling of β-cyclodextrin 
 
 
 
 Initial structure-function studies with βCDPs demonstrated the importance of 
intercharge spacing to transfection efficiency and toxicity [14]. Significant effects on 
transfection efficiency were observed when the interamidine distance was reduced by just 
2 Å. Upon the basis of this finding, we initiated a more complete structure-function 
investigation using linear, cyclodextrin-containing polycations. In part 1 of our study, we 
showed that cellular toxicity was related to the distance of the charge center from the 
carbohydrate unit (whether it be a cyclodextrin or trehalose) and that increasing 
polycation hydrophilicity provides decreasing toxicity [15]. Part 2 of our work revealed 
that the type of charge center can dramatically change the delivery efficiency [16]. With 
the βCDPs, amidine charge centers give greater gene delivery than quaternary 
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functionalization at the cyclodextrin, i.e., 3A,3B-dideoxy-3A,3B-diamino-β-and γ-CD, as 
compared to the previously used 6A,6D-dideoxy-6A,6D-diamino-β-CD, to prepare a 
distinct series of linear, cyclodextrin-containing polycations. Additionally, we report the 
effects of spacer length between the cyclodextrin and the charge center in order to make 
direct comparisons between otherwise identical β-and γ-CD-based polyamidines. The 
polycations were characterized and assayed for plasmid DNA (pDNA) binding, polyplex 
size and ζ-potential, and in vitro transfection efficiency and toxicity.  
 
2.3 Materials and methods  
2.3.1 Polycation synthesis 
 β-and γ-cyclodextrins were purchased (Wacker Biochem Corp., Adrian, MI) and 
dried in vacuo at 120 °C overnight before use. Chlorosulfonic acid (Alfa Aesar; Ward 
Hill, MA) was distilled before use. Dimethyl suberimidate‚ 2HCl (DMS) was purchased 
from Pierce Endogen (Rockford, IL) and used without further purification. All other 
reagents were obtained from commercial suppliers and were used as received. Ion-
exchange chromatography was run on a Toyopearl SP-650M (TosoHaas; 
Montgomeryville, PA) column (NH4+ form), and products were eluted with aqueous 
ammonium bicarbonate up to 0.4 M. Thin-layer chromatography was performed on Silica 
Gel 60 F 254 plates (EM Separations Technology; Gibbstown, NJ), and the amino 
compounds were eluted with 5:3:3:1 n-PrOH:AcOEt:H2O:NH3(aq) and visualized by 
reaction with ninhydrin. Matrix-assisted, laser desorption/ionization time-of-flight mass 
spectroscopy (MALDI-TOF-MS) was performed on a PerSeptive Biosystems Voyager 
DE PRO BioSpectrometry Workstation in the positive ion mode using a 2,5-
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dihydroxybenzoic acid matrix. NMR spectra were recorded on a Bruker AMX500 
spectrometer as dilute solutions of either D2O or DMSO-d6. Dialysis was conducted with 
a 3500 molecular weight cutoff regenerated cellulose dialysis cassette (Pierce Endogen). 
 Synthesis of benzophenone-3,3′-disulfonyl chloride (Scheme 2.1, “1”). 
Benzophenone (26.06 g, 0.143 mol) was added in small portions to 190 mL (2.86 mol) of 
freshly distilled chlorosulfonic acid under an argon atmosphere. The solution was then 
heated to 120 °C with reflux. After 20 h at 120 °C, the cooled solution was added slowly 
to about 1000 g of ice in a 2 L Erlenmeyer flask. The slurry was poured into a separatory 
funnel, then extracted with chloroform (350 mL, then 300 mL) and washed with saturated 
NaHCO3 (200 mL), water (200 mL), and saturated NaCl (200 mL, twice). The 
chloroform was removed under reduced pressure. The yellow solid obtained was 
recrystallized twice from chloroform/hexanes. First-crop yielded 30 g of off-white 
crystals; second-crop yielded 5.4 g. (65% yield). Anal. (C13H8Cl2O5S2) C, H, Cl, S. 
 
 
Scheme 2.1  Synthesis of benzophenone-3,3’-disulfonyl chloride 
 
 Synthesis of benzophenone-3,3′-disulfonyl imidazole (Scheme 2.1, “2”).  
Benzophenone-3,3′-disulfonyl chloride (13 g, 34.3 mmol) was dissolved in 150 mL of 
chloroform. Imidazole (4.95 g, 72.7 mmol) and Et3N (10.2 mL, 73.2 mmol) were added. 
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After 30 min of stirring, 50 mL of dichloromethane was added to the slurry and allowed 
to stir for an additional 30 min. About 200 mL of dichloromethane was required to 
homogenize the reaction slurry, which was then washed with water (200 mL, twice) and 
dried with sodium sulfate. Benzophenone-3,3′-disulfonyl imidazole was recrystallized 
from dichloromethane/ethyl acetate giving 13.9 g of colorless needles (92% yield). Anal. 
(C19H14N4O5S2) C, H, N, S. NMR data were in agreement with published chemical shifts 
[17].  
 Synthesis of cyclodextrin polycations (Scheme 2.2, “6a-d” and “7a-d”). Syntheses 
of 2A,2B-disulfonated β-cyclodextrin (3a) [17] and 2A,2B-disulfonated γ-cyclodextrin (3b) 
[18] were carried out according to literature methods. NMR and mass spectra data were 
in agreement with published values [17, 18]. 
 Syntheses of 3A,3B-di(aminoalkylamino)-β- and 3A,3B-bis(aminoalkoxyamino)- γ-
cyclodextrins (Scheme 2.2, “4a-d” and “5a-d”) were carried out as exemplified by the 
following procedure:  Synthesis of 5c.  Hexamethylenediamine (5.89 g, 50.7 mmol) was 
dissolved in 35 mL of degassed water. 3b (1.50 g, 0.88 mmol) was added at once and 
stirred at 37 °C under nitrogen for 19 h.  The reaction was further carried out at 70 °C for 
3 h then concentrated under reduced pressure.  Cyclodextrins were precipitated with 11:1 
ace-tone:methanol and collected by filtration. Ion-exchange chromatography yielded the 
pure product (855 mg, 54% yield). MALDI-TOF-MS [M+H]+) 1493.7. 
 The polycations were prepared as exemplified by the following procedure:  
Synthesis of 7c. 5c (100 mg, 54.7 µmol) and DMS (15.5 mg, 56.7 µmol) were taken up in 
108 µL of 0.5M Na2CO3 and stirred for 13 h. Acidification with 1 N HCl to pH 2.0 
followed by exhaustive dialysis yielded 58.4 mg of a white powder (56% yield).  
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Scheme 2.2  Synthesis of cyclodextrin polycations 
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2.3.2 Light scattering and molecular weight determination 
 The specific refractive index (RI) increment, dn/dc, of each polycation was 
determined by fitting a linear curve to plots of RI versus concentration (five data points 
per polycation). Polycations were then analyzed on a Hitachi D6000 HPLC system 
equipped with an ERC-7512 RI detector and a Precision Detectors PD2020/DLS light 
scattering detector using a PL aquagel-OH column (Polymer Laboratories, Amherst, 
MA). The eluent was 0.8 M ammonium acetate with 0.05% sodium azide, adjusted to pH 
2.8 with phosphoric acid and flowing at 0.7 mL/min. RI values were measured on a Carl 
Zeiss refractometer (Max Erb Instrument Co., Burbank, CA) in the same eluent as used 
for HPLC analysis. 
 
2.3.3 Plasmid DNA 
 Plasmid pGL3-CV (Promega, Madison, WI) was amplified with the DH5R strain 
of E. coli (Gibco BRL, Gaithersburg, MD) and purified using the Ultra-mobius 1000 kit 
(Novagen; Madison, WI). This plasmid encodes the firefly luciferase gene under control 
of the SV40 promoter.  
 
2.3.4 Polyplex formation and characterization 
 Polyplexes were formulated by adding polycation solutions in dH2O to an equal 
volume of plasmid DNA (pDNA) in dH2O (0.05 mg/mL final pDNA concentration) and 
incubating for 30 min. Desired charge ratios were achieved by using appropriate 
concentrations of polycation solution. Each polycation was examined for its ability to 
bind pDNA through a gel electrophoresis assay using a 0.8% agarose gel (30 µg ethidium 
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bromide/50 mL TAE buffer). Particle size and ζ-potential of polyplexes were analyzed 
using a ZetaPALS instrument (Brookhaven Instruments, Holtsville, NY). 
 
2.3.5 Cell culture and transfections 
 BHK-21 cells were maintained at 37 °C in 5% CO2 atmosphere in Dulbecco’s 
Modified Eagle’s Medium supplemented with 10% fetal bovine serum, 100 U/mL 
penicillin, 0.1 mg/mL streptomycin, and 0.25 µg/mL amphotericin B (Gibco BRL). For 
transfections, cells were seeded at 50000 cells/well in 24-well plates. Trypan blue 
exclusion was used to verify cell viability above 95%. At 1 day, cells were exposed to 
200 µL of serum-free medium containing 1 µg of pGL3-CV plasmid pre-assembled with 
CD-containing polycations at various charge ratios. After 4 h, polyplex solutions were 
removed from the cells and replaced with 1 mL of regular growth medium. For 
measurement of luciferase activity and toxicity, cells were lysed 2 days after transfection 
with 1X Cell Culture Lysis Reagent (Promega). The Luciferase Assay System (Promega) 
was used to measure luciferase activity of cell lysates on a Monolight 2010 luminometer 
(Becton Dickinson Biosciences; San Jose, CA). Total protein content of cell lysates was 
assessed with the DC Protein Assay (Bio-Rad, Hercules, CA) that is a derivative of the 
Lowry assay.  
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2.4 Results 
2.4.1 Polycation synthesis and characterization 
 β-and γ-CDs were selectively difunctionalized through a stapling reaction with 
benzophenone-3,3′-disulfonyl imidazole (Scheme 2.1).  These intermediates react with 
various alkyl- and alkoxy-diamines to yield 3A,3B-bis(aminoalkylamino)-CDs with 
various spacing groups between the carbohydrate ring and the primary amine (Scheme 
2.2).  The difunctionalized amino-CD monomers were polymerized with DMS to give 
polycations with properties shown in Table 2.1.  The choice of CD-comonomer 
influences the polymerization with DMS; polymerization yield increases with distance 
between the cyclodextrin ring and the primary amine on the CD-monomer.  Similar yield 
trends were observed for otherwise identical β-and γ-CD polycations.  CD-monomers 
with fewer than four methylenes between the cyclodextrin and primary amine yielded 
polycations with an average degree of polymerization (DOP) of 5 or 6, while those 
synthesized from monomers with over four spacer methylenes produced an average DOP 
of 7 or 8.  An increase in polydispersity accompanied the increase in polycation length. 
 
 
 
Polycation Polymerization
Yield (%) 
dn/dc 
(mL/g)
Mw (kDa) Mw/Mn Average degree 
of polymerization
6a 32 0.1029 10.0 1.1 6 
6b 44 0.1406 8.1 1.3 5 
6c 61 0.1515 13.9 1.7 8 
6d 74 0.1322 13.0 1.4 7 
7a 32 0.1085 9.3 1.1 5 
7b 47 0.1386 9.6 1.4 5 
7c 56 0.1237 14.7 1.6 8 
7d 58 0.1279 13.3 1.3 7 
 
Table 2.1  Effect of cyclodextrin comonomer structure on polymerization 
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2.4.2 Polyplex formation and characterization 
 To demonstrate polycation interaction with pDNA, polyplexes were formulated 
and run on a 0.8% agarose gel at a range of charge ratios. Polycations 6a and 7a did not 
completely retard DNA below a charge ratio of 1.5, while 6b-d and 7b-d retarded DNA at 
charge ratios of 0.5 and above (Figure 2.2). The diameter of polycation/pDNA polyplexes 
varied between 100 and 150 nm, while the associated ζ-potentials were all found to be 
positive (Table 2.2).  
 
Figure 2.2  Agarose gel electrophoresis of polycation/pDNA complexes 
For each polycation, complexes were formulated at charge ratios (±) of 0, 0.5, 1.0, 1.5, 
2.0, 2.5, and 3.0 and run in order of increasing charge ratio (left to right) on a 0.8% 
agarose gel. 
 
 
Polycation Particle diameter (nm) ζ-potential (mV) 
6a 121.5 ± 1.3 12.5 ± 0.3 
6b 96.4 ± 1.1 6.4 ± 1.1 
6c 107.7 ± 0.9 16.7 ± 1.7 
6d 88.2 ± 6.9 27.7 ± 1.0 
7a 124.1 ± 1.6 23.3 ± 0.5 
7b 118.6 ± 23.9 17.5 ± 3.0 
7c 153.3 ± 1.7 9.6 ± 1.1 
7d 102.9 ± 1.0 30.7 ± 1.4 
 
Table 2.2  Particle sizing and ζ-potential of polycation/pDNA complexes formulated at 
charge ratio of 5± 
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2.4.3 In vitro transfection efficiency 
 In vitro transfection efficiency to BHK-21 cells was assessed in triplicate at 
charge ratios (+/-) of 2, 4, 6, 8, 10, 15, and 20. Lysates of transfected cells were assessed 
for luciferase activity by measuring the relative light units (RLU) normalized by total 
protein content (Figure 2.3). Among the diaminoalkyl-CD analogues, 6a-c and 7a-c, 
increased spacer length produced greater transfection efficiency, with more pronounced 
enhancements between the a and b variants in each series. The diaminoalkoxy-CD 
analogues, 6d and 7d, demonstrated intermediate levels of luciferase expression, below 
that achieved with the b analogues. Generally speaking, the β-CD and γ-CD polycations 
with identical spacers produced similar luciferase gene expression.  
Figure 2.3  Tranfection efficiency as a function of charge ratio for cyclodextrin-
polycation/pDNA complexes 
Complexes were formulated at various charge ratios and exposed to BHK cells in serum-
free medium for 4 h.  48 h after exposure, the cells were assayed for luciferase activity.  
Charge ratio of 0 indicates naked pDNA. 
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2.4.4 In vitro cellular toxicity 
 The total protein content of cell lysates was used as a measure of polyplex and/or 
polycation toxicity (Figures 2.4 and 2.5). The fractional cell survival of transfected cells 
was assessed by comparison to untransfected cells. Among the charge ratios investigated, 
polycations 6a-c and 7a-c demonstrated a marked decrease in cell viability with increased 
spacer length; 6d and 7d were essentially nontoxic at the concentrations employed. For 
the b and c analogues, cell viability decreased with increasing charge ratio and was worse 
for the β-CD polycations than for the γ-CD polycations. The toxicity of each polycation 
was independent of the presence of pDNA, as determined by comparison of polyplex-
transfected cells with those exposed to an equal amount of polycation alone (Figure 2.5).  
 
Figure 2.4  Cell viability to exposure of polycation/pDNA complexes 
Cells were assayed for viability 48 h after exposure to complexes formulated at various 
charge ratios; data were normalized with respect to untreated cells. 
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Figure 2.5  Toxicity comparison of polycation alone and polycation/pDNA complexes 
Cells were exposed to polycation alone or to an equal amount of polycation complexed 
with pDNA; “charge ratio” for polycation alone merely represents amount of polycation. 
Total protein concentrations in cell lysates were used as measure of viability; data were 
normalized using values for untreated cells. 
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2.5 Discussion 
 Previous studies of β-cyclodextrin-containing polycations (βCDPs) have 
demonstrated the importance of polycation structure to cellular toxicity and in vitro 
transfection efficiency. The effect of interamidine distance [14] has been elucidated, as 
has the importance of using a bulky cyclodextrin instead of a smaller carbohydrate such 
as trehalose [15]. Here, we investigated the relevance of cyclodextrin ring size by 
studying otherwise identical series of β-and γ-cyclodextrin polycations. Within each 
series, the length and character of the spacer between the cyclodextrin ring and the 
amidine charge center were varied to understand the importance of these additional 
variables in our system. Such an approach allows the direct evaluation of the effect of 
cyclodextrin-type on in vitro transfection efficiency and cellular toxicity as well as 
providing further insights into the role of charge spacing along the polycationic 
backbone. For in vivo application of the polycations described in this report, 
modifications are required to impart salt and serum stability. Methodologies for 
modifying similar cyclodextrin-based polycations for in vivo use are available in an 
earlier publication [20].  
 The β-and γ-CD-based series of polycations follow remarkably similar trends in 
the DOP. DOP is found to increase with distance between the reactive primary amines of 
the CD-monomers and the cyclodextrins themselves. As the number of methylenes 
between the cyclodextrin and primary amine increases, an increase in DOP is observed 
with an accompanying increase in polydispersity. All polycations shown here have an 
average DOP between 5 and 8, corresponding to an average of 10-16 amidine charge 
centers per polycation chain. Assuming these differences in DOP do not significantly 
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affect polycation performance, a direct correlation may be made between polycation 
structure and the observed performance. 
 Previous work demonstrated that the transfection efficiency and toxicity achieved 
with CD-containing polycations is affected by the presence of cyclodextrins and by the 
alkyl chain length between charge centers [14,15]. Here, it is demonstrated that the 
transfection efficiency and toxicity of a related set of polycations is affected by the 
structure of the spacer separating the CD ring from the charge centers and, to a lesser 
degree, the type of CD used. 
 Diaminoalkyl-CD polycations 6a-c and 7a-c exhibit a marked increase in 
transfection efficiency as the spacer length increases, particularly with the increase from 
2 to 4 methylene units. Dramatic differences between the a and b analogues are observed 
despite only a small change in polycation structure (a 2 Å increase in distance between 
the cyclodextrin and the amidine charge center). A smaller but significant increase in 
transfection efficiency is observed between the b and c analogues. Polycations 6a and 7a 
gave low levels of luciferase expression that gradually increased with increasing charge 
ratio. Optimum expression levels observed with these two polycations were of the same 
order as transfection efficiencies seen with polycations 6b, 6c, 7b, and 7c at the lowest 
charge ratios. Having reached relatively high transfection efficiencies at the lowest 
investigated charge ratios, polycations 6b, 6c, 7b, and 7c did not display the steady and 
marked increase with charge ratio seen with 6a and 7a. Beyond a charge ratio of 6±, only 
7b demonstrated a significant increase in luciferase expression.  
 The least effective polycations, 6a and 7a, are also observed to require the highest 
charge ratio to completely retard pDNA in the electrophoresis assay. Previous work with 
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CD-containing polycations has shown a correlation between relative binding efficiency 
and transfection efficiency [15]. The reduced binding efficiency associated with 
decreased spacer length may result from the bulky cyclodextrins impeding the access of 
polycation amidines to pDNA phosphates.  
 The presence of CDs in the polycation backbone gives a dramatic reduction in 
toxicity of β-CD-containing polycations [13-16]. In part 1 of our study [15], 6A,6D-
dideoxy-6A,6D-diamino-β-CDs were studied, while 3A,3B-dideoxy-3A,3B-diamino-β-
and γ-CDs are investigated here. The transfection and toxicity assays employed in this 
series of papers do not indicate any advantages of functionalization of the CD at the C(3)-
position over functionalization at the C(6)-position. In part 1 it was shown that longer 
spacer lengths between the CD and the charge center result in increased toxicity, which is 
in agreement with the result that polycations 6a-c and 7a-c demonstrate an increase in 
toxicity as the CD-amidine distance is increased. These results suggest that there is a 
toxicity-mitigating influence of the CD on the cationic center, regardless of the site of 
CD-derivatization. The CD may be affecting the interaction of the amidine charge centers 
with intracellular entities through its steric bulk and/or large sphere of hydration and thus 
lowering the toxicity of amidine-containing polycations. The bulkiness of the CD also 
hinders access of polycation amidines to pDNA phosphates. Since CD bulkiness and/or 
sphere of hydration correlate with the trends in both toxicity and transfection efficiency, 
the observation that decreases in toxicity are associated with decreases in transfection 
efficiency and effective pDNA binding strength are self-consistent.  
 The diaminoalkoxy-CD polycations 6d and 7d demonstrate an intermediate level 
of transfection efficiency and insignificant toxicity. Although this polycation pair pro-
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vides the largest spacing between the CD and amidine residues among polycations in this 
study, the hydrophilic nature of the alkoxy spacer likely enlarges the effective hydration 
sphere around the cyclodextrin ring. In addition, the alkoxy spacer has more flexibility 
than alkyl spacers. These factors somehow mitigate the toxicity of polycations 6d and 7d. 
The change in transfection efficiency as a function of charge ratio is also intermediate 
relative to the diaminoalkyl-CD polycations; RLU/mg protein readings with polycations 
6d and 7d rose gradually up to a charge ratio of 6±, above which no increase is observed.  
Each polycation produced measurable luciferase expression above background levels; the 
luciferase activities of untreated cells and cells treated with polycation alone are roughly 
5×103 RLU/mg protein (data not shown), while the luciferase activity of cells treated with 
pDNA alone is roughly 5×104 RLU/mg protein. For comparison, BHK-21 cells were 
transfected with complexes of pDNA formulated with 25 kDa branched polyethylenimine 
or with βCDP6 [14]. Polyethylenimine complexes at an N/P of 5 were found to give 
luciferase activity of 5×109 RLU/mg protein (data not shown). βCDP6 complexes 
produced 2×108 RLU/mg protein at a charge ratio of 10± (data not shown).  
 Here, analogous β-and γ-CD-containing polycations produced similar levels of 
gene expression, with the exception that polycations 6b and 6c outperform their γ-CD-
containing analogues 7b and 7c at charge ratios of two and four; these differences do not 
persist as the charge ratio is increased.  At higher charge ratios, toxicity differences 
between the β-CD-containing polycations 6b and 6c and the γ-CD-containing analogues 
become apparent, with the γ-CD-containing polycations being less toxic. It is again 
interesting to note the correlation between enhanced transfection efficiency and increased 
toxicity.  
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 The peripheral diameter of γ-CD is about 17.5 Å while that of β-CD is about 15.4 
Å [19], highlighting the importance of even small variations in the CD-containing 
polycation system to in vitro performance. Since the polycation backbone goes through 
adjacent sugar residues of the cyclodextrin ring in the case of the β-and γ-CD polycations 
discussed in this report, the linear backbone structure varies minimally between the two. 
However, the remainder of the cyclodextrin-ring, which can be considered pendant to the 
backbone, is certainly larger in the case of γ-over β-CD.  
 Reineke and Davis showed that trehalose-based polyamidines are more toxic than 
those based on β-CD [15]. Here, CD-containing polycations demonstrate an increase in 
toxicity with an increase in distance between the CD and the amidine charge center and 
with a decrease in the size of the CD-ring. Together, these results are consistent with the 
hypothesis that the size of the carbohydrate moiety and its associated sphere of hydration 
(overall increase in hydrophilicity) mitigate the toxicity of the amidine-based polycations.  
 We have described the synthesis and characterization of a family of cyclodextrin-
containing polycations and demonstrated significant and clear effects of polycation 
structure on in vitro gene expression efficiency and cellular toxicity against BHK-21 
cells. The structure of diaminated cyclodextrins was found to influence both the 
molecular weight and polydispersity of polycations resulting from reaction of these 
compounds with dimethyl suberimidate. Longer alkyl regions in the polycation backbone 
increased transfection efficiency and toxicity, while increasing hydrophilicity was 
toxicity-reducing. Further, γ-CD polycations were shown to be less toxic than otherwise 
identical β-CD polycations.  
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CHAPTER 3:  PEGYLATION SIGNIFICANTLY AFFECTS CELLULAR 
UPTAKE AND INTRACELLULAR TRAFFICKING OF NON-VIRAL GENE 
DELIVERY PARTICLES† 
 
3.1 Abstract 
 In vitro studies of non-viral gene delivery vectors are typically not performed at 
physiological conditions, and thus may not provide meaningful results for in vivo 
investigations.  We determine if polycation-plasmid DNA complexes (polyplexes) 
exploited for in vitro studies behave similarly to variants more applicable to in vivo use 
by examining their cellular uptake and trafficking.  Branched polyethylenimine (25 kD) 
or a linear β-cyclodextrin-containing polymer are each used to formulate polyplexes, 
which can be PEGylated (PEG: poly(ethylene glycol)) to create particles stable in 
physiological salt concentrations.  Particle size, cellular uptake, intracellular trafficking, 
and reporter gene expression are reported for polyplexes and for their PEGylated 
variants.  PEGylation confers salt stability to particles but produced a reduction in 
luciferase expression.  Examination of in vitro particle internalization by transmission 
electron microscopy shows unmodified polyplexes entering cells as large aggregates 
while PEGylated particles remain small and discrete, both outside and within cells.  
Unmodified and PEGylated particles enter cells through the endocytic pathway and 
accumulate in a perinuclear region.  Immunolabeling reveals unpackaged exogenous 
DNA in cell cytoplasm and nuclei.  It appears all particle types traffic towards the 
nucleus within vesicles and undergo degradation in vesicles and/or cytoplasm, and 
                                                 
† Reprinted with permission from Euro. J. Cell Biol. 2004, 83, 97-111.  Copyright 2004 Elsevier. 
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eventually some exogenous DNA enters the nucleus, where it is transcribed.  In 
comparing polyplexes and their PEGylated variants, significant differences in particle 
morphology, cellular uptake, and resultant expression suggest that in vitro studies should 
be conducted with particles prepared for physiological conditions if the results are to be 
relevant to in vivo performance. 
 
3.2 Introduction 
 Non-viral gene delivery vectors have the potential to be used in therapeutic 
applications.  These delivery vehicles avoid the DNA size limitations and 
immunogenicity that are possible with viral vectors, and benefit from straightforward 
formulation with easily manufactured, relatively low cost materials.  Cationic lipids and 
cationic polymers are among the broad classes of materials that have shown utility in 
non-viral gene delivery; they both self-assemble with nucleic acids, condensing them to 
an appropriate size for delivery into cells. 
 The discovery of promising candidate vectors, e.g., polyethylenimine (Figure 1a), 
and identification of the various barriers to their use has been followed by more rationally 
designed modifications to existing materials and the development of new lipids and 
polymers.  An example of the latter approach with cationic polymers is a vector 
containing β-cyclodextrin (Figure 1b) that was developed in our laboratories [1,2] and 
reveals extremely low toxicity both in vitro and in vivo. 
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b 
 
Figure 3.1  Non-viral gene delivery vectors 
(a) Branched polyethylenimine, bPEI.   (b) Reaction of difunctionalized β-cyclodextin 
and dimethylsuberimidate to produce a linear, β-cyclodextrin-containing polymer, βCDP. 
 
 
 Polycation-nucleic acid complexes (polyplexes) prepared with polycations such as 
branched polyethylenimine (bPEI) or the β-cyclodextrin-containing polymer (βCDP) 
have been studied extensively in vitro.  These polyplexes bear a positive surface charge 
and aggregate in the presence of physiological salt concentration (150 mM) and/or serum 
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proteins.  Steps to provide salt stabilization and protection against interactions with serum 
proteins are necessary for polyplexes to be applicable for in vivo use.  Thus, non-viral 
gene delivery particles appropriate for in vivo use are significantly different from the 
unmodified polyplexes that are typically employed for in vitro studies.  To prepare non-
viral gene delivery formulations that are stable in the presence of physiological salt 
concentrations, we and others have incorporated hydrophilic polymers such as 
poly(ethylene glycol) (PEG), either before [3-6] or after [3,7] vector complexation with 
the nucleic acid. 
Here, we investigate the physicochemical properties of unmodified polyplexes 
and their PEGylated variants and examine how these particles interact with and traffic in 
cultured cells.  bPEI polyplexes were PEGylated through grafting of a reactive PEG 
molecule to free amine groups [7] while βCDP polyplexes were PEGylated through 
formation of inclusion complexes between a PEG-containing conjugate and the 
cyclodextrin moieties of the polymer [3] (Figure 3.2). 
We monitored the size, zeta potential, and salt stability of these particles, and 
administered them to cultured cells for examination by transmission electron microscopy.  
The particles were further characterized by quantifying uptake of plasmid DNA (pDNA) 
and measuring expression of a delivered reporter gene.  Collectively, these methods 
provide visual and quantitative means to characterize the particles and their interactions 
with cells in vitro.  Our results demonstrate that the PEGylated particles encounter and 
enter cells in a manner distinct from that of unmodified polyplexes.  As such, we suggest 
that the behavior of unmodified polyplexes in vitro will have limited relevance to the 
expected in vivo behavior of their salt-stabilized and physiologically relevant variants.  
 35
Further, our observations suggest a plausible process by which pDNA delivery results in 
measurable gene expression. 
 
 
 
 
 
 
 
a 
 
 
b 
 
 
Figure 3.2  Preparation of PEGylated particles 
Polyplexes were prepared and subsequently PEGylated.  (a) bPEI polyplexes were 
PEGylated through grafting of a succinimidyl propionate (SPA)-PEG5000 conjugate to 
free amines of bPEI [7].  (b) βCDP polyplexes were PEGylated using an adamantane-
PEG5000 conjugate [3].  The terminal adamantane is able to form inclusion complexes 
with β-cyclodextin in the polymer. 
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3.3 Materials and methods 
3.3.1 Polyplex formulation and PEGylation 
 Branched 25 kD polyethylenimine (bPEI) was obtained from Aldrich 
(Milwaukee, WI). The beta-cyclodextrin-containing polymer (βCDP) and an 
adamantane-PEG5000 conjugate (AD-PEG) were synthesized as described previously [3].  
The DNA plasmid pGL3-Control Vector (5256 bp) was obtained from Promega 
(Madison, WI) and amplified by Elim Biopharmaceuticals (Hayward, CA).  Solutions of 
bPEI (0.067 mg/mL in 20 mM HEPES, 5% glucose) [8] and βCDP (1.03 mg/mL in 
dH2O) were prepared, and polyplexes were formulated by adding polycation solution to 
an equal volume of pDNA (0.1 mg/mL in same solution) and incubating at room 
temperature for 30 minutes.  bPEI polyplexes were PEGylated by addition of 4 mg 
methoxy-PEG5000-succinimidyl propionate (Nektar, San Carlos, CA; 20 mg/mL in dH2O) 
per microgram pDNA [7].  βCDP polyplexes were PEGylated by addition of 35 μg AD-
PEG (100 mg/mL in dH2O) per microgram pDNA [3].  Polyplex solutions were left at 
room temperature for an additional 30 minutes following PEGylation. 
 
3.3.2 Particle sizing and zeta potential 
 The particle size and zeta potential of polyplexes were analyzed using a 
ZetaPALS instrument (Brookhaven Instruments, Holtsville, NY).  Polyplex solutions 
were diluted 40X in dH2O immediately before particle sizing and zeta potential 
measurements.  To investigate effects of salt on particle size, measurements were paused 
briefly for the addition of 0.11 volumes of 10X phosphate-buffered saline (PBS) 
(Invitrogen, Carlsbad, CA) such that the final solution contained 1X PBS. 
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3.3.3 Cell culture and transfections 
 BHK-21 cells were maintained at 37°C in 5% CO2 atmosphere in Dulbecco's 
Modified Eagle's Medium supplemented with 10% fetal bovine serum, 100 U/mL 
penicillin, 0.1 mg/mL streptomycin, and 0.25 g/mL amphotericin B (Invitrogen).  
Exclusion of trypan blue (Invitrogen) was used to confirm cell viability above 95%. 
 One day prior to transfection, cells were plated at a density of 5x104 cells/mL in 
6-well plates (electron microscopy, 5 mL/well), Lab-Tek 4-well chambered coverslips 
(Nalge-Nunc, Rochester, NY) (confocal microscopy, 1 mL/well), or 24-well plates (flow 
cytometry and luciferase assay, 1 mL/well).  For transfection, polyplex solutions were 
diluted 10X in pre-warmed Opti-MEM serum-free medium (Invitrogen).  The entire 
volume of regular medium was aspirated from the cells and replaced with one-fifth that 
volume of polyplex-containing serum-free medium (5 μg DNA/mL).  For sample 
timepoints beyond four hours, the polyplex-containing medium was aspirated at four 
hours and replaced with regular growth medium equal to the original volume. 
 
3.3.4 Transmission electron microscopy 
 At increasing timepoints after transfection, the medium was aspirated and the 
cells were rinsed with PBS.  Cells were fixed with 2% glutaraldehyde in 100 mM sodium 
cacodylate with 2% sucrose, collected by scraping, and pelleted by centrifugation.  Cell 
pellets were post-fixed in osmium tetroxide, dehydrated in ethanol, and embedded in 
Epon-Spurr resin.  Thin sections were prepared on an Ultracut S ultramicrotome (Leica 
Microsystems, Deerfield, IL), contrasted with uranyl acetate and lead citrate, and imaged 
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on a BioTwin CM120 transmission election microscope (FEI, Hillsboro, OR) operating at 
80 kV. 
 
3.3.5 Flow cytometry and luciferase assay 
 For flow cytometry, pDNA was labeled prior to polyplex formation with YOYO-
1 (Molecular Probes, Eugene, OR) at a density of 1 dye molecule per 100 bp DNA.  
Labeled polyplexes were used to transfect cells as described, and four hours after 
transfection, the polyplex-containing medium was aspirated and the cells were collected 
using trypsin-EDTA (Invitrogen).  Cells were washed (10 U/mL DNase, 3 mM MgCl2 in 
Hank’s buffered saline solution (HBSS)), suspended in propidium iodide-containing 
buffer (HBSS, 2.5 mg/mL bovine serum albumin, 0.01 mg/mL propidium iodide), and 
analyzed on a FACScalibur instrument (Becton Dickinson, Franklin Lakes, NJ) with a 
488 nm excitation line.  Samples were initially gated by forward and side scatter, and 
viable cells were assayed for YOYO-1 fluorescence.  Luciferase assays were conducted 
in triplicate, 48 hours after transfection, as previously described [9]. 
 
3.3.6 Rhodamine labeling of polymer termini 
 βCDP and tetramethylrhodamine isocyanate (2:1 mole TRITC:βCDP) were dried 
under vacuum for 30 min. in a flask wrapped with aluminum foil.  DMSO was added 
under argon and the mixture was stirred for 30 min. at room temperature.  EDC (1:1) and 
NHS (1:1) were added to the solution, which was kept in dark and under argon for 24 h 
and then dialyzed against water for 72 h in a Spectra/Pro 7 10,000 MWCO membrane 
(Fisher Scientific, Hampton, NH) in an aluminum-foiled 4 L beaker.  Water was changed 
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6-8 times until it acquired no color with prolonged dialysis, after which the polymer 
solution was lyophilized to yield a red, dry solid. 
 
3.3.7 Confocal microscopy 
 For laser scanning confocal microscopy, pDNA was labeled prior to polyplex 
formation with YOYO-1 at a density of 1 dye molecule per 100 bp DNA.  Polyplexes 
were formulated with unlabeled or rhodamine-labeled βCDP and administered to cells.  
At selected timepoints after transfection, cells were rinsed with PBS and fixed with 4% 
formaldehyde in 100 mM HEPES.  After 15 minutes, the fixative was removed; the cells 
were rinsed twice with PBS, and left in a third PBS wash.  Microscopy was conducted at 
the Caltech Biological Imaging Center using a Zeiss 410 laser scanning confocal 
microscope set up from an inverted Axiophot microscope.  Excitation wavelengths of 488 
nm and 568 nm were used for YOYO-1 and rhodamine, respectively.  YOYO-1 was 
detected with a 515-540 nm band pass filter and rhodamine was detected with a 580-620 
nm band pass filter.  The labeled polyplexes’ fluorescence properties were verified with a 
fluorimeter system (Photon Technology International, Monmouth Junction, NJ). 
 
3.3.8 Post-embedding immunolabeling experiments with electron microscopy 
 For immunolabeling experiments, pDNA was labeled with the LabelIT biotin-
labeling kit (Mirus, Madison, WI) at a density of roughly 10 labels per plasmid and 
purified by ethanol precipitation.  Polyplexes were formulated with βCDP and 
administered to cells.  At desired timepoints after transfection, the medium was aspirated 
and the cells were rinsed with PBS.  Cells were fixed with 4% formaldehyde in 200 mM 
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HEPES, collected by scraping, and pelleted by centrifugation.  Cell pellets were 
infiltrated in 2.3 M sucrose, frozen by immersion in liquid nitrogen, freeze substituted at  
-80°C with dry methanol, and embedded at -50°C in Lowicryl HM20 resin (Electron 
Microscopy Sciences, Fort Washington, PA).  Thin sections were prepared on an Ultracut 
S ultramicrotome and immunolabled with a mouse anti-biotin primary antibody (Sigma, 
St. Louis, MO), a rabbit anti-mouse secondary antibody (Organon Technika, Durham, 
NC), and colloidal gold (10 nm)-labeled protein A (University of Utrecht, The 
Netherlands).  1X PBS containing 10% fetal calf serum was used as the blocking 
solution, and immunolabeled sections were contrasted with uranyl acetate and lead citrate 
and imaged on a BioTwin CM120 transmission election microscope operating at 80 kV.  
Immunolabeling of control samples prepared without biotin-labeled pDNA was used to 
determine appropriate concentrations for antibody and colloidal gold labeling.  An 
iterative process was used to minimize background labeling from gold-labeled protein A 
alone, the secondary antibody and gold-labeled protein A together, and finally both 
antibodies and gold-labeled protein A together. 
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3.4 Results 
3.4.1 PEGylation confers salt stability to polyplexes 
 bPEI polyplexes were prepared at an N/P ratio of 5/1 and PEGylated by 
subsequent addition of a 10:1 weight:weight ratio of methoxy-PEG5000-SPA (methoxy -
PEG5000-SPA:bPEI).  βCDP polyplexes were prepared at an N/P ratio of 5/1 and 
PEGylated by subsequent addition of a 1:1 mol ratio of AD-PEG5000 
(adamantane:cyclodextrin).  Dynamic light scattering was used to monitor the size and 
salt stability of the particles (Figure 3.3).  When diluted in water, both bPEI and βCDP 
polyplexes are roughly 100 nm in size.  The PEGylated particles show a slightly higher 
diameter (ca. 110 nm) than the polyplexes.  Upon addition of 0.1 volume 10X phosphate-
buffered saline (PBS), the measured size of the unmodified polyplexes steadily increased, 
indicating aggregation of polyplexes.  The PEGylated particles did not aggregate in the 
presence of PBS; thus, the PEGylation methods employed here conferred salt stability to 
the particles.  Both unmodified and PEGylated polyplexes had positive zeta potentials in 
dH2O; bPEI polyplexes showed a more significant reduction in surface charge upon 
PEGylation than did βCDP polyplexes (Figure 3.4). 
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Figure 3.3  Particle sizing by dynamic light scattering 
Dynamic light scattering was used to assess polyplex size.  After initial dilution in water, 
unmodified polyplexes were observed to be slightly smaller than their PEGylated 
variants.  After 2 minutes, measurements were paused for addition of 0.11 volumes 10X 
phosphate-buffered saline (PBS).  The aggregation of unmodified polyplexes in 150 mM 
salt was observed as a steady increase in polyplex size.  The size of PEGylated 
polyplexes remained stable in salt.  bPEI polyplexes (?), PEGylated bPEI particles (?), 
βCDP polyplexes (?), PEGylated βCDP particles (?). 
 
 
 
Figure 3.4  Zeta potential of polyplexes 
The surface charge of polyplexes was measured using a phase analysis light scattering 
instrument.  PEGylation produced only a slight decrease in the zeta potential of 
polyplexes.  Samples run in triplicate. Error bar for PEGylated βCDP particles is too 
small to be observable in this figure. 
 43
3.4.2 Electron microscopy shows distinctive particles entering and within cells 
 Particle interactions with and uptake by cultured cells were visualized using 
transmission electron microscopy.  Intact polyplexes were easily identifiable by 
comparison with control samples.  Unmodified polyplexes were seen as irregular 
aggregates roughly 300-500 nm in diameter.  The 100-nm polyplexes observed by light 
scattering in water are likely the rounded components in some of the aggregates.  In 
contrast, PEGylated particles were visualized as discrete, individual entities on the order 
of 100 nm in diameter, consistent with the size observed by light scattering. 
 Aggregates of unmodified polyplexes were found to be associated with cell 
surfaces, and invaginations of cell surfaces often conformed to these polyplex aggregates 
(Figures 3.5a-3.5b, 3.6a-3.6c).  Also, the cell membrane often appeared noticeably 
thicker and darker in the immediate proximity of the polyplexes, a possible indication of 
clathrin accumulation on the cytoplasmic face of the cell membrane.  Polyplexes were 
observed intracellularly as large aggregates, and as the time between the initial exposure 
to polyplexes and the cells’ fixation was increased from 0.5 to 24 hours, an increasing 
number of polyplex aggregates appeared in the vicinity of the cell nucleus. 
Most intracellular, polyplex-containing vesicles conformed to the aggregates’ 
shape and contained little to no void space beyond that occupied by the aggregates 
(Figures 3.5c-3.5f, 3.6d-3.6i).  The increasing size of the aggregates closer to the nucleus 
suggested an aggregation of polyplex aggregates was occurring.  These TEM 
observations of polyplex aggregates are similar to those reported for lipopolyamine-DNA 
complexes administered to cells [10]. 
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Figure 3.5  TEMs of bPEI polyplexes 
BHK-21 cells were exposed to bPEI polyplexes and prepared for TEM imaging.  
Polyplexes appear as large aggregates and are seen associated with cell membranes, often 
directly with invaginations of these cell membranes (a-b).  The cytoplasmic face of these 
membranes often appeared thicker and darker near the polyplexes, possibly indicating 
clathrin accumulation (a-b).  The large aggregates proceed into cells in large vesicles that 
conform to the shape of the aggregates (c-d).  At later times, polyplexes are more 
commonly found in the periphery of the cell nucleus and some are observed in the 
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cytoplasm without surrounding membranes (e-g).  Also, the structure of some aggregates 
appears to be degrading (h-i).  Bars, 200 nm.  Cell nucleus, nu. 
 
 
 
 
 
Intact membranes were not observed to surround all intracellular polyplex 
aggregates.  In some cases, the surrounding cytoplasm extended directly to the observed 
aggregates (Figures 3.5f, 3.6k-3.6m), whereas in other cases the aggregates bordered void 
spaces (Figures 3.5g, 3.6j-3.6k, 3.6n).  Intact polyplexes or their aggregates were not 
observed within any cell nucleus.  Some polyplexes appeared to be disassembling, with 
less distinct and defined borders than most aggregates (Figures 3.5g-3.5i, 3.6q-3.6r).  
These degrading polyplexes were found more commonly within vesicles than free in 
cytoplasm. 
PEGylated bPEI particles consistently appeared as discrete, individual particles 
roughly 100 nm in diameter.  Extracellularly, these particles were primarily distributed 
irregularly across small stretches of cell membranes.  Individual particles could be seen in 
invaginations of the membrane or in small vesicles in the immediate vicinity of the 
membrane (Figures 3.7a-3.7d).  Moving away from the cell membrane towards the 
nucleus, larger vesicles distributed in the cytoplasm contained increasing numbers of the 
distinct, identifiable particles (Figures 3.7e-3.7i).  The vesicles had variable diameters 
and enclosed moderate numbers of individual particles that were packed loosely together.  
As with the unmodified polyplexes, some PEGylated bPEI particles were not contained 
within vesicle membranes (Figures 3.7l-3.7n, 3.7p-3.7r).  Again, the surrounding 
cytoplasm at times extended directly to the observed particles.  No PEGylated bPEI 
particles were observed within a cell nucleus. 
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Figure 3.6  TEMs of βCDP polyplexes 
BHK-21 cells were exposed to βCDP polyplexes and prepared for TEM imaging.  The 
results were similar to those obtained with bPEI polyplexes. βCDP polyplexes appear as 
large aggregates and are seen associated with cell membranes, often directly with 
invaginations of these cell membranes (a-c).  The cytoplasmic face of these membranes 
often appeared thicker and darker near the polyplexes, possibly indicating clathrin 
accumulation (a-c).  The aggregates proceed into cells in large vesicles that conform to 
the aggregates’ shape (d-i).  Some membranes do not fully surround the polyplexes (h-i).
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(Figure 3.6, continued) At later times, many polyplexes are observed in the cytoplasm 
without surrounding membranes (j-n).  The cytoplasm appears to contact the polyplexes 
in some cases, whereas in others there is a void space between the polyplexes and the 
surrounding cytoplasm.  Later timepoints show an accumulation of polyplexes in a 
perinuclear region (o-p).  As with bPEI polyplexes, some βCDP polyplexes appear to be 
undergoing degradation (q-r).  Bars for (a-i), 200 nm.  Bars for (j-r), 500 nm.  Cell 
nucleus, nu. 
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Figure 3.7  TEMs of PEGylated bPEI particles 
PEGylated bPEI particles appear as small, discrete entities roughly 100 nm in diameter.  
Individual particles are distributed unevenly across small stretches of cell membranes and 
occasionally can be seen in invaginations of the membrane or in small vesicles in the 
immediate vicinity of the membrane (a-d).  Most intracellular PEGylated bPEI particles 
are contained within circular vesicles in moderate numbers and continue to appear as
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(Figure 3.7, continued) distinct, individual particles (e-i).  At later times, large vesicles 
filled with these PEGylated particles collect in a perinuclear location (g-h).  Bars for (a-i), 
500 nm.  The particles fill many vesicles near the cell nucleus, while other vesicles 
contain smaller numbers of particles or contain particles of more irregular appearance (j-
o).  In some cases, collections of particles are seen in the absence of surrounding 
membranes (j-l, p-r).  Bars for (j-r), 500 nm.  Cell nucleus, nu. 
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In contrast to the PEGylated bPEI particles, PEGylated βCDP particles have not 
been identified within cells.  Beyond the absence of polyplexes, untransfected cells and 
cells exposed to either pDNA alone or βCDP alone appeared identical to transfected 
cells. 
 
3.4.3 Volume density analysis confirms accumulation of polyplexes in cells 
 To verify the apparent accumulation of polyplexes in cells, volume density 
analysis [11] was undertaken for βCDP polyplexes.  A lattice was overlaid on a randomly 
collected sampling of images, and the fraction of vertices on polyplexes was compared 
with the fraction of vertices on cell cytoplasm.  This process was repeated for cells fixed 
at four different timepoints.  The results showed a linear increase over time in the 
intracellular space occupied by βCDP polyplexes (Figure 3.8). 
 
Figure 3.8  Volume density estimate for βCDP polyplexes 
The intracellular space occupied by βCDP polyplexes in electron micrographs is seen to 
increase as the time after the initial exposure of cells to polyplexes increases.  Data were 
collected from 21 micrographs for each timepoint. 
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3.4.4 Flow cytometry provides a measure of pDNA uptake 
 Flow cytometry analysis provided a relative measure of pDNA uptake to cells 
(Figure 3.9).  Delivery of YOYO-1-labeled pDNA by bPEI or βCDP increased the mean 
cellular fluorescence by two orders of magnitude above untransfected or non-complexed 
pDNA controls.  PEGylation of bPEI particles did not inhibit their uptake, as the mean 
fluorescence of transfected cells was slightly greater than that obtained with the 
unPEGylated counterpart.  The PEGylated βCDP particles, however, showed 
significantly reduced uptake relative to the unmodified βCDP polyplexes; the mean 
fluoresence of transfected cells was only one order of magnitude above that of the 
controls.  Rather than indicating reduced uptake from every cell, the reduced mean 
cellular fluorescence results from a sharp drop in the number of cells exhibiting the 
highest levels of pDNA uptake. 
 
Figure 3.9  Uptake of fluorescently labeled DNA by flow cytometry 
Plasmid DNA labeled with YOYO-1 was administered to cells using various means.  
Four hours after initial exposure, cells were collected, washed, and analyzed for YOYO-1 
fluorescence by flow cytometry.  Untransfected cells (a) and cells treated with naked 
DNA (b) have low levels of fluorescence. bPEI polyplexes (c) and PEGylated bPEI 
particles (d) both deliver significant amounts of pDNA to cells.  PEGylated βCDP 
particles (f) show markedly less uptake than pDNA complexed to βCDP (e).  Number 
indicates mean fluorescence.  Samples are for duplicate measurements. 
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3.4.5 PEGylation of polyplexes reduces expression of a delivered reporter gene 
 The DNA plasmid pGL3-Control Vector expresses firefly luciferase under the 
control of the SV40 promoter.  In vitro transfections with this plasmid showed that 
polyplexes prepared with bPEI or βCDP produced luciferase expression levels 2-3 orders 
of magnitude above that achieved by pDNA alone (Figure 3.10).  Both types of 
PEGylated particles produced expression levels less than 1 order of magnitude greater 
than levels produced by pDNA alone. 
 
Figure 3.10  Assay for expression of delivered reporter gene 
pDNA encoding the gene for firefly luciferase was administered to BHK-21 cells.  The 
naked pDNA, polyplexes, or PEGylated polyplexes were exposed to cells for 4 hours in 
serum-free medium, after which the polyplex solutions were replaced with regular 
medium.  Two days after transfection, cells were lysed and cell lysates were assayed for 
luciferase activity.  Polyplexes produce significant levels of luciferase expression, but 
PEGylation of polyplexes reduces the observed luciferase activity nearly to the level 
achieved with naked pDNA. 
 53
3.4.6 Confocal microscopy indicates most pDNA remains associated with βCDP 
 Laser scanning confocal microscopy was used to visualize delivery of βCDP 
polyplexes (Figure 3.11).  In samples containing YOYO-1-labeled pDNA and unlabeled 
βCDP, YOYO-1-labeled DNA was easily identifiable, distributed in a punctate manner 
on or within cells. In samples containing rhodamine-labeled βCDP and YOYO-1-labeled 
pDNA, the rhodamine signal appeared in a punctate pattern as observed for YOYO-1-
labeled pDNA in the previous samples.  However, there was no discernible YOYO-1 
signal. 
Examination of complexes on a fluorimeter indicated that the YOYO-1 signal is 
quenched in complexes formed between YOYO-1-labeled pDNA and the rhodamine-
labeled βCDP (Figure 3.12).  Dissociation of complexes by addition of sodium dodecyl 
sulfate restored the YOYO-1 signal, indicating that the YOYO-1 signal should be seen 
for unpackaged, labeled pDNA within cells. 
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Figure 3.11  Confocal microscopy images 
BHK-21 cells were exposed to βCDP polyplexes and examined by laser scanning 
confocal microscopy.  Left, Ex=488 nm and Em=515-540 nm.  Center, Ex=568 nm and 
Em=580-620 nm.  Right, brightfield image.  For YOYO-1-labeled pDNA and unlabeled 
βCDP (a), a punctate YOYO-1 signal is visible in cells.  For YOYO-1-labeled pDNA and 
rhodamine-labeled βCDP (b), the YOYO-1 signal is no longer visible and a punctate 
rhodamine signal appears.  For unlabeled pDNA and rhodamine-labeled βCDP (c), a 
punctate rhodamine signal appears as in the previous sample.  Diffuse cytoplasmic 
staining in rhodamine channel indicates free rhodamine-labeled βCDP.  Bars, 10 μm. 
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Figure 3.12  Fluorescence of labeled polyplexes 
βCDP polyplexes were formulated by adding either unlabeled βCDP or rhodamine-
labeled βCDP to either unlabeled pDNA or YOYO-1-labeled pDNA.  The polyplexes 
were examined on a fluorimeter using an excitation wavelength of 488 nm.  In water, 
singly-labeled polyplexes display expected emission spectra, but the YOYO-1 
fluorescence is quenched in doubly-labeled polyplexes (a).  Dissociation of doubly-
labeled polyplexes by addition of an equal volume of 1% sodium dodecyl sulfate restored 
the fluorescence of the YOYO-1-labeled pDNA (b).  Unlabeled βCDP + YOYO-1-
labeled pDNA (short dashes), rhodamine labeled βCDP + unlabeled pDNA (long 
dashes), rhodamine-labeled βCDP + YOYO-1-labeled pDNA (solid line). 
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3.4.7 Unpackaged intracellular pDNA can be visualized with immunolabeling 
 Examination of immunolabeled sections successfully demonstrated the presence 
of intracellular pDNA not contained in βCDP polyplexes.  In cells transfected with 
biotin-labeled pDNA complexed with βCDP, polyplexes were consistently labeled with 
numerous gold particles, indicating successful immunolabeling of biotin in polyplexes 
(Figures 3.13a-3.13d).  Clusters of roughly 5-10 gold particles were also seen outside of 
polyplexes in some cells (Figures 3.13c-3.13g).  Most often circular in arrangement, gold 
clusters in the cytoplasm did not display an obvious distribution relative to the cell 
membrane or nucleus.  In a few cells, gold clusters were found in the nucleus (Figure 
3.13g).  Neither gold clusters nor gold-labeled polyplexes were observed in samples 
transfected with unlabeled pDNA complexed with βCDP; similarly, cells transfected with 
biotinylated pDNA and βCDP showed no colloidal gold labeling when incubated with 
only secondary antibody and gold-labeled protein A (not shown).  These controls suggest 
that the gold clusters and the prominent labeling of polyplexes indicate specific labeling 
of biotin. 
 
 
 
 
 
 
 
 
Figure 3.13  Visualization of intracellular pDNA by immunolabeling 
Biotin-labeled pDNA was delivered to cells by means of βCDP polyplexes.  TEM sample 
preparation included anti-biotin immunolabeling with colloidal gold.  Polyplexes are
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(Figure 3.13, continued) consistently labeled with numerous gold particles (a-d).  In 
addition, some cells contain clusters of colloidal gold outside of polyplexes (c-g, arrows), 
an indication of intracellular pDNA that has unpackaged from polyplexes.  A few of the 
intracellular gold clusters are within a cell nucleus (g).  Equivalently immunolabeled 
samples that had been transfected with βCDP polyplexes containing unlabeled pDNA do 
not show colloidal gold labeling of polyplexes or colloidal gold clustering (not shown). 
Bars, 500 nm.  Cytoplasm, cy; nuclear envelope, en; cell nucleus, nu. 
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3.5 Discussion 
Exposure to physiological salt concentrations transforms unmodified polyplexes 
with diameters of 100 nm into 300-500 nm-wide aggregates.  This aggregation process 
takes place in solution, before polyplexes enter cells. Thus, it is likely that unmodified 
polyplexes transfect adherent cells more successfully than suspension cells in vitro 
because the aggregates of unmodified polyplexes can simply sediment onto adherent cells 
[8,12,13], a scenario far removed from that which polyplexes would encounter in vivo. 
Modification with PEG is an effective means of stabilizing polyplexes against 
physiological salt.  PEGylated particles are only slightly larger than their unmodified 
variants, and as expected, retain a small positive zeta potential that is reduced from the 
higher values obtained with polyplexes.  This surface charge can be controlled with 
additional components [3].  Consistent with published results, flow cytometry did not 
show uptake inhibition of bPEI polyplexes PEGylated with a 10/1 (w/w) PEG/PEI ratio 
[14].  The similar levels of uptake between unmodified and PEGylated bPEI complexes 
are interesting given the fact that the cells are clearly encountering particles of quite 
different size, surface coating, and morphology. 
The difference in uptake inhibition between bPEI and βCDP polyplexes cannot be 
explained by differences in the surface charge of the PEGylated variants, as PEGylated 
bPEI particles were observed to have a lower zeta potential than PEGylated βCDP 
particles.  The flow cytometry data suggest that PEGylation inhibits the uptake of βCDP 
polyplexes, but this reduction in uptake is not sufficient to explain our inability to 
observe intracellular PEGylated βCDP particles by TEM.  Intracellular particles are 
clearly observed by confocal microscopy (not shown).  Thus, it is likely that PEGylated 
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βCDP particles are not revealed by - or are disassociated by - the staining techniques 
employed here for electron microscopy. 
 Association of gene delivery particles with clathrin-like structures, visualization 
of intracellular particles contained in vesicles, and gradual progression of particles 
towards a perinuclear location together confirm that polyplexes enter cells by and 
proceed through the endocytic pathway.  As they approach the cell nucleus, polyplex 
aggregates appear to grow in size, while vesicles containing PEGylated bPEI particles 
show increasing numbers of particles.  These observations suggest that multiple polyplex-
containing or particle-containing vesicles fuse to concentrate the polyplexes in 
perinuclear vesicles. 
Using confocal microscopy, Sonawane et al. recently indicated that intact bPEI 
polyplexes are released from endosomes but are unlikely to be transported into the cell 
nucleus [15].  Here, electron microscopy results show that bPEI polyplexes, βCDP 
polyplexes, and PEGylated bPEI particles are all found free in the cytoplasm (Figures 
3.5f-3.5g, 3.6j-3.6k, 3.6m-3.6n, 3.7l-3.7n, 3.7p-3.7r) and are not found as intact entities in 
cell nuclei.  The significant levels of gene expression achieved with unmodified 
polyplexes indicate that some pDNA reaches the site of transcription, i.e., the cell 
nucleus.  Thus, some degree of pDNA-polycation dissociation occurs before the pDNA is 
transcribed.  Our observations of intracellular polyplexes that appear to be in the process 
of disassembly (Figures 3.5g-3.5i, 3.6q-3.6r) and of unpackaged pDNA in the cytoplasm 
(Figures 3.13c-3.13f) demonstrate that the dissociation can occur prior to pDNA entering 
the nucleus. 
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Post-embedding immunolabeling with colloidal gold is a proven means of 
visualizing intracellular biotin-labeled nucleic acids [16]; this technique was successfully 
used here to visualize unpackaged intracellular and intranuclear pDNA.  The 
demonstration of βCDP polyplex dissociation outside of the cell nucleus raises the 
question of how the pDNA is eventually delivered to the nucleus.  Diffusion of pDNA in 
cytoplasm is severely restricted [17,18].  Nuclear delivery may occur through events 
associated with cell division [19-22] or through pDNA association in cytoplasm with 
newly synthesized proteins that are bound for the nucleus [23-26].  Confocal microscopy 
of βCDP samples did not reveal pDNA that was not associated with the polymer, and in 
the immunolabeling experiments, gold clusters appeared only infrequently in the cell 
nucleus.  Thus, we believe that despite the measurable levels of gene expression, only 
small amounts of pDNA - below our detection limit by confocal microscopy - are 
delivered to the cell nucleus by transfections with βCDP. 
PEGylation led to significantly reduced expression of the luciferase reporter gene 
with both polycations.  For the case of βCDP polyplexes, at least part of the loss in 
expression may be attributable to the reduced uptake of the PEGylated variants.  With 
either polycation, PEGylation does not reduce the level of uptake or the level of 
luciferase expression to that of pDNA alone.  For bPEI polyplexes, the severe reduction 
in luciferase expression with PEGylation occurred despite similar levels of pDNA uptake 
to cells.  PEGylation and/or reaction to primary amines on the surface of bPEI polyplexes 
may impair the “proton sponge” effect [15,27], a significant factor in the effectiveness of 
bPEI as a delivery vector.  For both bPEI and βCDP, unmodified polyplexes may escape 
from intracellular vesicles more readily because of the manner in which aggregated 
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polyplexes fill vesicles and contort their membranes.  In contrast, vesicles containing 
PEGylated bPEI particles are generally smooth and circular in appearance, even as the 
vesicles contain increasing numbers of particles.  Finally, the observation of PEGylated 
bPEI particles as small, discrete entities within intracellular vesicles indicates that 
PEGylation confers stability to these particles even intracellularly.  The reduction in 
luciferase expression might also result if the PEGylation stability is associated with a 
reduction in intracellular DNA unpackaging from polyplexes. 
The development of non-viral gene delivery vectors for therapeutic applications 
must take into account the vectors’ eventual exposure to physiological environments.  
PEGylation is a common and effective means of conferring salt stability to polyplexes.  
However, as shown here, unmodified polyplexes and PEGylated particles encounter cells 
as substantially different entities and behave differently upon cell entry.  Thus, in vitro 
characterizations of unmodified polyplexes likely provide limited conclusions about in 
vivo performance of the PEGylated variants.  Such in vitro studies will carry more 
significance if the materials examined have physiological relevance.  Further, in vivo 
application of non-viral vectors will require particles that are stable against physiological 
salt and serum concentrations and are specifically targeted.  Given the results presented 
here, it is worthwhile to consider if particle alterations necessary to meet in vivo 
requirements also significantly impact in vitro performance.  In summary, our 
observations suggest the need for further investigation of the intracellular mechanisms of 
gene delivery with particles that are appropriately modified for in vivo application. 
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CHAPTER 4: SINGLE CELL KINETICS OF INTRACELLULAR, NON-VIRAL, 
NUCLEIC ACID DELIVERY VEHICLE ACIDIFICATION AND 
TRAFFICKING† 
 
4.1 Abstract 
 Mechanistic understanding of the intracellular trafficking of non-viral nucleic acid 
delivery vehicles remains elusive.  A live, single cell-based assay is described here that is 
used to investigate and quantitate the spatiotemporal, intracellular pH microenvironment 
of polymeric-based nucleic acid delivery vehicles.  Polycations such as polyethylenimine 
(PEI), poly-L-lysine (PLL), beta-cyclodextrin-containing polymers lacking or possessing 
imidazole termini (CDP or CDP-imid), and cyclodextrin-grafted PEI (CD-PEI) are used 
to deliver an oligonucleotide containing a single fluorophore with two emission lines that 
can be employed to measure the pH.  Delivery vehicles were also sterically stabilized by 
addition of poly(ethylene glycol) (PEG) and investigated.  The intracellular trafficking 
data obtained via this new methodology show that vectors such as PEI and CDP-imid can 
buffer the endocytic vesicles while PLL and CDP do not.  Additionally, the PEGylated 
vectors reveal the same buffering capacity as their unstabilized variants.  Here, the live 
cell, spatiotemporal mapping of these behaviors is demonstrated and, when combined 
with cell uptake and luciferase expression data, shows that there is not necessarily a 
correlation between buffering capacity and gene expression. 
 
                                                 
† Reprinted with permission from Bioconjug. Chem. 2005, 16, 986-994. Copyright 2005 
American Chemical Society. 
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4.2 Introduction 
 Recent difficulties and costs with viral delivery vectors have helped to renew 
interest in replacing these systems with biocompatible, polymeric vectors for gene 
delivery and potential gene therapy in humans [1,2].  Although viruses can be useful for 
ex vivo gene delivery, they present many problems for systemic, in vivo use, including 
stimulation of immune responses, potential pathogenicity, lack of designable targeting to 
specific tissues and cell types, and cost of manufacturing.  By comparison, polymeric 
vectors can be prepared so that they do not elicit an immune response and are capable of 
carrying nucleic acids of virtually any size.  Additionally, synthetic delivery vehicles can 
be targeted to specific cells using appropriate ligands [3-6]. 
 Improving the delivery efficiency remains a major challenge in non-viral nucleic 
acid delivery.  For effective delivery, the vector must first reach the cell of interest. Once 
internalized by receptor-mediated endocytosis, the delivery system should actively 
transport the nucleic acid out of the endocytic pathway and allow for movement into the 
nucleus.  At some point during the delivery process, the non-viral vector must release the 
nucleic acid payload, although it is unclear where unpackaging should occur to enable the 
most effective delivery.  Thus, the synthetic vector must perform multiple functions for 
effective intracellular trafficking [7-9]. 
 An important portion of the intracellular trafficking of non-viral delivery vehicles 
is their behavior in the endocytic pathway. The vehicles enter into this pathway by 
endocytosis and must escape in order to avoid degradation by the lysosomal system [10-
12].  Little is known about the spatiotemporial pH changes that the vectors face as they 
travel intracellularly or how these changes affect delivery and expression [13,14].  
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Certain polymers, such as polyethyleneimine (PEI), are said to exhibit a “proton sponge” 
effect since they have titratable amine groups (pKa values in the  range of 4-7) and have 
the ability to buffer pH changes as endocytic vesicles acidify [15].  Other polymers, such 
as poly-L-lysine (PLL) or beta-cyclodextrin-containing polymers (CDP), do not possess 
this ability [16].  It is not well understood how the delivery vectors respond to pH 
changes in the endocytic pathway and how those responses affect export to the cytoplasm 
to allow the cytoplasmic transport and nuclear delivery of the nucleic acid. 
 Prior studies examining endosomal pH changes utilized flow cytometry to look at 
averages of hundreds of cells simultaneously for different types of polyplexes (PLL and 
PEI) [10,17] or employed an indirect approach that depended on colocalization of 
dextrans [18].  Here, we develop a new methodology to monitor in single cells the 
spatiotemporial pH experienced by nucleic acids delivered using polymeric delivery 
vehicles.  Our work differs from previous nucleic acid delivery studies in that we employ 
a single pH-sensitive fluorophore, SNARF-4F, directly conjugated to the nucleic acid of 
interest.  This method avoids concerns about relative labeling density or interactions 
between multiple fluorophores, makes no assumptions regarding colocalization, and 
directly evaluates the pH microenvironment of the nucleic acid of interest.  While 
valuable, previous studies involving average values from numerous cells do not offer the 
specificity of the single cell approach described below.  Also, gene delivery particles that 
are in different locations in the cell or are endocytosed at different times cannot be 
distinguished by cell averaging methods.  In contrast, the single cell analysis method we 
present here using laser scanning confocal microscopy allows for direct examination of 
uptake of delivery particles in single cells in real time.  Particles at different locations in 
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the cell can easily be identified, and pH differences quantified, as transport of such 
particles from the periphery of the cell towards the nucleus can take on the order of tens 
of minutes. 
 Identifying pH differences as a function of delivery particle chemical composition 
and location within the cell will be important for better understanding of how trafficking 
occurs and may assist in the design process and search for more efficient delivery 
vectors.  Here, we show that the pH microenvironment can be correlated to transfection 
progression and particle location through direct visualization.  This method allows for 
monitoring of the entire pathway, from early internalization onwards, and for direct 
visualization in real time to measure individual differences among cells. 
 
4.3 Materials and methods 
4.3.1 Labeled oligonucleotide and delivery vectors 
 A 21-base RNA phosphorothioate oligonucleotide was synthesized (Caltech 
Biological Synthesis Facility, Pasadena, CA) with sequence 5’-
GACGUAAACGGCCACAAGUUC-3’.  The 5’ end of the oligonucleotide was capped 
with the 5’-amino modifier 5 (Glen Research, Sterling, VA), supplying a 5’ terminal 
primary amine to which an NHS-ester of the SNARF-4F fluorophore could be reacted.  
To carry out this reaction, the dry oligonucleotide was re-suspended in phosphate-
buffered saline (pH 7.4).  The pH-sensitive fluorescent molecule SNARF-4F-carboxylic 
acid (Molecular Probes, Eugene, OR) was converted to an NHS-ester by reaction with 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (1:1 molar eq.) and 
N-hydroxysulfosuccinimide (sulfo-NHS) (5:1 molar eq.) in MES buffer (pH 6.0) for 15 
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minutes.  Subsequently, the oligonucleotide was added to the reaction mixture (10:1 
molar eq., SNARF-4F:oligonucleotide) and reacted for 2 hours at room temperature in 
the dark.  The SNARF-4F-labeled oligonucleotide was purified from unreacted SNARF-
4F with CentriSep 20 columns (Princeton Separations, Adelphia, NJ).  In multiple 
reactions, the yield of labeled oligonucleotide was 50-60%. 
 The beta-cyclodextrin-containing polycation (CDP) and imidazole-terminated 
beta-cyclodextrin-containing polycation (CDP-imid) were synthesized as described 
previously [19].  Solutions of these cyclodextrin-containing polycations were prepared at 
2.06 mg/mL in dH2O.  25 kD branched polyethylenimine (bPEI) (Aldrich, Milwaukee, 
WI) solution was formulated at 0.067 mg/mL in 20 mM HEPES buffer with 5% glucose.  
Poly-L-lysine (Sigma) solution was prepared at 0.06 mg/mL in 0.3 M NaCl.  
Cyclodextrin-grafted linear polyethylenimine (CD-PEI) was synthesized as described 
previously [20] and a solution formulated at 10 mg/mL in dH2O.  Lipofectamine 
(Invitrogen) was diluted to 0.025 mg/mL in Opti-MEM serum-free medium 
(Gibco/Invitrogen). 
 
4.3.2 Formulation and PEGylation of complexes 
 To formulate labeled complexes, the SNARF-4F-labeled oligonucleotide was 
diluted in dH2O to a concentration of 0.1 mg/mL.  Polycation-oligonucleotide complexes 
were prepared by adding a polycation solution (as described above) to an equal volume of 
SNARF-4F-oligonucleotide.  Complexes were then incubated at room temperature for 30 
minutes.  These conditions produce complexes at an N/P ratio of 10/1 for CDP and CDP-
imid, 5/1 for bPEI, and 3/1 for poly-L-lysine.  Lipoplexes were prepared by adding 
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lipofectamine at a concentration of 25 μg/mL in Opti-MEM to the nucleic acid at a 
concentration of 10 μg/mL in Opti-MEM.  
 
 For PEGylation of CDP complexes, an adamantane-poly(ethylene glycol)5000 
conjugate (AD-PEG) was prepared as previously described [19].  CDP complexes and 
CDP-imid complexes were salt-stabilized by the addition of 35 micrograms AD-PEG 
(100 mg/mL in dH2O) per microgram oligonucleotide.  bPEI complexes were salt-
stabilized by addition of 4 micrograms methoxy-PEG5000-succinimidyl propionate 
(Nektar, San Carlos, CA; 20 mg/mL in dH2O) per microgram oligonucleotide.  Solutions 
were incubated at room temperature for an additional 30 minutes after PEGylation. For 
examples of these types of PEGylation methods and results of stabilization within cells 
see [21]. 
 
4.3.3 Cell culture 
 HeLa cells were grown in 10-cm culture dishes (Becton Dickinson) at 37ºC in a 
humid 5% CO2 atmosphere.  Each dish held 10 mL of growth media, which consisted of 
DMEM with 10% fetal bovine serum, 100 units/mL penicillin, 100 units/mL 
streptomycin, 10 mM HEPES, 0.1 mM non-essential amino acids, and 2 mM L-glutamine 
(Irvine Scientific, Santa Ana, CA).  The cells were passaged once a week and plated onto 
glass-bottom tissue culture plates (Labtek) for each imaging experiment.  The total 
medium volume per well was 0.7 mL after seeding, and the cells were incubated for 24 
hours before transfection. 
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4.3.4 Fluorescence microscopy 
 An inverted Zeiss LSM 510 META confocal microscope was used for all 
fluorescence and brightfield measurements.  A 63x oil objective (NA 1.4) was employed 
for all measurements.  Excitation of the SNARF fluorophore was achieved with the 543 
nm line of the He-Ne laser line supplied with the microscope.  The fluorescence signal 
was detected by the photomultiplier tubes within the META detector after passing 
through a variable confocal pinhole set to 2 Airy units (chosen to maximize the S/N ratio 
while minimizing out-of-plane light).  The META detector allows for the emitted 
wavelengths to be separated into ~10 nm bins of light.  For the SNARF fluorophore, the 
collected emission light was separated into 3 distinct bins: 569-601 nm, 601-633 nm, and 
633-687 nm. 
 
4.3.5 pH Calibration Assay 
 Buffers with pH = 4.2, 5.0, 6.0, 7.0, and 8.0 were prepared as follows:  The pH 
4.2 and pH 5 buffers were made by adjusting the pH of a 0.2 M potassium acetate 
solution to the appropriate pH with glacial acetic acid.  The pH 6.0 buffer was prepared 
by mixing 1.2 mL of 1 M Na2HPO4 and 8.8 mL of 1 M NaH2PO4.  The pH 7.0 buffer was 
formulated by mixing 5.8 mL of 1 M Na2HPO4 and 4.2 mL of 1 M NaH2PO4.  The pH 
8.0 buffer was prepared by mixing 9.3 mL of 1 M Na2HPO4 and 0.7mL of 1 M NaH2PO4.  
The pH of these latter three buffers was adjusted with 6 M NaOH.  To determine the pH 
calibration curve, PLL, CDP, and PEGylated CDP particles were incubated as follows:  2 
μL of each polyplex solution (prepared as described above) were added to 100 μL of each 
buffer and allowed to equilibrate for at least three hours.  Each sample was then imaged 
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under the microscope, as described, and the intensity measurements for each of the three 
bins were collected.  The intensity values were normalized with respect to the middle bin 
(601-633 nm emission light) to generate calibration curves for the different pH values. 
The ratios of the intensity values of the 633-687 emission bin divided by those of the 
569-601 emission bin do not differ significantly for all three types of particles at the same 
pH values; hence, we are able to use these ratios to determine intracellular pH. 
 
4.3.6 In vitro transfection imaging 
 After 24 hours, the growth medium in each well was removed and replaced with 
an equal amount of Opti-MEM medium.  2 μL of delivery particle containing solution 
were then added to each well and placed in a 37 ºC incubator for 2 hours to allow for 
sufficient uptake.  The cells were then imaged at 37 ºC, with the fluorescence emission 
collected into 3 channels as previously described.  Cells with delivery particles at 
different locations and stages of transport were imaged to generate a “pH map” of the 
cell.  Fluorescence intensity ratios were then calculated and compared to the calibrated 
pH values to determine the intracellular pH environment for each of the individual 
signals. 
 
4.3.7 Plasmid uptake and expression 
 The firefly-luciferase-expressing DNA plasmid pGL3-Control Vector (5256 bp) 
(Promega, Madison, WI) was amplified using the Ultramobius 1000 kit (Novagen, 
Madison, WI).  One day prior to transfection, HeLa cells were plated at a density of 
5×104 cells/mL in 24-well plates (1 mL/well).  For transfection, polyplex solutions were 
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diluted 10X in pre-warmed Opti-MEM serum-free medium (Invitrogen), while lipoplex 
solutions were applied as formulated (in Opti-MEM).  Uptake was assessed four hours 
after transfection as described previously [21].  Briefly, cells were transfected in 
duplicate with YOYO-1-labeled plasmid DNA, and the YOYO-1 fluorescence of viable 
cells was measured four hours after transfection using a FACScalibur instrument (Becton 
Dickinson, Franklin Lakes, NJ).  Expression of firefly luciferase was assayed as 
previously described [22].  Briefly, the polyplex-containing medium was aspirated four 
hours after transfection and replaced with regular growth medium equal to the original 
volume, and luciferase assays were conducted in triplicate 48 hours after transfection. 
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4.4 Results 
4.4.1 Fluorescence pH assay 
 The emission spectrum of SNARF-4F varies as a function of pH and has two 
peaks, one at 575 nm that increases in intensity as the pH declines, and one at 650 nm 
that increases in intensity as the pH increases; the crossover occurs at ~620 nm (Figure 
4.1a).  Thus, SNARF-4F can be used alone to monitor the pH in the range of 4-8, 
precisely the region useful for following the intracellular trafficking involving the 
endocytic pathway. SNARF-4F was conjugated to the 5’ end of an RNA 
phosphorothioate oligonucleotide and the pH sensitivity of the conjugate was observed 
whether the labeled oligonucleotide was free in solution or was bound by a cationic 
polymer and condensed into delivery particles. SNARF-4F signals are approximately the 
same pH value independent of whether it is free in solution, conjugated to the nucleic 
acid, or bound in a delivery vehicle (Figure 4.1b).  The labeled oligonucleotide was used 
to prepare particles with a variety of non-viral gene delivery vectors; for most systems 
examined, the resulting particles were ~100±25 nm in size (Figure 4.2), and the 
oligonucleotide exhibited stability against serum when packaged in the delivery particles 
(data not shown).  The intracellular trafficking of these fluorescently-labeled particles 
was monitored in cultured cells as described below.   
 To measure pH changes in cells via confocal microscopy, a META attachment 
was employed to separate the fluorescence emission into three wavelength bins (569-601, 
601-633, and 633-687 nm). In order to generate a pH calibration curve, PLL and 
PEGylated CDP particles were prepared with the SNARF-4F RNA conjugate, incubated 
in buffers with pH ranging from 4.2-8.1, and directly visualized under the 
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Figure 4.1  Fluorescence of SNARF-4F 
(a) Fluorescence emission spectra of SNARF-4F as a function of pH.  At low pH values, 
the peak at 575 nm is prominent, while the peak at 650 nm is low.  As the pH rises, the 
575 nm peak decreases in intensity, while the 650 nm peak rises to a maximum.  pH 
measurements were taken in buffers with pH of 4.2, 5, 6, 7, and 8. 
(b) Ratio of emission intensities for SNARF-4F dye, assessed via fluorimeter.  Attaching 
the dye to oligonucleotides or complexing the labeled oligonucleotides into particles does 
not appreciably change the emission spectrum of the dye, compared to free dye in 
solution. 
(c) From the fluorescence microscope, mean fluorescence signal from 633-687 nm 
divided by signal from 569-601 nm for SNARF-4F as a function of pH for different 
particles in buffered solutions. 
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microscope.  The pH of the environment was quantified by measuring the SNARF-4F 
emission in all three bins and sequentially calculating the ratios of all three bins 
compared to one another.  The ratios did not differ significantly for PLL and PEGylated 
CDP particles in solution, and the data were combined to generate a single calibration 
curve.  It was determined that the 633-687/569-601 nm ratio was the most sensitive to pH 
changes.  An exponential curve was fit to these data points to determine an equation for 
calculating pH from the fluorescence intensity ratios, which was then used to determine 
intracellular endosomal pH values (Figure 4.1c). 
 
 
 
 
 
 
 
Figure 4.2  Average diameters of the various particles used in this study 
Dynamic light scattering was employed to measure the effective diameters of the 
particles formulated.  Most of these particles were formulated with an average effective 
diameter between 75-125 nm.  Complexation of the polycation to either the SNARF-
oligonucleotides or plasmid DNA resulted in particles of similar size.  
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 By labeling the nucleic acids, and not the delivery vectors, the assay determines 
the pH environment of the delivered nucleic acids whether bound to the delivery vector 
or free in solution.  It is relatively straightforward to directly visualize the SNARF-4F 
fluorescence when it is in a particle (Mishra et al. show high resolution TEM and 
fluorescent confocal microscopy results that confirm vesicle containment of intact 
particles using some of the vector systems employed here [21]), as the signal appears as a 
round cluster.  Figure 4.3 shows an example of intact PLL polyplexes after 4 hours 
incubation and PEI polyplexes after 24 hours incubation imaged within different regions 
of the cell.  The pH is depicted colorimetrically in this image; those polyplexes 
experiencing a lower pH environment appear more strongly blue colored whereas those 
experiencing a higher pH appear more strongly red colored.  Diffuse staining indicative 
of unpackaged SNARF-oligonucleotide was not observed in these experiments, 
suggesting that unpackaged conjugate is diluted below the detection limit. 
 
4.4.2 Intracellular pH measurements 
 HeLa cells were exposed to the delivery particles for 2 hours to allow for uptake 
and trafficking.  While this time may seem long for endocytic processes, numerous 
reports have indicated that particle uptake and trafficking is notably slower [6, 10].  The 
media was then replaced to remove most of the free particles in solution, and the cells 
were incubated for up to 24 hours before imaging.  Because of the direct nature of our 
assay, it is not necessary to completely remove the free particles; in fact, particles that 
have entered more recently can be visualized and the endosomal pH values individually 
quantitated. 
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Figure 4.3  Examples of SNARF-oligo particles observed within cells 
In the top row of these images, the left image represents the 569-601 nm channel, the 
center the 601-633 nm channel, and the right the 633-687 nm channel.  (a) Image of PLL 
particles within cells after two hours incubation.  In this case, the large spot has not 
acidified, while the smaller one to the right has acidified to pH 4.5.  This image illustrates 
the inherent cell-cell variability of the uptake process, indicating that acidification does 
not occur uniformly or in a set time window.  (b) Image of PEI particles in a cell after 24 
hours incubation.  The spots below the nucleus are at ~ pH 6, while the large one in the 
upper right corner is still at pH 7.5, suggesting that the particles in the upper right may 
have entered much later than the others.  Scale bars = 1 μm. 
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 A major advantage of direct visualization is that different regions of an individual 
cell can be quantitated separately and not averaged into a bulk measurement.  We have 
found that early in the transfection process (less than 4 hours), there appear to be regional 
differences in pH values within the cell (Figures 4.3 and 4.4).  Specifically, the cytoplasm 
can be divided into three regions – region I: within 2 μm of the cell membrane; region II: 
the cytoplasmic region between the other regions; and region III: within 2 μm of the 
nuclear membrane.  We did not observe intact particles or labeled nucleic acids within 
the nucleus for any imaging condition. This is not unexpected for the CDP delivery 
systems, as Mishra et al. have shown that intact particles do not enter the nucleus (only 
released nucleic acids can be visualized in the nuclear compartment) [21]. 
 
 
Figure 4.4  A schematic of a cell depicting the three regions described in the text 
Region I is the area of the cell within 2 μm of the cell membrane, region III is the region 
within 2 μm of the nucleus, and region II depicts the area in between.  Scale bar = 1 μm. 
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 As the particles are first internalized, their pH is uniformly high in region I for all 
examined classes of delivery vectors; however, the pH drops for PLL, CDP, and 
lipofectamine particles as they travel towards the nucleus (Figures 4.5 and 4.6).  The 
reduction in pH for PLL is rather rapid and is complete by 2 hours after initial incubation 
for those particles that reach region II.  For the CDP vector, particles in region I are still 
at neutral pH after four hours, those in region II are at an average pH of 6.1 with 
significant variability in pH, while those close to the nucleus have acidified by four hours 
to an average pH of 5.2.  Lipofectamine particles also display such an acidification, 
reaching an average pH of 4.6 by 16 hours.  Again, the average value does not tell a 
complete story; certain particles in region II have fully acidified, while others are slower 
to do so. 
 
 
Figure 4.5  Plots of average pH of all cells and regions as a function of time 
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Figure 4.6  Regional pH values as a function of time and region within the cell 
As seen with PEI (a), CDP (b), and CDP-imidazole (c) particles, particles experience 
intracellular pH variability across regions.  For non-buffering systems such as CDP, 
differences are pronounced at earlier times. 
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 In contrast, PEI particles display relatively consistent pH values for each time 
point, independent of region.  Over time, the PEI particles do acidify from pH ~6.6 to pH 
~5.8; however, the decrease is not as prominent as for PLL or CDP, which have acidified 
in all three regions by 24 hours.  Even at this time point, however, there are still a few 
cells (~1-4%) that show particles that are not acidified, possibly because they have 
entered the cells only recently; these particles are indicated as being in region IV (Figure 
4.6).  CD-PEI exhibits acidification to pH ~5.5 rather quickly, even in region I.  
However, it does not fully acidify below this pH, even after 16 hours. 
 Although CDP particles do not buffer pH, modifications can be introduced to 
allow for buffering capacity.  Conjugation of an imidazole group to the polymer termini 
produces CDP-imid, a vector that displays a limited buffering of pH.  The acidification of 
CDP-imid particles occurs gradually, and even after 16 hours, the average endosomal pH 
was ~6.3.  Further acidification was observed to occur, with the average pH reaching ~6 
by 24 hours.  Administration of chloroquine in conjunction with CDP particles resulted in 
a comparable buffering effect, with the pH remaining at ~6.6 even after 16 hours. 
 Three types of particles (CDP, CDP-imid, PEI) permitted facile comparison 
between PEGylated and unPEGylated variants.  Interestingly, differences between 
PEGylated and unPEGylated variants of the same polyplex type were minor.  For 
instance, at 16 hours after transfection, the average pH for PEGylated CDP-imid was 
~6.4, while it was ~6.3 for the unPEGylated CDP-imid (Figure 4.4).  Similar results were 
obtained for the other types of particles at each time point (data not shown). 
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4.4.3 Transfection data 
 To explore the implications of the buffering behavior on the gene delivery 
efficiency of the examined delivery vectors, the delivery of luciferase plasmid DNA was 
employed.  The examined delivery vectors generate similarly-sized particles regardless of 
whether they are used to condense the SNARF-labeled oligonucleotide or plasmid DNA 
(Figure 4.2).  The gene delivery activity of the various delivery vectors was assessed by 
transfecting cells with firefly luciferase-expressing plasmid DNA and assaying for 
luciferase expression (Figure 4.7). 
 
 
 
Figure 4.7  Gene delivery efficiency for each of the particles used in this study 
The delivery vectors were complexed with plasmid DNA encoding luciferase, and used 
to transfect HeLa cells.  The relative luciferase expression varies markedly for each type 
of particle.  In general, stabilizing particles through PEGylation resulted in lower 
luciferase expression. 
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 DNA uptake by cells was quantified using fluorescently-labeled plasmid DNA 
and analysis by flow cytometry (Figure 4.8).  The cellular fluorescence intensity can be 
correlated with relative uptake of plasmid DNA because the fluorescent label used 
(YOYO-1) was shown on a fluorimeter to be pH-insensitive (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8  Measure of DNA uptake for each type of particle 
Fluorescently labeled plasmid DNA was complexed with each type of delivery vector, 
and administered to HeLa cells.  After four hours, the cells were collected and analyzed 
by flow cytometry.  The mean cellular fluorescence was used as a measure of DNA 
uptake.  
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4.5 Discussion 
 The fluorescence-based pH assay described herein provides the ability to follow 
and track individual particles within cells over time and thus gives insight into the nature 
of their trafficking within the cell.  The development of this methodology was enabled by 
the facile labeling of the oligonucleotide and by the preservation of the label’s pH 
sensitivity even when the conjugated oligonucleotides were condensed into delivery 
particles.  Here, only a single fluorophore is used per nucleic acid molecule, thus 
avoiding the issue of uneven labeling (of nucleic acids or within particles) that can be 
present with two-fluorophore experiments. 
 Individual cells are examined in this assay, and particles residing in different 
zones within a given cell can be visualized and their local pH environment examined.  
Specifically, a “pH map” of the delivery vectors can be determined as a function of the 
time-dependent spatial locations (i.e., close to the cell membrane, near the nucleus, or in 
between) of the vectors as they traverse the cell.  The relevance of this approach is 
demonstrated, for example, by the small percentage of cells showing PEI particles in 
region IV (those that are not acidified even after 24 hours).  In a bulk assay, this 
information would be lost, with such individual differences combined into a statistical 
average. Here, we directly access spatiotemporal information and use it to refine models 
of intracellular trafficking of delivery particles. 
 The current model of delivery vehicle transport through the cell suggests that the 
particles are first internalized within endosomal compartments, after which the 
compartments mature from early endosomes to late endosomes and finally to lysosomes; 
the pH of these compartments progressively declines until reaching pH ~4.5 [10,17,23].  
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Our results support this model of trafficking through the endocytic pathway by 
demonstrating and quantifying the reduction in pH experienced by delivered nucleic 
acids as they move through the cell.  The ability of the delivery vehicles to circumvent or 
alter the steps of the endocytic pathway is of interest for understanding how efficiencies 
and transport rates are affected.  Specifically, those particles that contain titratable amines 
at pH values between approximately 4 and 7 (such as PEI) are thought to buffer the 
endosomal compartments and prevent maturation into lysosomes.  The buffering thus 
affects delivery.  It is believed that those polymers that can buffer act as “proton sponges” 
and promote osmotic swelling and lysis of endosomes.  This lysis is speculated to allow 
endocytic pathway release that thus improves delivery efficiency [11,15]. 
 In general, these models have been developed without an assessment of the spatial 
and temporal localization of the relevant pH changes.  Each endosome is an individual 
entity and acidifies at a different rate that is dependent upon cell type and other factors.  
Here, we specifically examine acidification within HeLa cells and find that spatial 
differences are prominent for CDP and PLL particles at early times (before 4 hours).  
When these particles have trafficked for more than 12 hours, they reach a pH of roughly 
4.8-5.0 and show little difference regardless of position within the cell.  These low pH 
values suggest that the endosomes have fully acidified and are at the lysosomal stage.  
For PEI, the spatial localization is less important than temporal differences, and the pH 
values are relatively constant throughout the cell for a given time point.  After 24 hours, 
the pH is ~5.8, indicating that full acidification does not occur.  For CDP-imid particles, 
the pH values are also relatively constant throughout the cell for a particular time point; 
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the imidazole group acts to buffer the pH (relative to CDP particles) and the pH remains 
above 6 for almost 24 hours (similar to PEI). 
 The uptake, intracellular trafficking, and gene delivery efficiency of PEGylated 
gene delivery particles differs from that of their unPEGylated variants [21].  Comparing 
PEGylated CDP, PEGylated CDP-imid, and PEGylated PEI particles to their 
unPEGylated variants, we observe no significant differences in the extent or kinetics of 
acidification.  This result indicates the PEG coating does not affect acidification or 
progression through the endocytic pathway.  Retention of buffering capacity with the 
PEGylated particles is significant because systemic, in vivo administraton of non-viral 
gene delivery particles will require PEGylation or other means of salt-stabilization.   
 The relatively high delivery efficiency of PEI has been linked to its ability to act 
as a “proton sponge,” and there is evidence to support this hypothesis [11,15,24,25].  
Improvements in non-viral transfection efficiency in the presence of chloroquine have 
also provided credence to the “proton sponge” hypothesis. It is shown here that 
chloroquine confers significant buffering activity to a vector system that otherwise 
readily acidifies.  However, by comparing vectors with and without pH buffering 
capacity, it is clear that buffering capacity alone does not necessarily correlate with gene 
delivery efficiency.  Despite similar pH buffering capacity, the three types of PEGylated 
particles generate reduced expression relative to their unPEGylated variants.  The 
terminal imidazole group confers significant pH buffering capacity to CDP-imid that is 
not present for CDP; at the charge ratio examined here, the buffering activity does not 
correlate with significant improvements in transfection efficiency.  Conversely, the 
significant buffering capacity of PEI is not seen in CD-PEI, but both vectors give strong 
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expression, consistent with published results [20].  The lack of correlation between 
buffering and gene expression has been observed by others [13,26].  Forrest et al. 
revealed that acetylated PEI gave both reduced buffering capacity and improved 
transfection efficiency relative to unmodified PEI [26].  (The buffering capacity of both 
CD-PEI and this acetylated PEI is reduced because some amine groups of PEI have been 
converted to other functionalities [20,26].)  Also, recent reports have shown that new 
polymeric vectors designed with buffering capacity do not necessarily perform well as 
gene delivery vectors [13,27]. 
 The data gathered here by a single-cell approach can be analyzed in aggregate for 
comparison with prior studies that have utilized flow cytometry to compile aggregate 
data.  Our results in HeLa cells and those of Akinc and Langer in NIH 3T3 cells [17] both 
indicate that PEI shows a strong buffering capacity relative to PLL.  This is consistent 
with a simple model where the titratable amines of PEI that are not present on PLL confer 
buffering capacity.  In contrast, Forrest and Pack observed almost the opposite behavior, 
with PEI showing little to no buffering capacity as a function of cell line and PLL 
particles showing sharp variability as a function of cell line [10], including almost no 
reduction in pH in HepG2 cells even 15 hours after transfection.  Of note, fluorescently-
labeled nucleic acids were utilized in our study and that of Akinc and Langer, while 
Forrest and Pack conducted their experiments by fluorescently-labeling the delivery 
vectors. 
 It has been widely observed that chloroquine treatment produces increases in 
transfection efficiency for many types of non-viral gene delivery particles [16,28], as 
seen in this study with CDP particles.  The mechanism of this improvement is unclear.  
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One possibility is that high intracellular or intravesicular concentrations of chloroquine 
induce the unpackaging of delivered nucleic acids from delivery vectors [28,29].  
Chloroquine is also known to buffer the vesicles of the endocytic pathway [30], and this 
buffering may inhibit the transfer of endocytosed gene delivery particles to lysosomes.  
Our results do not resolve the questions surrounding this mechanism, but they do show 
that chloroquine treatment inhibits acidification of intracellular CDP particles in HeLa 
cells.  In the bulk assay of Akinc and Langer, chloroquine buffered the average pH of 
PLL particles in NIH 3T3 cells.  In contrast to our results, their data included a sharp 
fluctuation where the average pH of the intracellular PLL particles dropped abruptly to 
pH ~4 in the first two hours before rising upward in the next two hours [17].  The kinetics 
of chloroquine uptake may differ for the two cell lines.  Although Forrest and Pack did 
not observe buffering by PEI, their bulk assay showed significant buffering when PEI 
transfection was accompanied by chloroquine [10]. 
 When acidification of endocytic vesicles is buffered by gene delivery particles, 
the vesicles still progress through the endocytic pathway.  PEI, for example, is shown 
here to demonstrate strong buffering capacity in a gene delivery particle.  Lecocq et al. 
used centrifugation methods to show that intracellular PEI eventually colocalizes with the 
lysosomal marker cathepsin C [31].  Kichler et al. observed that in vitro reporter gene 
expression was impaired when endosome acidification was inhibited with bafilomycin 
A1, indicating that, despite its buffering activity, PEI relies on the acidification process 
for transfection [32].  Similarly, Singh et al. histidylated two cationic lipids to confer pH 
buffering and found that gene delivery with these lipids was less efficient in the presence 
of bafilomycin A1 [33]. 
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 Single-cell methods can supply new information on intracellular trafficking that 
will be useful in the design of improved gene delivery vectors.  For example, various 
researchers have sought to enhance intracellular vector unpackaging by preparing acid-
labile polycation-DNA particles [14,34].  A detailed description of the spatial and 
temporal pH changes experienced by these particles in cells would indicate the probable 
intracellular location(s), timing, and extent of the particle degradation, thus facilitating 
refinement of the pH-sensitive vectors. 
 The compact, intense clusters of SNARF-4F fluorescence observed within cells 
are assumed to represent nucleic acids contained within vesicles.  The small size of the 
SNARF-oligonucleotide suggests that the fluorescent signal from unpackaged 
intracellular oligonucleotides would appear diffuse.  The absence of such diffuse staining 
could indicate that the majority of delivered nucleic acids remained within the delivery 
particles [21].  Alternatively, the unpackaged oligonucleotide may present a signal so 
diffuse that it is below the detection limit, or it may be rapidly degraded and/or expelled 
from cells. 
 One question that arises is why there might be any particles still remaining in 
region I (near the cell membrane) at 12 or even 24 hours after transfection.  One plausible 
explanation is that these particles have entered only a few hours earlier and have not had 
time to acidify.  Particles in this category might have been stuck on the outer surface for 
hours before being endocytosed.  However, this does not fully explain the existence of 
very low pH endosomes near the cell membrane.  A second possibility is that such 
endosomes are trafficking very slowly towards the nucleus, or are traveling in a random 
trajectory and have fully acidified but happen to be close to the membrane when imaged.  
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The particles must be transported along microtubules within endosomes in order to 
navigate the cytoplasm; the trajectories of these endosomes are often stochastic [35,36].   
 The advantages of the method presented here include the ability to directly 
visualize each cell and follow the internalization and endosome trafficking of delivery 
vehicles over time.  This approach avoids or minimizes some of the problems of bulk 
imaging by flow cytometry that include quantitation of dead cells, presence of particles 
on the surface of the cell, and suppression of variability by intracellular region.  The 
dynamics of the uptake and acidification process can be quantitated in both time and 
space, and any escape or other behavior can be monitored.  By analyzing single cells, any 
variability in the process can be revealed and not buried in the overall average.  This 
variability is especially evident at early times, as particles in certain spatial regions 
exhibit a broad range of pH values.  We can also measure and segregate small 
subpopulations that would otherwise be combined into the statistical mean.  Through the 
use of this assay, individual cells can be tracked for hours, and the spatial and temporal 
pH profile can be analyzed to better understand intracellular trafficking of non-viral gene 
delivery vectors.  In summary, this new methodology has yielded data from which we 
have carried out further analyses of prior experiments performed in aggregate, quantified 
the differences in buffering capacity among a variety of delivery vectors, revealed that 
PEGylation does not significantly affect buffering capacity, and verified that chloroquine 
can confer buffering to gene delivery particles.  The results presented here raise further 
questions about the role of pH buffering in the endocytic pathway and its importance to 
gene delivery efficiency. 
 91
4.6 References 
 
1. Davis ME (2002) Non-viral gene delivery systems. Curr. Opin. Biotechnol. 
13:128-131. 
2. Godbey WT, Mikos AG (2001) Recent progress in gene delivery using non-viral 
transfer complexes. J. Control. Release 72:115-125. 
3. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, 
Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells 
in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92:7297-
7301. 
4. Luo D, Saltzman WM. (2000) Synthetic DNA delivery systems. Nat. Biotechnol. 
18:33-37. 
5. Stayton PS, Hoffman AS, Murthy N, Lackey C, Cheung C, Tan P, Klumb LA, 
Chilkoti A, Wilbur FS, Press OW (2000) Molecular engineering of proteins and 
polymers for targeting and intracellular delivery of therapeutics. J. Control. 
Release 65:203-220.  
6. Godbey WT, Wu KK, Mikos AG. (1999) Tracking the intracellular path of 
poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. 
USA 96:5177-81. 
7. Bieber T, Meissner W, Kostin S, Niemann A, Elsasser HP. (2002) Intracellular 
route and transcriptional competence of polyethylenimine-DNA complexes. J. 
Control. Release 82:441-454. 
8. Remy-Kristensen A, Clamme JP, Vuilleumier C, Kuhry JG, Mely Y (2001) Role 
of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA 
complexes. Biochim. Biophys. Acta 1514:21-32. 
9. Hwang SJ, Davis ME (2001) Cationic polymers for gene delivery: designs for 
overcoming barriers to systemic administration. Curr. Opin. Mol. Ther. 3:183-
191. 
10. Forrest ML, Pack DW (2002) On the kinetics of polyplex endocytic trafficking: 
implications for gene delivery vector design. Mol. Ther. 6:57-66. 
11. Sonawane ND, Szoka FC, Verkman AS (2003) Chloride accumulation and 
swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. 
Biol. Chem. 278:44826-44831. 
12. Akinc A, Lynn DM, Anderson DG, Langer R (2003) Parallel synthesis and 
biophysical characterization of a degradable polymer library for gene delivery. J. 
Am. Chem. Soc. 125:5316-5323. 
13. Funhoff AM, van Nostrum CF, Koning GA, Schuurmans-Nieuwenbroek NM, 
Crommelin DJ, Hennink WE (2004) Endosomal escape of polymeric gene 
delivery complexes is not always enhanced by polymers buffering at low pH. 
Biomacromolecules 5:32-39.  
14. Choi JS, MacKay JA, Szoka FC (2003) Low-pH-sensitive PEG-stabilized 
plasmid-lipid nanoparticles: preparation and characterization. Bioconjug. Chem. 
14:420-429.  
15. Behr JP (1997) The proton sponge: A trick to enter cells the viruses did not 
exploit. Chimia 51:34-36. 
 92
16. Gonzalez H, Hwang SJ, Davis ME (1999) New class of polymers for the delivery 
of macromolecular therapeutics. Bioconjug. Chem. 10:1068-1074. 
17. Akinc A, Langer R (2002) Measuring the pH environment of DNA delivered 
using nonviral vectors: implications for lysosomal trafficking. Biotechnol. 
Bioeng. 78:503-508. 
18. Chen QR, Zhang L, Luther PW, Mixson AJ (2002) Optimal transfection with the 
HK polymer depends on its degree of branching and the pH of endocytic vesicles. 
Nucleic Acids Res. 30:1338-134. 
19. Davis ME, Pun SH, Bellocq NC, Reineke TM, Popielarski SR, Mishra S, Heidel 
JD (2004) Self-assembling nucleic acid delivery vehicles via linear, water-
soluble, cyclodextrin-containing polymers. Curr. Med. Chem. 11:179-197. 
20. Pun SH, Bellocq NC, Liu A, Jensen G, Machemer T, Quijano E, Schluep T, Wen 
S, Engler H, Heidel J, Davis ME (2004) Cyclodextrin-modified polyethylenimine 
polymers for gene delivery. Bioconjug. Chem. 15:831-840. 
21. Mishra S, Webster P, Davis ME (2004) PEGylation significantly affects cellular 
uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. 
Cell. Biol. 83:97-111.  
22. Popielarski SR, Mishra S, Davis, ME (2003) Structural effects of carbohydrate-
containing polycations on gene delivery. 3. Cyclodextrin type and 
functionalization. Bioconjug. Chem. 14:672-678. 
23. Sonawane ND, Thiagarajah JR, Verkman AS (2002) Chloride concentration in 
endosomes measured using a ratioable fluorescent Cl- indicator: evidence for 
chloride accumulation during acidification. J. Biol. Chem. 277:506-5513. 
24. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring 
polyethyleneimine-mediated DNA transfection and the proton sponge hypothesis. 
J. Gene Med. 7:657-663. 
25. Fukushima S, Miyata K, Nishiyama N, Kanayama N, Yamasaki Y, Kataoka K 
(2005) PEGylated polyplex micelles from triblock catiomers with spatially 
ordered layering of condensed pDNA and buffering units for enhanced 
intracellular gene delivery. J. Am. Chem. Soc.  127:2810-2811. 
26. Forrest ML, Meister GE, Koerber JT, Pack DW (2004) Partial acetylation of 
polyethylenimine enhances in vitro gene delivery. Pharm. Res. 21:365-371. 
27. Dubruel P, Christiaens B, Rosseneu M, Vandekerckhove J, Grooten J, Goossens, 
V, Schacht E (2004) Buffering properties of cationic polymethacrylates are not 
the only key to successful gene delivery. Biomacromolecules 5:379-388. 
28. Erbacher P, Roche AC, Monsigny M, Midoux P (1996) Putative role of 
chloroquine in gene transfer into a human hepatoma cell line by 
DNA/lactosylated polylysine complexes. Exp. Cell. Res. 225:186-194. 
29. Allison JL, O'Brien RL, Hahn FE (1965) DNA: reaction with chloroquine. 
Science 149:1111-1113. 
30. Maxfield FR (1982) Weak bases and ionophores rapidly and reversibly raise the 
pH of endocytic vesicles in cultured mouse fibroblasts. J. Cell. Biol. 95:676-681. 
31. Lecocq M, Wattiaux-De Coninck S, Laurent N, Wattiaux R, Jadot M (2000) 
Uptake and intracellular fate of polyethylenimine in vivo. Biochem. Biophys. Res. 
Commun. 278:414-418. 
 93
32. Kichler, A., Leborgne, C., Coeytaux, E., and Danos, O. (2001) Polyethylenimine-
mediated gene delivery: a mechanistic study. J. Gene. Med. 3:135-144. 
33. Singh RS, Goncalves C, Sandrin P, Pichon C, Midoux P, Chaudhuri A (2004) On 
the gene delivery efficacies of pH-sensitive cationic lipids via endosomal 
protonation: a chemical biology investigation. Chem. Biol. 11:713-723. 
34. Walker GF, Fella C, Pelisek J, Fahrmeir J, Boeckle S, Ogris M, Wagner E (2005) 
Toward Synthetic Viruses: Endosomal pH-Triggered Deshielding of Targeted 
Polyplexes Greatly Enhances Gene Transfer in vitro and in vivo. Mol. Ther. 
11:418-425. 
35. Kulkarni RP, Wu DD, Davis ME, Fraser SE (2005) Quantitating intracellular 
transport of polyplexes by spatio-temporal image correlation spectroscopy. Proc. 
Natl. Acad. Sci. USA 102:7523-7528.  
36. Suh J, Wirtz D, Hanes J (2003) Efficient active transport of gene nanocarriers to 
the cell nucleus. Proc. Natl. Acad. Sci. USA 100:3878-3882. 
 
   
 
94
 
CHAPTER 5: CHLOROQUINE (CQ), ITS CHEMICAL ANALOGUES, AND 
THEIR EFFECTS ON NON-VIRAL GENE DELIVERY 
 
5.1 Abstract 
 The presence of chloroquine (CQ) dramatically enhances transfection efficiency 
of many types of polyplexes (complexes of nucleic acids and polycations).  The 
mechanism of this action is not well understood and has not been extensively 
investigated.  Here, a number of CQ analogues are synthesized, with variations either on 
the alkyl amino side chain or on the aromatic ring, in order to develop a structure-
function correlation among CQ and its analogues in non-viral, polycation-based gene 
delivery. 
 It was found that the tertiary amino moiety is important to CQ’s enhancement of 
gene expression, as its removal eliminates the enhancement.  Further, the enhancement is 
dramatically affected by changes to the aromatic ring.  Quinacrine (QC), a CQ analogue 
with a tricyclic aromatic acridinyl structure, shows much higher cytotoxicity than CQ and 
can enhance transfection similarly to CQ at a concentration 10 times lower.  N4-(7-
Chloro-4-pyridinyl)-N1,N1-diethyl-1,4-pentanediamine (CP), a CQ analogue with a 
pyridinyl aromatic ring, gives lower cytotoxicity than CQ but has no effect on gene 
expression.  Transfection in the presence of N4-(7-trifluoromethyl-4-quinolinyl)-N1,N1-
diethyl-1,4-pentanediamine (CQ7a), a 7-trifluoromethyl CQ analogue, shows luciferase 
activity one order of magnitude higher than in the presence of CQ at same concentration 
(200 μM), while transfection in the presence of N4-(4-quinolinyl)-N1, N1-diethyl-1,4-
pentanediamine (CQ7b), a 7-H CQ analogue, shows no effect on transfection. 
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 CQ and CQ7a both demonstrate activity in buffering the pH experienced by 
polyplexes within the endocytic pathway, but CQ7a is more potent in enhancing gene 
transfer.  CQ7a has higher binding affinity to DNA than CQ as well as a greater tendency 
to competitively displace the polycation from polyplexes at an achievable intracellular 
concentration.  These findings suggest that in addition to pH-buffering activity, CQ’s 
competitive displacement of polycations and its own interaction with nucleic acids are 
important to its enhancement of gene expression in non-viral nucleic acid delivery 
systems. 
 
5.2 Introduction 
 The intracellular transport of polycation/DNA complexes (polyplexes) involves 
their cellular uptake, release from the endocytic pathway into the cytoplasm, and delivery 
of DNA to the cell nucleus.  To achieve transgene expression, polyplexes must overcome 
several extra- and intracellular barriers [1].  A large body of literature suggests that 
entrapment of polyplexes in the endocytic pathway, and their resulting degradation in 
lysosomes, represents a major impediment to transfection efficiency [1-3]. 
 Significant increases in gene expression with many non-viral gene delivery 
systems are observed when chloroquine (CQ) is present during the transfection [4-8].  We 
have observed increased transfection efficiency in the presence of CQ in our studies 
using cyclodextrin-containing polycations (CDP) for the delivery of nucleic acids [9-14].  
Although CQ has been widely used as a transfection enhancement reagent, the 
mechanism by which CQ enhances gene expression remains unclear.  CQ is a weak base 
with pKa’s of 8.1 and 10.2 [15], and can buffer the luminal pH of endosomes [16,17].  
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This activity could improve transfection efficiency by facilitating DNA release from the 
endocytic pathway (as it may generate swelling and destabilization of endosomes) [18] or 
by inhibiting lysosomal enzyme degradation [19,20].  Such hypotheses are supported by 
the observation that polyethyleimine (PEI), itself known to buffer endosomes, does not 
benefit from the presence of CQ [7,21].  Noting that CQ interacts with DNA [7,22,23], 
others have suggested that CQ may increase the transfection efficiency by facilitating 
dissociation of DNA from polyplexes [7]. 
 Here we attempt to understand the mechanism of CQ-induced increases in gene 
expression by designing several CQ analogues (Figure 5.1) and studying gene transfer in 
the presence of these compounds.  By correlating the chemical structures of CQ 
analogues with their contributions to gene transfer, information on the role of CQ is 
obtained.  A similar structure-property approach has been applied to understand the 
mechanism of CQ’s antimalarial activity [24-27]. 
 
 
 
 
 
Figure 5.1  Chemical structures of chloroquine and analogues 
A series of chloroquine analogues were synthesized to study the effects of variations in 
side chain, variations in ring structure, or removal of the secondary amine. 
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5.3 Materials and methods 
 Chemicals reagents were purchased from Sigma-Aldrich (St. Louis, MO) and 
used without further purification unless otherwise indicated.  NMR spectra were collected 
on Varian 300 MHz and Inova 500 MHz spectrometers.  Chloroquine (CQ) and 
quinocrine (QC) were purchased from Sigma. 
 
5.3.1 Polycation 
 A linear β-cyclodextrin-containing polymer (CDP) was synthesized and used for 
condensing DNA in this study.  The synthesis of CDP has been described in detail 
elsewhere [9,10].  The average molecular weight of the polycation used in this study is 
6000 Da.  The structure of CDP is shown in Scheme 5.1.  Each repeat unit contains two 
positively-charged amidine groups that can efficiently bind and condense DNA [10]. 
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Scheme 5.1  Structure of CDP 
   
 
98
 
5.3.2 Synthesis of CQ analogues 
 Chloroquine (CQ) is a quinoline analogue with a chloro group at the 7-position 
and an alkyl amino group at the 4-position (Figure 5.1).  CQ analogues with side alkyl 
amino side chain variation were synthesized via substitution reaction of an appropriate 
amine and 4,7-dichloroquinoline.  CQ analogues of ring-size variations and ring-
substituent variations were synthesized similarly using an appropriate quinoline or 
pyridine derivative as starting materials. 
 Synthesis of CQ4a.  A mixture of 4,7-dichloroquinoline (619 mg, 3.1 mmol) and  
1,5-dimethylhexylamine (3.1 g, 23.7 mmol) was heated at 100 °C for 1 h and then at 155 
°C for 3 h.  The reaction was monitored by TLC to ensure the completion of reaction.  
Unreacted amines were distilled under vacuum and could be reused.  The resulting 
brownish residue was applied to a silica gel flash column and a solvent mixture 
(CHCl3/CH3OH /Et3N (25/1/1)) was used as eluent.  CQ4a was isolated in 64% yield 
after combining elution fractions. CQ4a was further purified by crystallization (CHCl3 
and hexane) to give 120 mg (13% yield) of white solid.  1H NMR (CDCl3) δ 8.52 (1H, d), 
7.95 (1H, d), 7.64 (1H, s), 7.37 (1H, d), 6.42 (1H, d), 4.78 (1H, br), 3.71 (1H, m), 1.67 
(2H, m), 1.59 (1H, m), 1.43 (2H, m), 1.32 (3H, d), 1.23 (2H, d), 0.87 (6H, d). ESI-MS: 
expected M 264, found [M+H]+ 265. 
 Synthesis of CQ4b.  4,7-Dichloroquinoline (1.98g, 10 mmol) and L-alanine (1.78 
g, 20 mmol) were heated in the presence of phenol (8 g) for one hour at 160 °C.  The 
solution was poured into a solution mixture of 10% KI (30 mL) and ethyl ether (30 mL).  
The aqueous layer was then washed with ether layer (3×30 mL).  The combined ether 
layer was extracted once with 10% KI (30 mL).  The pH of the combined aqueous phase 
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was adjusted to 7.  The aqueous solution was let uncovered for slow evaporation at room 
temperature.  After about 24 h, white crystals were filtered and dried under vacuum 
(1.25g, 55%).  1H NMR (CDCl3) δ 8.43 (1H, m), 8.33 (1H, m), 7.76 (1H, s), 7.56 (1H, 
m), 6.66 (1H, m), 4.26 (1H, m), 1.66 (3H, d) 
 Synthesis of CQ4c.  CQ4c was synthesized using the same method as CQ4a with 
corresponding amine (26%).  1H NMR (CDCl3) δ 8.53 (1H, d), 7.94 d (1H, d), 7.70 (2H, 
m), 7.36 (1H, m), 5.92 (1H, br.), 3.28 (2H, t), 2.68 (2H, t), 2.30 (6H, s)     
 Synthesis of CQ4d.  4,7-Dichloroquinoline (0.62g) and excess N1-isopropyl-
diethylenetriamine (2 mL) was heated at 100 °C for 1 h and then at 155 °C for additional 
3 h.  TLC analysis indicated that 4,7-Dichloroquinoline was completely consumed after 4 
h.  Unreacted amine was distilled at 85-110 °C using a Kugelrohr apparatus under a 
vacuum of approximately 50 millitorr. The remaining brown oil was transferred to a 
silica gel flash column.  A solvent mixture (CH2Cl2/CH3OH/NH4OH (70/28/2), 200 mL) 
was used as eluent, followed by another eluent (CH2Cl2/CH3OH/NH4OH (5/20/4), 200 
mL).  Three fractions were isolated and analyzed by 1H NMR (data not shown).  The 
second fraction (Rf=0.1  in CH2Cl2/NH4OH/CH3OH (40/1.5/80)) was found to be CQ4d 
with some impurities.  All of the fractions were combined and transferred to another 
silica gel column and eluted (CHCl3/CH3OH /Et3N (10/1/1), 200 mL).   Clean fractions 
were combined.  Solvents were removed by vacuum to give a slight yellow oil (35%). 
ESI-MS: expected M=306, found [M+H]+=307.  1H NMR (CD3CD) δ 8.52 (1H, d), 7.94 
(1H, d), 7.70 (1H, d), 7.35 (1H, m), 6.32 (1H, d), 5.98 (1H, br.), 3.36 (2H, m), 3.06 (2H, 
m), 2.80 (3H, m), 2.07 (2H, m), 1.07 (6H, d). 
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 Synthesis of CQ4e.  4,7-Dichloroquinoline (0.5g) and excess 1,4-piperazine-
dipropanamine (5 mL) were heated at 135 °C for 12 h.  TLC analysis indicated that 4,7-
Dichloroquinoline was completely consumed.  Unreacted amine was distilled at 85-110 
°C using a Kugelrohr apparatus under a vacuum of approximately 50 millitorr. The 
remaining brown oil was transferred to a silica gel flash column.  A solvent mixture 
(CH2Cl2/CH3OH/NH4OH (70/28/2), 800 mL) was used as eluent, followed by elution in 
CH2Cl2/CH3OH/NH4OH ((5/20/4), 200 mL) and CH3OH/NH4OH ((1/1), 200 mL).   
Three different compounds were observed on TLC (CH2Cl2/CH3OH/NH4OH (5/20/4)) 
and each was analyzed by 1H NMR (data not shown).  The fraction with Rf=0.33 was 
found to be CQ4e. The combined fractions were transferred to another column and 
eluented with (CHCl3/CH3OH /Et3N (10/1/1), 200 mL). Clean fractions were obtained 
and combined.  Solvents were removed under vacuum to give a colorless oil (31%).  ESI-
MS: expected M=361, found [M+H]+=362.  1H NMR (CD3CD) δ 8.35 (1H, d), 8.07 (1H, 
d), 7.77 (1H, d), 7.39 (1H, m), 6.53 (1H, d), 3.39 (2H, d), 2.41-2.69 (14H, m), 1.93 (2H, 
m), 1.64 (2H, m).      
 Synthesis of CQ4f.  4,7-Dichloroquinoline (0.68g) and excess of Tris-(2-
aminoethyl)-amine (5 mL) were heated at 135 °C for 12 h.  TLC analysis indicated that 
4,7-Dichloroquinoline was completely consumed.  Unreacted amine was distilled at 85-
110 °C using a Kugelrohr apparatus under a vacuum of approximately 50 millitorr. The 
remaining brown oil was transferred to a silica gel flash column.    A solvent mixture 
(CH2Cl2/CH3OH/NH4OH (70/28/2), 800 mL) was used as eluent, followed by elution 
with CH2Cl2/CH3OH/NH4OH ((5/20/4), 200 mL) and CH3OH/NH4OH ((1/1), 200 mL).   
Three different compounds were observed on TLC (CH2Cl2/CH3OH/NH4OH (5/20/4)) 
   
 
101
 
and each was analyzed by 1H NMR (data not shown).   The fraction with Rf=0.2 was 
found to be CQ4f. The combined fractions were transferred to another column and 
eluented with (CHCl3/CH3OH/NH4OH (20/5/1), 200 mL). Clean fractions were obtained 
and combined.  Solvents were removed under vacuum to give a colorless oil (15%). ESI-
MS: expected M=307, found [M+H]+=308.  1H NMR (CD3CD) δ 8.50 (1H, d), 7.98 (1H, 
m), 7.92 (1H, d), 7.32 (1H, m), 6.69 (1H, br), 6.35 (1H, d), 3.36 (2H, m), 2.85 (6H, m), 
2.63 (4H, m), 1.59 (4H, br). 
 Synthesis of CQ7a.  4-chloro-7-trifluoromethyl quinoline (0.5g, 2.16 mmole) and 
2-amino-5-diethylaminopentane (2.61 g, 15.7 mmole) were heated together at 100 °C for 
1 hour and then 155 °C for 4.5 hours.   Reaction was then cooled to room temperature 
and excess unreacted amine was removed by Kugelrohr distillation at 120 °C under 
vacuum.  The remaining brown crude oil was then dissolved in CHCl3 and purified by 
preparative TLC using CHCl3/CH3OH/Et3N (25/1/1) as an eluent to yield a colorless oil 
(32%).  1H NMR (CD3OD) δ 8.62 (1H, d), 8.23 (1H, d), 7.91 (1H, m), 7.58 (1H, m), 6.52 
(1H, d), 5.55 (1H, m), 3.75 (1H, m), 2.56 (6H, m), 1.80 (2H, m), 1.67 (2H, m), 1.36 (3H, 
d), 1.06 (6H, d). 
 Synthesis of CQ7b.  CQ7b was synthesized using the same method as CQ4a using 
4-chloroquinoline and 2-amino-5-diethylaminopentane (10%). 1H NMR (CD3OD) δ  8.53 
(1H, d), 7.97 (1H, d), 7.76 (1H, d), 7.61 (1H, m), 7.40 (1H, m), 6.42 (1H, d), 5.21 (1H, 
br), 3.75 (1H, m), 2.50 (6H, m), 1.76 (2H, m), 1.62 (2H, m), 1.31 (3H, d), 1.08 (6H, d).    
 Synthesis of CP.  4-Chloropyridine hydrochloride (1.0g, 6.66 mmole) and 2-
amino-5-diethylaminopentane (8.06 g, 50.88 mmole) were heated at 100oC for 1 hour, 
155oC for 3 hours, and 135oC for 16 hours.   Reaction was then cooled to room 
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temperature and the unreacted excess amine was removed by Kugelrohr distillation of the 
crude reaction mixture at 120oC under vacuum.   The remaining crude brown oil was then 
dissolved in CHCl3 and purified by preparative TLC using CHCl3/CH3OH/NH4OH 
(5/1/0.2) as an eluent to yield a colorless oil (24%) 1H NMR (CD3OD) δ 8.14 (1H, dd), 
6.37 (1H, dd), 4.44 (1H, br), 3.51 (1H, m), 2.54 (4H, m), 2.41 (2H, m), 1.18-1.54 (4H, 
m), 1.19 (3H, d), 1.02 (6H, t). 
 Synthesis of CQO.  NaH (60% dispersion in mineral oil, 0.234 g, 5.84 mmole) 
was added to a flame-dried round bottom.  Anhydrous DMF (16.1 mL) was added to the 
flask under N2.  To this suspension was added dropwise a solution of N,N-diethyl-2-
aminoethanol (0.71 mL, 5.35 mmole) in DMF (16.1 mL) and the resulting mixture was 
stirred 30 minutes (gas evolution had stopped).  A solution of 4,7-dichloroquinoline (0.96 
g, 4.87 mmole) in DMF (14.6 mL) was then added to the reaction.  Reaction was 
complete after 30 minutes as monitored by TLC.  The reaction mixture was then poured 
into 200 mL water.  The product was extracted with EtOAc (3 × 100mL).  The organic 
layer was then dried over Na2SO4, filtered, and concentrated in vacuo to give the title 
compound in 95% yield (1.29 g).  1H NMR (CD3OD) δ 8.14 (1H, dd), 6.37 (1H, dd), 4.44 
(1H, br), 3.51 (1H, m), 2.54 (4H, m), 2.41 (2H, m), 1.18-1.54 (4H, m), 1.19 (3H, d), 1.02 
(6H, t).  1D-NOE experiments confirmed the positioning of the amino substituent. 
 
5.3.3 Cell culture and transfection experiments 
 Plasmid pGL3-CV (Promega, Madison, WI)  containing the luciferase gene under 
the control of the SV40 promoter was amplified by E. coli strain DH5α and was then 
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purified using the Ultramobius 1000 plasmid kit (Novagen, San Diego, CA).  HepG2 and 
HeLa cells were purchased from the ATCC (Rockville, MD).  Cells were cultured 
according to recommended procedures using Minimum Essential Medium (HepG2) or 
Dulbecco’s Modified Eagle’s Medium (HeLa), with 2 mM L-glutamine, 1.5 g/L sodium 
bicarbonate, 0.1 mM non-essential amino acids, 1.0 mM sodium pyruvate, and 10% fetal 
bovine serum.  Media and supplements were purchased from Gibco BRL (Gaithersburg, 
MD).  Cells were transfected in serum-reduced medium with CDP/pDNA polyplexes as 
described previously, in the presence of CQ or CQ analogues at various concentrations.   
Determination of cell viability and total protein concentration was conducted by a 
modified Lowry protein assay, also described previously [1]. 
 For cell transfection and luciferase assay, cells were plated at 5×104 cells/well in 
24-well plates 24 h in advance.  Immediately prior to transfection, cells were rinsed once 
with PBS (pH 7.4), and 200 μL of Optimem (Gibco) was added to each well.  pGL3-CV 
(1 μg, 5 μL of a 0.2 μg/μL solution in DNAse-free water) was mixed with an equal 
volume of polymer (5 μL of 24.9 mg/mL freshly prepared CDP solution in DNAse-free 
water) to give charge ratio 5±.  185-190 μL of Optimem and an appropriate amount of 
CQ (or CQ analogues) solution were mixed with CDP/pDNA complexes (10 μL) to give 
a final volume of 200 μL. These solutions were immediately transferred to each well.  
After 4 h of incubation (37 °C, 5% CO2), the media in each well was replaced with 1 mL 
of culture media.  After another 44 h, the media was removed by aspiration.  Cells were 
washed twice with PBS (pH 7.4) before addition of 100 μL of 1x cell culture lysis buffer 
(Promega).  Cell lysates were analyzed for luciferase activity with luciferase assay 
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reagent (Promega).   Light units were integrated over 10 s in duplicate with a 
luminometer (Monolight 2010, Analytical Luminescence Laboratory, San Diego, CA). 
 The amount of protein in cell lysates obtained 48 h after transfection was used as 
a measure of cell viability. Protein levels of transfected cells were determined by the DC 
Protein Assay (Bio-Rad, Hercules, CA) and normalized with protein levels of cells 
transfected with naked DNA. A protein standard curve was run with various 
concentrations of bovine IgG (Bio-Rad) in cell culture lysis buffer.  
 
5.3.4 Uptake of polyplexes in the absence or presence of CQ analogues 
 pDNA was prepared for fluorophore binding by reacting with Label-IT Amine 
(Mirus, Madison, WI).  After 1 hour at 37 °C, the amine-terminated DNA was recovered 
by precipitation with ethanol, then incubated overnight with Alexa-fluor-488 NHS ester 
(Molecular Probes, Eugene, OR).  The labeled DNA was purified by precipitation with 
ethanol.  The percentage of pDNA labeling was determined to be 3.3 wt% by measuring 
the fluorescence intensity of labeled DNA (λexcitation 488 nm; λemission 535 nm) using a 
Spectrafluor Plus plate reader (Tecan, Durham, NC) and comparing with a standard 
curve. 
 Labeled pDNA was condensed with CDP prior to being administered to HepG2 
cells at a concentration 5 μg DNA/mL culture medium (same concentration as in gene 
transfection study).  Uptake was terminated at 30 min and at 2 hours.  Cells were treated 
with 0.25% trypsin, washed with phosphate-buffered saline and Hanks balanced salt 
solution, and analyzed by fluorescence-activated cell sorting (FACS). 
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5.3.5 Uptake and intracellular accumulation of CQ, CQ7a, and CQ7b 
 HepG2 cells (2×106 cells) were incubated at 37 °C in 2 mL Opti-MEM (pH 7.4) 
without or with pDNA/CDP (3 pmol/20 nmol) in the presence of 100 μM of CQ, CQ7a 
or CQ7b. After incubation in a humidified atmosphere (95% air, 5% CO2) for scheduled 
time, the medium was removed; cells were washed three times with cold PBS containing 
100 μM of corresponding CQ analogue, washed three more times in cold PBS, and then 
lysed by 20 min incubation in 1 mL of 1x cell culture lysis buffer.  The lysates was 
diluted with 1 mL NaOH (0.1N), and 80 μL of such solution was analyzed on a 
Spectrafluor Plus plate reader (Tecan) at excitation wavelength of 360 nm and emission 
wavelength of 465 nm.  The resulting fluorescence results were converted to 
concentrations of CQ or CQ analogues using a standard curve.  The cellular concentration 
of CQ or CQ analogues was calculated assuming a cell volume of 3 ×10-6 μL [5]. 
 
5.3.6 Interaction of pDNA with CQ analogues 
 Varying amounts of pDNA were added to a 20 μM solution of CQ or CQ 
analogues, giving pDNA concentrations between 0 and 150 nM.  UV absorbance of the 
mixture was recorded on a Cary 3G UV-Vis spectrophotometer (Varian, Palo Alto, CA) 
at room temperature. 
 
5.3.7 Electrophoretic mobility of pDNA in the presence of CQ analogues 
 Each polycation was examined for its ability to bind pDNA through gel 
electrophoresis experiments as previously described [9,10].  pGL3-CV (5 μL of a 0.2 
μg/μL solution in DNAse-free water) was mixed with an appropriate amount of CQ, 
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CQ7a, or CQ7b.  Each solution was incubated for approximately 10 min.  Loading buffer 
(5 μL) was added to each sample, followed by an appropriate volume of Borax buffer 
(0.025 M, pH 8.4) to give a final volume of 25 μL for each sample.  10 μL of such 
mixture was transferred into the wells of a 0.5% agarose gel (6 μg of ethidium 
bromide/100 mL TAE buffer (40 mM Tris-acetate, 1 mM EDTA)) and electrophoresed. 
 
5.3.8 Displacement of DNA from polyplexes by CQ analogues 
 pGL3-CV (2 μg, 0.6 pmol) in 10 μL of DI water was complexed with CDP (24 
μg, 4 nmol) in 10 μL.  The solution was diluted by adding 80 μL PBS and kept for 30 
min at 25 °C. The effect of CQ or CQ analogues on the stability of the complexes was 
studied as described [28] by increasing the concentration of CQ or CQ analogues upon 
adding 100 μL of a solution containing twice as much as the concentrations of interest.  
After a further 30 min at 25 °C, each solution was passed through a Pall Life Science 
Supor Membrane (100 nm) presoaked and rinsed with a solution containing the 
equivalent concentration of the CQ analogues.  40 μL of the filtrate was mixed with 40 
μL of 5.6 μM 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI).  The amount of 
unpackaged DNA was determined from the fluorescence intensities (λexcitation 350 nm; 
λemission 465 nm) of the DAPI-containing filtrate solution [7]. The percentage of pDNA 
dissociated from polyplexes was calculated according to (If-I0)/(It-I0)×100, where It is the 
fluorescence intensity of DAPI in the presence of the total full of pDNA, I0 is the 
fluorescence intensity of DAPI in the absence of pDNA, and If is the fluorescence 
intensity of the filtrate containing dissociated pDNA. 
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5.3.9 Dye exclusion assay to evaluate accessibility of condensed pDNA 
 The accessibility of polyplexes in the presence of CQ analogues was evaluated by 
dye exclusion through adaption of a published procedure [30].  After formulation, 
polyplexes were diluted 2.5x in dH2O.  For each sample, 25 μL of polyplex solution was 
transferred to a well of an opaque, black 96-well plate and combined with 25 μL of CQ 
analogue solution at twice the concentration of interest.  Separately, a 200x dilution of the 
supplied PicoGreen stock solution (Molecular Probes) was prepared in 10 mM HEPES 
buffer.  After polyplex-CQ analogue solutions were incubated for 5 min at room 
temperature, each 50 μL sample was combined with 50 μL of PicoGreen solution and the 
fluorescence (λexcitation 488 nm, λemission 535 nm) of the resulting solutions was evaluated 
with a Spectrafluor Plus plate reader (Tecan, Durham, NC).  The percentage dye 
exclusion was calculated from the ratio ((FDNA-Fsample)/(FDNA-FH2O)), where FDNA is the 
fluorescence of a sample of DNA alone (no polycation), Fsample is the sample 
fluorescence, and FH2O is the fluorescence of a blank (control) sample. 
 
5.3.10 Intracellular buffering activity of CQ analogues 
 The activity of CDP and CDPimid in buffering the pH environment of 
intracellular polyplexes was evaluated using the method of Kulkarni, et al. [29].  Briefly, 
polyplexes were formulated between the polymer of interest and an oligonucleotide 
labeled with the pH-sensitive fluorophore SNARF-4F (Molecular Probes, Carlsbad, CA).  
HeLa cells were treated with the polyplexes and imaged using an inverted Zeiss LSM 510 
META confocal microscope with a 63x oil objective (NA 1.4).  Excitation of the SNARF 
fluorophore was achieved with the 543 nm line of the He-Ne laser line supplied with the 
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microscope.  After passing through a variable confocal pinhole, the SNARF-4F emission 
was collected by the META detector in distinct wavelength bins of 569-601 nm and 633-
687 nm.  Using a standard curve, the relative intensity of individual signals across these 
bins was used to evaluate the pH environment of the corresponding intracellular 
polyplex(es). 
 
5.3.11 Measure of unpackaged intracellular nucleic acids 
 To obtain a relative measure of intracellular nucleic acid unpackaging, HeLa cells 
in 24-well plates were transfected with polyplexes of CDP or CDPimid and a FITC-
labeled DNA oligonucleotide (FITC-oligo).  Fourteen hours after transfection, cells were 
collected by trypsinization and pelleted by centrifugation (6 min at 2400 rpm).  Each 
sample was resuspended in 10 μL 1x cell culture lysis buffer (Promega) and stored at 4 
°C.  Controls consisted of known amounts of FITC-oligo in 1x cell culture lysis buffer.  
After 30 min incubation, each sample was mixed with 25 μL of 37 °C low-melting-point 
agarose (1% in TAE buffer) and transferred immediately to a well of an agarose gel 
(0.5% in 60 mL TAE buffer).  The agarose gel was subjected to gel electrophoresis and 
imaged under UV illumination.  Detection of FITC-oligo was achieved through its 
fluorescent signal.  Migration of FITC-oligo from control samples was used to indicate 
the expected migration of FITC-oligo unpackaged from cells. 
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5.4 Results 
5.4.1 Synthesis of CQ analogues 
 Chloroquine (CQ) is a quinoline analogue with an alkyl amino group at the 4-
position (Figure 5.1).  Here, a family of CQ analogues was prepared with a fixed ring 
structure (7-chloroquinoline) and variable side chains (CQ4a-f, CQO, Figure 5.1).  CQ4a-
f and CQO are readily synthesized in a one-step substitution reaction between 4,7-
dichloroquinoline and the corresponding aliphatic amines [31].  A second group of CQ 
analogues that contained 2-amino-5-diethylaminopentane as the side chain (identical to 
CQ) was prepared with variable 7-substitutes on the quinoline ring (CQ7a-b) or with 
variable aromatic ring sizes (CP and QC).  CQ7a-b and CP were synthesized via the 
substitution reaction between 2-amino-5-diethylaminopentane and the corresponding 4-
chloroquinoline derivatives or 4-chloro pyridine, respectively.  The resulting products 
were either crystallized or separated by column chromatography to give high purity. 
 
5.4.2 Transfection with CQ analogues in HepG2 cells 
 One microgram of pGL3-CV (0.3 pmol), encoding for the luciferase gene under 
the control of the SV40 promoter, was complexed with CDP (12 μg, 2 nmol) at a charge 
ratio (5±) that gives complete DNA binding.  The polyplexes were added in the presence 
of CQ or CQ analogues to HepG2 cells in 24-well plates.  Transfection efficiencies were 
determined by assaying for luciferase protein activity and reported in relative light units 
(RLU) per milligram of total cellular protein (Table 5.1). 
 The observed luciferase activity increased from 4.3×106 RLU/mg protein in the 
absence of CQ to 15.6×106 RLU/mg protein in the presence of CQ.  When the tertiary 
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alkyl amine side chain of CQ was replaced with either a hydrocarbon (CQ4a) or with a 
negatively charged carboxylate moiety (CQ4b), the luciferase activities of transfected 
cells were roughly the same as that in the absence of CQ (Table 1). CQ4c, a CQ analogue 
possessing a tertiary amine, enhances transfection to a degree similar to CQ.  These 
observations show the importance of the terminal tertiary amine moiety of CQ for 
enhancing polyplex transfection efficiency.  When more amine groups were introduced to 
the side chain of CQ (three amine groups in CQ4d-e and four amine groups in CQ4f), the 
maximal luciferase activities were only slightly higher than with CQ for HepG2 cells 
transfected in the presence of those analogues. 
 
 
 
 
CQ Analogues (conc.) RLU/mg protein (x 10-6) Cell Viability (%) 
None 4.3 100 
CQ (200 μM) 15.6 60 
CQ4a (150μM) 4.7 89 
CQ4b (150 μM) 4.3 84 
CQ4c (150 μM) 24.7 64 
CQ4d (200 μM) 21.5 74 
CQ4e (100 μM) 20.2 74 
CQ4f (150 μM) 25.0 83 
CQ7a (200 μM) 168.0 61 
CQ7b (200 μM) 2.7 100 
CP (200 μM) 6.4 85 
QC (20 μM) 24.6 57 
Table 5.1  Transfection of HepG2 Cells in the presence of CQ analogues 
HepG2 cells were transfected for 4 h with CDP/pGL3-CV polyplexes in the absence or 
presence of CQ or CQ analogues.  Gene expression was evaluated 48 h later by assaying 
the luciferase activity (in relative light units, RLU) of cell lysates.  The viability of the 
cells was assessed by measuring the total amount of recovered protein.  The CQ analogue 
concentrations represented in the table are those which gave the optimal increase in 
transfection efficiency. 
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 Dramatic changes in luciferase activity were observed for cells transfected in the 
presence of CQ analogues with variations on the quinoline ring and the same side chain 
moiety as CQ (Table 1 and Figure 5.2).  Replacement of the 7-chloro of CQ by a 
lipophilic trifluoro group (CQ7a) gave an order of magnitude increase in luciferase 
activity (15.6×106 RLU/mg protein for CQ to 168×106 RLU/mg protein for CQ7a).  
When the 7-substituent was removed (CQ7b), the CQ analogue completely lost the 
capacity for transfection enhancement.  CP, a CQ analogue with a pyridinyl structure, 
also had no contribution to transfection.  Quinacrine (QC), a CQ analogue having an 
acridine ring structure, enhanced transfection to a similar degree as CQ but at one-tenth 
the concentration.  QC is more toxic than CQ; a concentration of QC higher than 50 μM 
leads to complete cell death. 
 
 
 
a      b 
 
 
Figure 5.2  Effect of CQ analogues on transfection of HepG2 cells 
HepG2 cells were transfected with CDP/pDNA polyplexes in the presence of various CQ 
analogues.  Luciferase activity was used as a measure of transfection efficiency (a) and 
total protein was used as a measure of cell viability (b). 
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5.4.3 Cellular uptake of polyplexes in the presence of CQ analogues 
 Flow cytometry analysis was used to give a relative measure of pDNA uptake into 
cells (Figure 5.3, Table 5.2).  pDNA was labeled with Alexa-fluor-488, condensed into 
particles with CDP, and exposed to HepG2 cells for 30 minutes or 2 hours in the presence 
or absence of CQ or CQ analogues.  Cells were then analyzed by fluorescence-activated 
cell sorting (FACS).  Uptake of naked pDNA was minimal, as the mean fluorescence of 
cells treated with naked pDNA is the same as that of as untreated cells (Table 2).  Cells 
exposed to complexes of labeled DNA and CDP displayed increases in mean cellular 
fluorescence, indicating that polyplexes were internalized by cells.  Similar observations 
of internalization have been reported elsewhere [7,32].  At both 30 min and 2 h, cells 
exposed to polyplexes revealed significant uptake regardless of the presence of absence 
of CQ or CQ analogues.  12-19% of cells at 30 min. and 65-75% of cells at 2 h contained 
detectable levels of fluorescently-labeled pDNA (% positive, Table 2).  The presence of 
CQ or CQ analogues gave slightly reduced uptake relative to the case of polyplexes 
alone.  Also, the fluorescence distribution pattern was very similar at both 30 min and 2 h 
for cells transfected in the presence and absence of CQ or CQ analogues.  Although cells 
transfected in the presence of QC gave similar % positive and mean fluorescence as cells 
transfected in the presence of other CQ analogues, the values may not reflect actual 
polyplex uptake because QC is itself fluorescent at the wavelengths used for the FACS 
analysis (data not shown). 
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30 min 2 h pDNA or 
Polyplexes 
CQ or 
CQ 
analogue 
% 
negative
% 
positive
Mean 
fluorescence
% 
negative
% 
positive 
Mean 
fluorescence
- - 99.2 0.8 4.1 99.7 0.3 3.45 
pDNA - 99.3 0.7 4.0 98.9 1.1 5.48 
Polyplexes - 82.8 17.5 12.9 20.9 79.3 125.7 
Polyplexes CQ 85.5 11.9 10.0 32.5 67.7 79.3 
Polyplexes CQ7b 82.2 18.8 15.0 24.7 75.5 88.3 
Polyplexes CQ7a 85.4 14.8 9.2 35.0 65.2 78.1 
Polyplexes CP 87.4 12.8 7.6 24.0 76.2 109.0 
Table 5.2  Summary of flow cytometry analysis of polyplex uptake in the absence or 
presence of CQ analogues 
 
 
 
 
Figure 5.3  Flow cytometry analysis of polyplex uptake in the presence of CQ analogues 
pDNA labeled with Alexa-fluor-488 was condensed with CDP and administered to 
HepG2 cells.  Uptake was terminated at 30 min and 2 h and cells were analyzed by flow 
cytometry.  Uptake of polyplexes was similar in the absence of any CQ analogue (a) or in 
the presence of 200 μM CQ (b), 200 μM CQ7b (c), or 200 μM CQ7a (d).  The cellular 
fluorescence was analyzed at 0 min (I), 30 min (II), or 2 h (III). 
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5.4.4 Uptake and intracellular concentration of CQ analogues 
 CQ can penetrate the cell membrane and accumulate in acidic compartments, 
especially in lysosomes, in a time-dependent manner [7].  The concentration of CQ in 
HepG2 cells (as measured by its fluorescence in cell lysates) increased as a function of 
treatment time and reached nearly 12 mM following 4 h of treatment with 100 μM CQ 
(Figure 5.4).  CQ accumulated in HepG2 cells with a cell-to-medium concentration ratio 
of ~100.  Relative to CQ, CQ7a achieved a more rapid intracellular accumulation and 
reached a concentration of 11 mM in cells only 30 min after exposure to 100 μM CQ7a 
(Figure 5.4).  Beyond this time, the intracellular concentration of CQ7a remained steady 
throughout the 4 h uptake study.  The achieved intracellular concentrations noticeably 
exceeded the 0.1 mM concentration in the surrounding medium. 
 The uptake of CQ and CQ7a into HepG2 cells was also investigated in the 
presence of pDNA/CDP polyplexes.  Both CQ and CQ7a exhibited strong uptake; after 4 
h, intracellular concentrations were 13-15 mM, slightly higher than their concentrations 
in the absence of polyplexes. 
 When the substituent at the 7-position of CQ was removed, the resulting CQ 
analogue (CQ7b) showed a lower tendency to accumulate in cells.  The maximum 
intracellular concentration of CQ7b was around 2 mM after 4 h treatment, about five 
times lower than that of CQ or CQ7a. These uptake analyses demonstrate that the 
transmembrane capability of CQ and its analogues are closely related to the substituent at 
the 7-position of the quinoleic ring.  The trifluoromethyl group is a strong electron-
withdrawing, lipophilic group, and CQ7a that contained this group showed fast cell-
membrane penetration and intracellular accumulation relative to CQ. 
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   The observed concentrations are averaged across cells; if taken into cells, CQ 
analogues that accept protons at the relevant pH are likely found at much greater 
concentrations in vesicles of the endocytic pathway.  CQ is believed to accumulate in 
such vesicles as a result of its intravesicular protonation [33]. 
 
 
 
 
 
 
 
 
Figure 5.4  Uptake and intracellular accumulation of CQ analogues 
HepG2 cells were exposed to CQ analogues (0.1 mM) in the presence or absence of 
polyplexes, and the fluorescence of cell lysates was used to evaluate the intracellular 
concentration of CQ analogues at various timepoints after initial exposure. 
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5.4.5 Interaction of CQ analogues with pDNA 
 It is well-known that CQ can bind DNA [22,34].  Previous work has indicated that 
CQ exists as a doubly-protonated cation in dilute aqueous solutions at physiological pH, 
and its binding to DNA is related to insertion of its quinoleic moiety into DNA base pairs 
and to electrostatic interaction between the cationic side chain and the phosphate anions 
along the DNA backbone [22].  The binding of CQ to DNA could lead to destabilization 
of the association between the plasmid and the delivery vehicle polycations [7]. 
 The binding of CQ and its analogues to DNA was evaluated by stepwise addition 
of small increments of pDNA to a solution containing a constant concentration of a CQ 
analogue at 20 μM.  As shown in Figure 5.5, progressive depression of the UV 
absorption peaks from the CQ analogues and a shift of these peaks towards longer 
wavelengths occurred with all the compounds studied.  These results suggest that CQ 
analogues can interact with pDNA.  
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a      b 
  
 
 
c      d 
  
 
 
Figure 5.5  Interaction of pDNA with CQ analogues 
The absorbance of CQ analogue solutions (20 μM) was monitored in the presence of 
varying concentrations of pDNA: 0 nM (A), 1.8 nM (B), 7.5 nM (C), 15 nM (D), 37.5 
nM (E), or 150 nM (F).  The CQ analogues examined – CQ (a), QC (b), CQ7a (c), and 
CQ7b (d) – all exhibited interactions with pDNA. 
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5.4.6 Electrophoretic mobility of pDNA in the presence of CQ analogues 
 pDNA was incubated in the presence of the CQ analogues at various 
concentrations, and the change of its mobility on an agarose gel was investigated (Figure 
5.6).  The band from pDNA treated with CQ7a at 100 μM showed essentially the same 
pattern as the untreated control, indicating that CQ7a had little effect on the mobility of 
pDNA at this concentration.  pDNA treated with CQ7a at a concentration one-order of 
magnitude higher (1 mM) showed slightly retarded movement while the motility of the 
pDNA was completed prohibited when treated with CQ7a at 10 mM.   For comparison, 
CQ7b had little effect on the pDNA retardation when treated with CQ7b at the same 
concentration range (0.1-10 mM).  CQ at 100 μM and 1 mM did not retard pDNA, but 
did so slightly at 10 mM. 
 
 
Figure 5.6  Electrophoretic mobility of pDNA in the presence of CQ, CQ7a, or CQ7b 
Plasmid DNA was incubated with various concentrations of CQ analogues, loaded to an 
agarose gel, and subjected to electrophoresis.  CQ7a showed the strongest interactions 
with DNA, and some interaction was also apparent with CQ. 
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5.4.7 DNA displacement from polyplexes by CQ, CQ7a, or CQ7b 
 Polyplexes can be separated from unpackaged pDNA by filtration.  To assess the 
stability of CDP/pDNA polyplexes against CQ analogues, solutions of polyplexes and 
CQ analogues were filtered to remove intact polyplexes, and unpackaged pDNA in the 
filtrate was measured by a fluorescence method (Figure 5.7).  CQ7a was able to displace 
40% of total condensed pDNA at a concentration as low as 500 μM.  40-50% of the 
pDNA was found in the filtrate for CQ7a concentrations of 500 μM to 10mM, and over 
70% of pDNA was displaced with a CQ7a concentration of 20 mM.  CQ displayed 
weaker ability to displace pDNA than CQ7a.  The pDNA displaced from the polyplexes 
by CQ gradually increased from 10% with 500 μM CQ to roughly 50% with 20 mM CQ.  
With CQ7b, less than 3% of free displaced pDNA was detected in the filtrate at a 
concentration of 2.5 mM or lower.  The displaced pDNA gradually increased from 10% 
to about 30% when polyplexes were treated with 5 mM to 20 mM of CQ7b, respectively. 
 
 
 
Figure 5.7  DNA displacement from polyplexes by CQ, CQ7a, or CQ7b 
CDP/pDNA polyplexes were incubated with various concentrations of CQ, CQ7a, or 
CQ7b, then filtered to remove intact polyplexes.  Displaced DNA in the filtrate was then 
quantified.  CQ7a showed the strongest ability to displace DNA, followed by CQ. 
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5.4.8 Accessibility of pDNA in the presence of CQ analogues 
 The examinations of CQ analogue interaction with nucleic acids (and/or 
polyplexes) led us to focus on a smaller set of molecules for further study: CQ, CQ7a 
(shows strong effects on transfection and strong interactions with DNA), and CP (not 
effective in increasing transfection; a single-ring structure that should impede interaction 
with DNA).  One of the motivations of our study was to elucidate the role of endocytic 
vesicle buffering by CQ in gene transfer; we synthesized an additional CQ analogue, CQO 
(where an oxygen replaces the secondary aniline at the 4 position of chloroquine), in order 
to examine a compound that retained CQ’s interaction with nucleic acids through its dual-
ring structure but had less ability to buffer the pH of endocytic compartments. 
 PicoGreen experiences significant fluorescence enhancement upon intercalation 
in nucleic acids, such that its exclusion indicates inaccessibility of the nucleic acids to 
intercalation [30].  This characteristic was used to evaluate the relative accessibility of 
pDNA in the presence of CQ analogues.  Polyplexes were incubated with various 
concentrations of CQ analogues, combined with solutions of PicoGreen, and evaluated 
for fluorescence intensity (Figure 5.8).  CQ7a, CQ, and CQO demonstrated 
enhancements in dye exclusion with increasing concentration.  Dye exclusion was ~30% 
for 0.5 or 1 mM CQ7a and rose to almost 100% at 4 mM.  Dye exclusion was ~23% for 
CQ (0.5 or 1 mM) and ~17% for CQO (0.5 or 1 mM), with slightly greater exclusion for 
CQ/CQO at 4 mM.  PicoGreen was not excluded from DNA by CP. 
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Figure 5.8  Dye exclusion from pDNA in the presence of CQ analogues 
pDNA was incubated with various concentrations of CQ analogues, then combined with 
solutions of PicoGreen, a DNA-intercalating dye.  DNA alone showed strong 
fluorescence, but CQ analogues produced marked increases in dye exclusion, most 
significantly with CQ7a. 
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5.4.9 Intracellular buffering activity of CQ analogues 
 To evaluate the actual intracellular buffering activity of CQO and other CQ 
analogues, we employed the method of Kulkarni, et al. [29], in which polyplexes labeled 
with the pH-sensitive fluorophore SNARF-4F are administered to cells and used to 
evaluate the local pH environment of polyplexes within individual cells.  The data can be 
compiled in aggregate to indicate the actual buffering activity of CQ analogues within 
cells (Figure 5.9).  By this measure, CQ and CQ7a (0.1 mM) displayed strong buffering 
activity relative to the absence of any CQ analogues.  CQO displayed mild buffering 
activity, while CP exhibited none. 
 
 
 
 
Figure 5.9  Intracellular buffering activity of CQ analogues 
The ability of CQ analogues to buffer the pH experienced by CDP polyplexes was 
evaluated.  Polyplexes containing CDP and a SNARF-4F-labeled oligonucleotide were 
administered to HeLa cells along with CQ analogues (0.1 mM).  Confocal microscopy 
was used to visualize intracellular SNARF-4F-labeled polyplexes.  The pH environment 
of the polyplexes could be evaluated using the pH-sensitivity of SNARF-4F [29].  CQ 
and CQ7a display strong, similar buffering activity, while CQO shows mild buffering and 
CP does not exhibit pH-buffering of polyplexes. 
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5.4.10 Transfection with CQ analogues in HeLa cells 
 The intracellular buffering activity of CQ analogues was evaluated in HeLa cells 
(Figure 5.8).  To compare these results more directly with effects on transfection 
efficiency, HeLa cells were transfected with CDP/pDNA polyplexes in the presence or 
absence of the selected CQ analogues (CQ, CQ7a, CQO, and CP).  The trends in the 
transfection levels for CQ, CQ7a, and CP in HeLa cells were consistent with 
transfections of HepG2 cells (Figure 5.10).  Both CQ and CQ7a conferred a 
concentration-dependent increase in transfection efficiency; this increase was greater 
with CQ7a.  CQO produced little to no increase in luciferase expression, and CP 
produced no increase. 
 
 
 
Figure 5.10  Effect of CQ analogues on transfection of HeLa cells 
HeLa cells were transfected with CDP/pDNA polyplexes in the presence of various CQ 
analogues.  Luciferase activity was used as a measure of transfection efficiency. 
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5.4.11 Measure of unpackaged intracellular nucleic acids following transfection in the 
presence of CQ analogues 
 The comet assay is a standard method of evaluating DNA damage [35,36].  In this 
assay, cells are gently lysed, embedded in an agarose gel on a glass slide or coverslip, and 
exposed to electrophoresis.  Only damaged cellular DNA is reduced to a size that permits 
migration within the gel, and this damaged DNA will generate a characteristic “comet” 
pattern upon subsequent intra-gel labeling of nucleic acids by a fluorescent marker.  The 
size and fluorescence intensity of the comet reflects the extent of DNA damage.  By this 
method, individual cells may be visually evaluated for DNA damage. 
 We have modified this assay to produce an aggregate separation and visualization 
of delivered and unpackaged nucleic acids.  Rather than evaluating samples on an 
individual-cell basis, cells are collected by centrifugation, lysed, embedded in an agarose 
gel, and subjected to electrophoresis in order to generate a relative measure of DNA 
unpackaging for a particular sample.  Also, we transfect cells using nucleic acids 
covalently modified with a fluorescent marker rather than adding a fluorescent label after 
electrophoresis.  Thus, we are able to distinguish exogenous (delivered) nucleic acids 
from cellular DNA.  The “unpackaged” oligonucleotide measured by this assay is that 
which migrates through the agarose gel to the same extent as in the case of direct gel 
loading of the oligonucleotide. 
 HeLa cells were transfected in the presence of CQ analogues and examined by 
this assay. Despite the activity of CQ and CQ7a in displacing pDNA from polyplexes 
(Figure 5.7), samples transfected with these CQ analogues actually generate less 
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unpackaged (migrating) DNA than samples transfected without CQ analogues or samples 
transfected in the presence of CQO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11  Separation of unpackaged nucleic acid from transfected cells 
When cells transfected with a FITC-labeled oligonucleotide are collected, lysed, 
embedded in an agarose gel, and subjected to electrophoresis, migrating oligonucleotide 
can be detected through the fluorescence of the FITC-label.  As the leading band of this 
oligonucleotide migrates to the same extent as oligonucleotide loaded directly to the gel 
(not shown), it can be interpreted to be unpackaged.  Cells transfected in the presence of 
CQ or CQ7a produce less unpackaged (migrating) FITC-oligo than cells transfected in 
the absence of chloroquine analogues or in the presence of CQO. 
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Discussion 
 Chloroquine (CQ) enhances the transfection efficiency of many non-viral gene 
delivery vectors, but the means by which this occurs is not well established.  Here, we 
contribute to the understanding of CQ-related increases in gene expression by studying a 
number of CQ analogues whose structures are designed to probe hypothesized 
mechanisms, i.e., pH buffering of endocytic vesicles.  This is the first study to correlate 
the CQ structure with its function during gene transfer. 
 Several CQ analogues were designed and synthesized and their ability to enhance 
gene transfer investigated.  As shown by the data in Table 5.1, the side chain structure of 
CQ is important to enhancing transfection.  CQ4a and CQ4b, CQ analogues that lack 
side-chain cationic amino groups, show no effects on gene transfer.  However, the side-
chain amino group is not entirely responsible for CQ’s activity, because transfection is 
not enhanced by some CQ analogues containing this group (CQ7b and CP). 
 CQ analogues bearing more than two amino moieties (CQ4d-f) are more basic 
than CQ.  Expression levels in the presence of those CQ analogues are essentially the 
same as CQ and as a CQ analogue with only two amino moieties (CQ4c), indicating that 
the basicity of CQ is not the major reason for its effects on gene transfer. 
 The aromatic ring structure of CQ clearly contributes to its function as a 
transfection-enhancing agent (Figure 5.2).  CP, a pyridinyl-based CQ analogue, does not 
increase gene expression at all, while QC, an acridine-based CQ analogue, enhances the 
transfection at an optimal concentration of 20 μM, ten times lower than the optimal 
concentration of CQ.  QC and CP show higher and lower toxicity than CQ, respectively.  
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Therefore, both CQ’s enhancement of gene expression and its toxicity are related to the 
aromatic ring structure. 
 Dramatic effects on gene expression occur with changes in the 7-substituent of the 
CQ aromatic ring (while maintaining the side chain of CQ).  When the 7-Cl group of CQ 
is replaced with a proton (CQ7b), the CQ analogue loses its capacity to enhance gene 
expression.  If a trifluoromethyl group (CQ7a) is used instead of the 7-Cl group, the 
transfection enhancement is markedly improved relative to enhancement by CQ (Table 
5.1, Figure 5.2, Figure 5.10). 
 There are no significant effects on the uptake of polyplexes in the presence of the 
CQ analogues, and the intracellular concentrations of CQ and CQ7a are similar at 4 h 
(Figure 5.3).  Apparently, the differences in transfection enhancement between CQ and 
CQ7a are not due to differences in uptake.  However, CQ7b indicates that the lipophilic 
or the electron-withdrawing character of the 7-substituent can contribute to the uptake of 
CQ analogues, providing some explanation for the lack of effect on transfection 
efficiency by CQ7b and possibly CP.  The absorbance spectra of CP and CQO do not 
allow their cellular uptake to be measured using the method employed for other CQ 
analogues. 
 The intracellular buffering activity of CQ, CQ7a, and CQO shows a correlation 
between gains in transfection efficiency and buffering of the pH experienced by 
polyplexes within cells (Figures 5.9, 5.10).  CQO does not enhance transfection 
efficiency; this molecule interacts with nucleic acids in a manner similar to CQ (Figure 
5.8) but displays reduced buffering activity.  CQ analogues without a side chain amino 
group (CQ4a, CQ4b) should have reduced pH-buffering activity, and they do not reveal 
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the enhancement in gene expression that is seen with variants containing one or more side 
chain amino groups (CQ, CQ4c-f) (Table 5.1).  Together, these results support the 
hypothesis that CQ’s pH-buffering of endocytic vesicles is necessary for its contributions 
to transfection efficiency. 
 Buffering does not, however, provide a full explanation of CQ’s contributions to 
transfection efficiency.  The participation of both the side chain and the aromatic ring in 
increasing transfection efficiency suggests that CQ may achieve its function through 
multiple mechanisms.  Also, the intracellular buffering by CQ and CQ7a is functionally 
similar, so the buffering hypothesis does not explain the significant additional increase in 
transfection efficiency when CQ is replaced with CQ7a.  Compounds such as monensin, 
methylamine, spermine, and ammonium chloride are known to buffer endocytic vesicles 
but do not contribute to transfection efficiency [7], providing additional indication that 
buffering activity is not a sufficient condition for improved transfection. 
 CQ, CQ7a, and QC all confer sharp gains in transfection efficiency, but dramatic 
variations in their performance suggest that CQ’s effect on transfection efficiency is 
related to its interactions with DNA.  Parker et al. have demonstrated that CQ can bind to 
both DNA and RNA in vitro, an interaction which can alter the biological and physical 
properties of the DNA [34].  Interactions between DNA and CQ analogues are strongly 
associated with the aromatic structures of those ligands.  Because of its acridine structure, 
QC exhibits strong interactions with DNA, and this molecule is a potent enhancer of gene 
transfer at relatively low concentration.  The single aromatic ring of CP should render 
this molecule unable to bind DNA as effectively as its multi-ring analogues, consistent 
with the fact that CP does not enhance gene transfer. 
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 In addition to ring structure, the electron-withdrawing character of the substituent 
at the 7-position can affect the strength of binding between CQ analogues and DNA [23].  
This effect is demonstrated by gel retardation of pDNA with various concentrations of 
CQ, CQ7a, and CQ7b (Figure 5.6).  CQ7a shows the strongest interaction with pDNA, 
displaying some retardation of pDNA electrophoresis at 1 mM and essentially complete 
retardation at 10 mM.  CQ7b shows a weaker interaction with pDNA, as pDNA mobility 
did not change in the presence of CQ7b over a wide range of concentrations.  The 
strength of interaction between CQ and pDNA is likely intermediate of those from CQ7a 
and CQ7b since CQ slightly retarded pDNA electrophoresis at 10 mM. 
 DNA must be dissociated from polycations in order to achieve gene expression.  
We have shown that CDP/pDNA polyplexes do not reach the nucleus of transfected cells, 
but deliver unpackaged pDNA to both the cytoplasm and cell nucleus [32].  It is likely 
that gene transfer is improved with enhanced intracellular unpackaging [37].  The 
presence of CQ analogues can destabilize polyplexes, generating unpackaged pDNA 
(Figure 5.7).  The ability to displace pDNA from CDP decreases in the order of CQ7a, 
CQ, and CQ7b, corresponding to the order of binding strengths displayed by the gel 
retardation assay.  Although cells may be exposed to relatively low concentrations of CQ 
analogues during transfection, intracellular accumulation drives the concentrations within 
cells to much higher levels (Figure 5.4).  For CQ and CQ7a, these concentrations are 
sufficient to disrupt polyplexes.  The cellular average concentrations measured here 
should be less still than the concentrations found in the vesicles of the endocytic pathway, 
where CQ accumulates within cells [33], it is therefore likely that polyplexes in the 
endocytic pathway will be subject to unpackaging in the presence of CQ. 
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 The biological and physical properties of DNA can be altered when it is bound by 
CQ [34].  CQ7a, which displays stronger binding affinity for DNA, can be expected to 
have similar effects.  Beyond their activity in displacing DNA from polyplexes, CQ and 
CQ7a appear to interact directly with nucleic acids, even when those nucleic acids have 
been delivered to cells (Figures 5.8, 5.11).  Strong binding by numerous CQ7a molecules 
could alter the physical properties of pDNA and reduce the overall negative charge of its 
backbone via electrostatic interaction between the anionic phosphate groups of pDNA 
and cationic amino side chains of CQ7a.  When bound by CQ, pDNA could achieve 
improved gene transfer due to changes in its intracellular processing or its rate of 
intracellular degradation [38-39]. 
 CQ7a greatly enhances gene expression over CQ (Figures 5.1, 5.9), an effect that 
is not explained by intracellular buffering activity alone.  The observed higher luciferase 
activity from transfection in the presence of CQ7a is likely due to CQ7a’s greater 
displacement of polycations (Figure 5.8) and its stronger interactions with intracellular 
nucleic acids (Figures 5.6, 5.10, 5.11). 
 In summary, a structure-function correlation among CQ and its analogues in non-
viral, polycation-based gene delivery is reported.  It is demonstrated that the tertiary 
amino moiety of CQ is important to its enhancement of gene expression.  Further, 
changes in the aromatic ring of CQ significantly affect its ability to enhance gene 
expression.  A CQ analogue with a three fused aromatic ring structure (QC) shows much 
high cytotoxicity than CQ and can enhance transfection similarly to CQ at a 
concentration 10 times lower.  A CQ analogue with one pyridinyl aromatic ring (CP) 
gives lower cytotoxicity than CQ but has no effect on gene transfer.  Variation at the 7-
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position of CQ dramatically changes its ability to enhance transfection.  Transfection 
with a 7-trifluoromethyl CQ analogue (CQ7a) shows luciferase activity an order of 
magnitude higher than transfection with the same concentration of CQ (0.2 mM), while 
transfection is not affected by in the presence of a 7-H CQ analogue (CQ7b).  The fused 
aromatic ring structure (acridinyl ring) in QC and the strong electron-withdrawing group 
(trifluoromethyl) in CQ7a endow these molecules with higher binding affinity to DNA.  
Also, the stronger intercalator, CQ7a, has a higher tendency than CQ to competitively 
displace the polycation from CDP/pDNA polyplexes at a concentration that is achievable 
intracellularly after several hours treatment.  Finally, CQ and CQ7a appear to interact 
directly with nucleic acids in cells. 
 Thus, we propose that the mechanism of CQ action is three-fold (Figure 5.12).  
One, intracellular accumulation of CQ drives its concentration to a point at which it is 
able to facilitate unpackaging of nucleic acids from the polyplexes.  CQ accumulates in 
cells to concentrations greatly exceeding that in the extracellular medium; it reaches still 
higher concentrations in the vesicles of the endocytic pathway, where internalized 
polyplexes are also delivered.  Second, consistent with numerous literature reports, CQ 
buffers the vesicles of the endocytic pathway, helping delivered nucleic acids escape 
from these vesicles and/or avoid lysosomal degradation.  Third, intracellular interactions 
between CQ and unpackaged nucleic acids contribute to gene expression.  CQ can bind to 
the DNA via interaction with DNA bases and through electrostatic interaction with 
anionic phosphate groups.  These interactions lead to changes in the biological and 
physical properties of the delivered nucleic acids, possibly altering their intracellular 
processing or slowing their degradation. 
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Figure 5.12  Proposed model for CQ enhancement of non-viral gene delivery 
The results of this work suggest that CQ acts to increase the transfection efficiency of 
non-viral gene delivery vectors through three modes.  First, polyplexes encounter high 
concentrations of CQ in the endocytic pathway, leading to enhanced unpackaging of 
delivered DNA.  Second, CQ buffers the pH of endocytic vesicles, helping the DNA 
escape the endocytic pathway.  Third, DNA binding by CQ also facilitates transfection, 
perhaps by altering the trafficking, processing, or degradation of the DNA within cells. 
   
 
133
 
5.6 Acknowledgment 
 Many people contributed to the work in this chapter, and their efforts are very 
much appreciated.  In particular, Jianjun Cheng and Ryan Zeidan were responsible for the 
synthesis of the chloroquine analogues and Rajan Kulkarni collected the data on 
intracellular pH-buffering activity.  This work also reflects contributions from Aijie Liu, 
Suzie Pun, Greg Jensen, and Nathalie Bellocq. 
 
5.7 References 
1. Hwang SJ, Davis ME (2001) Cationic polymers for gene delivery: Designs for 
overcoming barriers to systemic administration. Curr. Opin. Mol. Ther. 3:183-
191. 
2. Davis ME (2002) Non-viral gene delivery systems. Curr. Opin. Biotechnol. 
13:128-131. 
3. Lechardeur D, Verkman AS, Lukacs GL. (2005) Intracellular routing of plasmid 
DNA during non-viral gene transfer. Adv Drug Deliv Rev. 57:755-67. 
4. Wagner E, Zenke M, Cotton M, Beug H, Birnstiel ML (1990) Transferrin-
Polycation Conjugates as Carriers for DNA Uptake into Cells. Proc. Natl. Acad. 
Sci. USA 87:3410-3414. 
5. Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel ML (1990) 
Receptor-Mediated Endocytosis of Transferrin Polycation Conjugates - an 
Efficient Way to Introduce DNA into Hematopoietic-Cells. Proc. Natl. Acad. Sci. 
USA 87:3655-3659. 
6. Midoux P, Mendes C, Legrand A, Raimond J, Mayer R, Monsigny M, Roche AC 
(1993) Specific gene transfer mediated by lactosylated poly-L-lysine into 
hepatoma cells. Nucleic Acids Res. 21:871-8.  
7. Erbacher P, Roche AC, Monsigny M, Midoux P (1996) Putative role of 
chloroquine in gene transfer into a human hepatoma cell line by 
DNA/lactosylated polylysine complexes. Exp Cell Res. 225:186-94. 
8. Monsigny M, Roche AC, Midoux P, Mayer R (1994) Glycoconjugates as carriers 
for specific delivery of therapeutic drugs and genes. Adv. Drug Deliv. Rev. 14:1-
24. 
9. Gonzalez H, Hwang SJ, Davis ME (1999) New class of polymers for the delivery 
of macromolecular therapeutics. Bioconjug. Chem. 10:1068-1074. 
10. Hwang SJ, Bellocq NC, Davis ME (2001) Effects of structure of beta-
cyclodextrin-containing polymers on gene delivery. Bioconjug. Chem. 12:280-
290. 
11. Pun SH, Davis ME (2002) Development of a nonviral gene delivery vehicle for 
systemic application. Bioconjug. Chem. 13:630-639. 
   
 
134
 
12. Reineke TM, Davis ME (2003) Structural effects of carbohydrate-containing 
polycations on gene delivery. 2. Charge center type. Bioconjug. Chem. 14, 255-
261. 
13. Reineke TM, Davis ME (2003) Structural effects of carbohydrate-containing 
polycations on gene delivery. 1. Carbohydrate size and its distance from charge 
centers. Bioconjug. Chem. 14, 247-254. 
14. Popielarski SR, Mishra S, Davis ME (2003) Structural effects of carbohydrate-
containing polycations on gene delivery. 3. Cyclodextrin type and 
functionalization. Bioconjug. Chem. 14, 672-678. 
15. Irvin JL, Irvin EM (1947) Spectrophotometric and Potentiometric Evaluation of 
Apparent Acid Dissociation Exponents of Various 4-Aminoquinolines. J. Am. 
Chem. Soc. 69:1091-99. 
16. Maxfield FR (1982) Weak Bases and Ionophores Rapidly and Reversibly Raise 
the Ph of Endocytic Vesicles in Cultured Mouse Fibroblasts. J. Cell Biol. 95:676-
681. 
17. Poole B, Ohkuma S (1981) Effect of Weak Bases on the Intralysosomal Ph in 
Mouse Peritoneal-Macrophages. J. Cell Biol. 90:665-669. 
18. Sonawane ND, Szoka FC, Verkman AS (2003) Chloride accumulation and 
swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J 
Biol Chem. 278:44826-31. 
19. Wibo M, Poole B (1974) Protein degradation in cultured cells. II. The uptake of 
chloroquine by rat fibroblasts and the inhibition of cellular protein degradation 
and cathepsin B1. J. Cell Biol. 63:430-40. 
20. Poole B, Ohkuma S, Warburton MJ (1977) The accumulation of weakly basic 
substances in lysosomes and the inhibition of intracellular protein degradation. 
Acta Biol Med Ger. 36:1777-88. 
21. Behr J-P (1997) The proton sponge: A trick to enter cells the viruses did not 
exploit. Chimia 51:34-36. 
22. Allison JL, O'Brien RL, Hahn FE (1965) DNA: reaction with chloroquine. 
Science 149:1111-3. 
23. Cohen SN, Yielding KL (1965) Spectrophotometric Studies of Interaction of 
Chloroquine with Deoxyribonucleic Acid. J. Biol. Chem. 240:3123-31. 
24. Egan T (2001) Structure-Function Relationships in Chloroquine and Related 4-
Aminoquinoline Antimalarials. Mini Reviews in Medicinal Chemistry 1:113-123. 
25. Kaschula CH, Egan TJ, Hunter R, Basilico N, Parapini S, Taramelli D, Pasini E, 
Monti D (2002) Structure-activity relationships in 4-aminoquinoline 
antiplasmodials. The role of the group at the 7-position. J. Med. Chem. 45:3531-9.   
26. Egan TJ, Hunter R, Kaschula CH, Marques HM, Misplon A, Walden J (2000) 
Structure-function relationships in aminoquinolines: effect of amino and chloro 
groups on quinoline-hematin complex formation, inhibition of beta-hematin 
formation, and antiplasmodial activity. J. Med. Chem. 43:283-91.  
27. De D, Krogstad FM, Byers LD, Krogstad DJ (1998) Structure-activity 
relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. 
J. Med. Chem. 41:4918-26. 
28.  Erbacher P, Roche AC, Monsigny M, Midoux P (1995) Glycosylated 
polylysine/DNA complexes: gene transfer efficiency in relation with the size and 
   
 
135
 
the sugar substitution level of glycosylated polylysines and with the plasmid size. 
Bioconjug Chem. 6:401-10. 
29. Kulkarni RP, Mishra S, Fraser SE, Davis ME (2005) Single-cell kinetics of 
intracellular, nonviral, nucleic acid delivery vehicle acidification and trafficking. 
Bioconjug. Chem. 16:986-94. 
30. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring 
polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. 
J. Gene Med. 7:657–63. 
31. De D, Byers LD, Krogstad DJ (1997) Antimalarials: Synthesis of 4-
aminoquinolines that circumvent drug resistance in malaria parasites. J. 
Heterocyclic Chem. 34:315-20. 
32. Mishra S, Webster P, Davis ME (2004) PEGylation significantly affects cellular 
uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. 
Cell Biol. 83:97-111. 
33. Poole B, Ohkuma S (1981) Effect of weak bases on the intralysosomal pH in 
mouse peritoneal macrophages. J. Cell Biol. 90:665-9. 
34. Parker FS, Irvin JL (1952) The Interaction of Chloroquine with Nucleic Acids and 
Nucleoproteins. J. Biol. Chem. 199:897-909. 
35. Ostling O, Johanson KJ (1984) Microelectrophoretic study of radiation-induced 
DNA damages in individual mammalian cells. Biochem. Biophys. Res. Comm. 
36. Singh NP, McCoy M, Tice RR, Schneider E (1988) A simple technique for 
quantitation of low levels of DNA damage in single cells. Exp. Cell Res. 175:184-
91. 
37. Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA (2000) Vector unpacking 
as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol 
Bioeng. 67:598-606.  
38. Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M, Graham RW, Beatty B, 
Squire J, O’Brodovich H, Lukacs GL (1999) Metabolic instability of plasmid 
DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6:482-97. 
39. Lukacs GL, Haggie P, Seksek O, Lechardeur D, Freedman N, Verkman AS 
(2000) Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 
275:1625-9. 
 136
CHAPTER 6: INTRODUCTION OF A TERMINAL IMIDAZOLE GROUP HAS 
MULTIPLE EFFECTS ON THE GENE DELIVERY BEHAVIOR OF A 
CYCLODEXTRIN-CONTAINING POLYCATION 
 
6.1 Abstract 
 The cyclodextrin-containing polycation (CDP) is one of many non-viral gene 
delivery vectors that show improved transfection efficiency when modified to have pH-
buffering capacity.  This feature is presumed to confer enhanced ability to escape the 
endocytic pathway.  Here, the differences in delivery behavior between CDP and its pH-
buffering, imidazole-terminated variant (CDPimid) are investigated in order to elucidate 
the mechanism(s) by which these related materials exhibit differences in gene delivery.  
In cell-free assays that include dye exlusion and heparan sulfate displacement, CDP 
appears to have weaker binding strength with nucleic acids than CDPimid.  Analysis of 
transfected cells, however, indicates that CDPimid more readily releases nucleic acids in 
the intracellular setting, suggesting that differences in transfection efficiency between 
CDP and CDPimid may result from factors beyond buffering activity and endosomal 
escape.  Transfection in the presence of chloroquine analogues provides further evidence 
of differences in the intracellular processing of CDP and CDPimid polyplexes. 
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6.2 Introduction 
 The delivery efficiency of non-viral vectors must be improved if these materials 
are to achieve their therapeutic potential.  A bevy of materials have been identified which 
are capable of condensing nucleic acids into small particles and delivering them to cells.  
Despite extensive uptake of exogenous nucleic acids by cells, non-viral vectors do not 
generate the levels of gene expression that are possible with viral vectors.  Further 
development of non-viral vectors has been hindered by poor understanding of the 
intracellular fate of the gene delivery particles. 
 Once internalized by cells, non-viral gene delivery particles are generally 
deposited into the endocytic pathway and must escape in order to avoid degradation by 
the lysosomal system [1-6].  Little is known about the particles’ intracellular trafficking 
or how these circumstances affect delivery and expression.  However, many researchers 
have considered that escape from the endocytic pathway may be facilitated by exploiting 
the progressive acidification of its compartments [7-8].  This approach has been inspired 
in part by the influenza virus, in which acidic pH triggers reorganization of the 
hemagglutinin protein and facilitates viral escape from the endocytic pathway.  The 
intracellular pH-buffering activity of some polymers, particularly polyethyleneimine 
(PEI), has been linked to increases in transfection efficiency [5,9], and the utility of pH-
buffering activity in nonviral gene transfer has been supported by increases in 
transfection efficiency in the presence of chloroquine, a small molecule that can buffer 
the vesicles of the endocytic pathway. 
 The majority of early non-viral vectors, including poly-L-lysine or the 
cyclodextrin-containing polycation (CDP), do not contain any pH buffering elements 
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[10,11].  However, the positive aspects of these non-buffering materials (such as the low 
cytotoxicity of CDP) have motivated efforts to improve their gene delivery performance 
through rational modification.  The relative effectiveness of pH-buffering vectors, most 
notably PEI, has prompted incorporation of buffering elements in both existing and novel 
non-buffering delivery vectors; these modified materials often exhibit improvements in 
transfection efficiency [11-15]. 
 Modification of CDP with a terminal imidazole group has been shown to improve 
its transfection efficiency at low charge ratios (of most interest for systemic 
administration) without concomitant increases in toxicity [12].  Recent reports, however, 
have shown that pH-buffering activity does not always correlate with improved 
transfection efficiency, raising questions about the value or necessity of this feature in 
non-viral vectors [16-19].  Differences in delivery behavior between CDP and its pH-
buffering, imidazole-terminated variant (CDPimid) were investigated in order to 
elucidate mechanism(s) by which these two related materials exhibit differences in gene 
delivery behavior.  The goal of this work is to obtain further experimental evidence to 
evaluate the value and necessity of pH-buffering components in non-viral gene delivery 
systems. 
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6.3 Materials and methods 
6.3.1 Polycations, pDNA, and polyplexes 
 A β-cyclodextrin-containing polycation (CDP) and its imidazole-terminated 
variant (CDPimid) were synthesized as described previously [12] (Figure 6.1).  The DNA 
plasmid pGL3-CV (Promega, Madison, WI), containing the luciferase gene under the 
control of the SV40 promoter, was amplified by E. coli strain DH5α and purified using 
the Ultramobius 1000 plasmid kit (Novagen, San Diego, CA).  Polyplexes were 
formulated at a charge ratio of 5± by adding solutions of polycation (CDP or CDPimid) 
(1.03 mg/mL in dH2O) to equal volumes of nucleic acids (0.1 mg/mL in dH2O) and 
incubating for 30 min.  For surface modification with poly(ethylene glycol) 
(PEGylation), 35 μg adamantane-PEG (Ad-PEG, 100 mg/mL in dH2O) per μg DNA was 
added to CDP or CDPimid polyplexes after formulation, and solutions were incubated a 
further 30 min [20].  25-kD branched polyethylenimine (PEI) (Sigma, St. Louis, MO) 
was used to formulate polyplexes as previously described [21]. 
Figure 6.1  Reaction of CDP to give CDPimid 
An imidazole end group can be directly conjugated to the termini of the cyclodextrin-
containing polycation (CDP). 
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6.3.2 Cell culture and transfections 
 HeLa and BHK-21 cells were maintained in Dulbecco’s Modified Eagle’s 
Medium with 2 mM L-glutamine, 1.5 mg/mL sodium bicarbonate, 0.1 mM non-essential 
amino acids, 1.0 mM sodium pyruvate, and 10% fetal bovine serum.  293-T7 cells, which 
constitutively express T7 RNA polymerase, were maintained in media as above with 0.8 
mg/mL geneticin (G418) [22].  The medium was purchased from Mediatech (Herndon, 
VA) and supplements were purchased from Gibco BRL (Gaithersburg, MD). 
 For evaluation of transfection efficiency through luciferase assay, cells were 
plated in 24-well plates at a density of 5×104 cells/well.  Polyplexes were formulated 
between CDP or CDPimid and the plasmid pGL3-CV (Promega), which encodes the 
firefly luciferase gene under control of an SV40 promoter.  One day after plating, cells 
were transfected in Opti-MEM serum-free medium (Invitrogen).  Two days after 
transfection, luciferase activity of cell lysates was evaluated with the Luciferase Assay 
System (Promega) and total protein concentration was assessed by the DC Protein Assay 
(Bio-Rad, Hercules, CA). 
 For transfections in the presence of chloroquine analogues, immediately after 
polyplex-containing media was added to cells for transfection, an appropriately-sized 
aliquot of chloroquine analogue stock solution (5 mM) was added to the media and 
mixed.  The chloroquine analogues investigated were chloroquine, CQ7a 
(trifluoromethyl- in place of chloro- at the 7 position of chloroquine), CQO (oxygen in 
place of secondary amine at the 4 position of chloroquine), and CP (pyridinyl aromatic 
ring in place of dual-ring structure in chloroquine). 
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6.3.3 Intracellular buffering activity of CDP and CDPimid 
 The activity of CDP and CDPimid in buffering the pH environment of 
intracellular polyplexes was evaluated using the method of Kulkarni, et al. [16].  Briefly, 
polyplexes were formulated between the polymer of interest and an oligonucleotide 
labeled with the pH-sensitive fluorophore SNARF-4F (Molecular Probes, Carlsbad, CA).  
HeLa cells were treated with the polyplexes and imaged using an inverted Zeiss LSM 510 
META confocal microscope with a 63x oil objective (NA 1.4).  Excitation of the SNARF 
fluorophore was achieved with the 543 nm line of the He-Ne laser line supplied with the 
microscope.  After passing through a variable confocal pinhole, the SNARF-4F emission 
was collected by the META detector in distinct wavelength bins of 569-601 nm and 633-
687 nm.  Using a standard curve, the relative intensity of individual signals across these 
bins was used to evaluate the pH environment of the corresponding intracellular 
polyplexes. 
 
6.3.4 Salt-induced dissociation of polyplexes 
 The stability of polyplexes against increasing salt concentration was evaluated by 
dye exclusion following a published procedure [23].  After formulation, polyplexes were 
diluted 5x in dH2O.  Separately, 200x dilutions of the supplied PicoGreen stock solution 
(Molecular Probes) were prepared in 10 mM HEPES buffer containing various 
concentrations of NaCl.  For each sample, 50 μL of polyplex solution was transferred to a 
well of an opaque, black 96-well plate and combined with 50 μL of PicoGreen solution; 
after 10 min, the fluorescence (λexcitation 488 nm; λemission 535 nm) of the polyplex-
PicoGreen solution was evaluated using a Spectrafluor Plus plate reader (Tecan, Durham, 
 142
NC).  The percentage dye exclusion was calculated from the ratio ((FDNA-Fsample)/(FDNA-
FH2O)), where FDNA is the fluorescence of a sample of DNA alone (no polycation), Fsample 
is the sample fluorescence, and FH2O is the fluorescence of a blank (control) sample. 
 
6.3.5 Heparan sulfate displacement of nucleic acids from polyplexes 
 Displacement of pDNA from polyplexes by heparan sulfate was evaluated by gel 
electrophoresis.  CDP and CDPimid polyplexes were formulated, and to 10 μL of 
polyplex solution was added an appropriate volume of heparan sulfate (5 mg/mL in 
dH2O).  After 5 min incubation at room temperature, 1 mL of loading buffer was added to 
each sample and the samples were transferred to a 0.5% agarose gel (30 µg ethidium 
bromide/50 mL TAE buffer), electrophoresed, and visualized under UV illumination. 
 
6.3.6 Measure of intracellular nucleic acid unpackaging 
 To obtain a relative measure of intracellular nucleic acid unpackaging, HeLa cells 
in 24-well plates were transfected with 2 μg of a FITC-labeled DNA oligonucleotide 
(FITC-oligo) packaged in CDP or CDPimid polyplexes.  At selected times after 
transfection, cells were collected by trypsinization and pelleted by centrifugation (6 min 
at 2400 rpm).  Each sample was resuspended in 10 μL 1x cell culture lysis buffer 
(Promega) and stored at 4 °C.  Control samples were prepared as solutions of known 
amounts of FITC-oligo in 10 μL 1x cell culture lysis buffer.  After 30 min incubation, 
each sample was mixed with 25 μL of low-melting-point agarose solution (1% in TAE 
buffer, 37 °C) and transferred immediately to a well of an agarose gel (0.5% in 60 mL 
TAE buffer).  The agarose gel was subjected to electrophoresis and then imaged under 
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UV illumination.  Detection of FITC-oligo was achieved through its fluorescent signal.  
Migration of FITC-oligo from control samples was used to indicate the expected 
migration of unpackaged FITC-oligo from cell lysates. 
 
6.3.7 Flow cytometry for evaluation of nucleic acid uptake 
 For flow cytometry, polyplexes were formulated with a FITC-labeled 
oligonucleotide.  Labeled polyplexes were used to transfect cells as described; four hours 
after transfection, the polyplex-containing medium was aspirated and replaced with 
regular growth medium.  Cells were washed (10 U/mL DNase, 3 mM MgCl2 in Hank’s 
buffered saline solution (HBSS)), suspended in propidium iodide-containing buffer 
(HBSS, 2.5 mg/mL bovine serum albumin, 0.01 mg/mL propidium iodide), and analyzed 
on a FACScalibur instrument (Becton Dickinson, Franklin Lakes, NJ) with a 488 nm 
excitation line.  Samples were initially gated by forward and side scatter, and viable cells 
were assayed for FITC fluorescence. 
 
6.3.8 Transmission electron microscopy of CDP and CDPimid polyplexes within cells 
 For transmission electron microscopy, BHK-21 cells were transfected with 
CDP/pDNA or CDPimid/pDNA polyplexes.  At increasing timepoints after transfection, 
the medium was aspirated and the cells were rinsed with PBS.  Cells were fixed with 2% 
glutaraldehyde in 100 mM sodium cacodylate with 2% sucrose, collected by scraping, 
and pelleted by centrifugation.  Cell pellets were post-fixed in osmium tetroxide, 
dehydrated in ethanol, and embedded in Epon-Spurr resin.  Thin sections were prepared 
on an Ultracut S ultramicrotome (Leica Microsystems, Deerfield, IL), contrasted with 
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uranyl acetate and lead citrate, and imaged on a BioTwin CM120 transmission election 
microscope (FEI, Hillsboro, OR) operating at 80 kV. 
 For immunolabeling experiments, pDNA was labeled with the LabelIT biotin-
labeling kit (Mirus, Madison, WI) at a density of roughly 10 labels per plasmid and 
purified by ethanol precipitation.  Polyplexes were formulated with CDP or CDPimid and 
administered to BHK-21 cells.  At desired timepoints after transfection, the medium was 
aspirated and the cells were rinsed with PBS.  Cells were fixed with 2% glutaraldehyde in 
100 mM sodium cacodylate with 2% sucrose, collected by scraping, and pelleted by 
centrifugation.  Cell pellets were infiltrated in 2.3 M sucrose, frozen by immersion in 
liquid nitrogen, freeze substituted at -80°C with dry methanol, and embedded at -50°C in 
Lowicryl HM20 resin (Electron Microscopy Sciences, Fort Washington, PA).  Thin 
sections were prepared on an Ultracut S ultramicrotome and immunolabled with a mouse 
anti-biotin primary antibody (Sigma), a rabbit anti-mouse secondary antibody (Organon 
Technika, Durham, NC), and colloidal gold (10 nm)-labeled protein A (University of 
Utrecht, The Netherlands).  1X PBS containing 10% fetal calf serum was used as the 
blocking solution, and immunolabeled sections were contrasted with uranyl acetate and 
lead citrate and imaged on a BioTwin CM120 transmission election microscope operating 
at 80 kV.  Immunolabeling of control samples prepared without biotin-labeled pDNA 
was used to determine appropriate concentrations for antibody and colloidal gold 
labeling.  An iterative process was used to minimize background labeling from gold-
labeled protein A alone, the secondary antibody and gold-labeled protein A together, and 
finally both antibodies and gold-labeled protein A together. 
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6.3.9 Polyplex accessibility in the presence of CQ, CQ7a, CP, and CQO 
 The accessibility of polyplex-compacted DNA in the presence of CQ analogues 
was evaluated by dye exclusion, through adaption of a published procedure [23].  After 
formulation, polyplexes were diluted 2.5x in dH2O.  For each sample, 25 μL of polyplex 
solution was transferred to a well of an opaque, black 96-well plate and combined with 
25 μL of CQ analogue solution at twice the concentration of interest.  Separately, a 200x 
dilution of the supplied PicoGreen stock solution (Molecular Probes) was prepared in 10 
mM HEPES buffer.  After polyplex-CQ analogues solutions were incubated for 5 min at 
room temperature, each 50 μL sample was combined with 50 μL of PicoGreen solution 
and the fluorescence (λexcitation 488 nm; λemission 535 nm) of the resulting solutions was 
evaluated with a Spectrafluor Plus plate reader (Tecan, Durham, NC).  The percentage 
dye exclusion was calculated from the ratio ((FDNA-Fsample)/(FDNA-FH2O)), where FDNA is 
the fluorescence of a sample of DNA alone (no polycation), Fsample is the sample 
fluorescence, and FH2O is the fluorescence of a blank (control) sample. 
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6.4 Results 
6.4.1 Transfection efficiency of CDPimid is greater than that of CDP 
 When used to deliver luciferase-expressing plasmid DNA to cultured cells, 
CDPimid generates greater levels of gene expression than CDP (Figure 6.2a).  This is 
true for a variety of cell lines transfected with pGL3-CV, a DNA plasmid (pDNA) which 
should be transcribed and expressed only when available to the transcriptional machinery 
within the cell nucleus.  293-T7 cells (constitutively expressing the cytoplasmic T7 RNA 
polymerase) were employed to investigate the possibility that differences in expression 
result from differences in nuclear delivery.  The plasmid pT7-Luc (a plasmid expressing 
luciferase under control of a T7 promoter) can be transcribed and expressed if delivered 
to the cytoplasm of 293-T7 cells [22], and its poor expression in 293 cells (lacking the T7 
RNA polymerase) confirms that the polymerase is responsible for pT7-Luc expression 
(Figure 6.2b).  The greater transfection efficiency of CDPimid versus CDP in the 293-
T7/pT7-Luc system indicates that such differences arise prior to nuclear delivery. 
 
a        b 
 
Figure 6.2  Transfection of HeLa or 293-T7 cells with CDP or CDPimid 
(a) CDP or CDPimid was used to transfect HeLa cells (pGL3-CV) or 293-T7 cells (pT7-
Luc) with pDNA.  In each case, CDPimid generated greater luciferase expression.  (b) 
When 293 cells are transfected with pT7-Luc, they do not show significant expression. 
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6.4.2 A terminal imidazole group introduces intracellular pH-buffering activity to CDP 
 The addition of an imidazole group to the termini of CDP is designed to impart 
intracellular pH-buffering capacity to the modified polycation, CDPimid.  To evaluate the 
actual intracellular buffering activity of CDP and CDPimid, we employed the method of 
Kulkarni, et al. [16], where an oligonucleotide is labeled with the fluorophore SNARF-4F 
and used to prepare polyplexes.  These polyplexes are administered to cells and the 
fluorescence emission of SNARF-4F is used to evaluate the local pH environment of 
polyplexes within individual cells.  The data can be compiled in aggregate to indicate the 
actual intracellular buffering activity of the polycations (Figure 6.3).  By this method, 
CDPimid demonstrates strong buffering activity relative to CDP. 
 
 
 
 
Figure 6.3  Intracellular buffering activity of CDP and CDPimid 
Polyplexes containing a SNARF-4F-labeled oligonucleotide were administered to HeLa 
cells.  Confocal microscopy was used to visualize intracellular polyplexes, whose pH 
environment could be calculated using the pH-sensitivity of SNARF-4F [16].  When 
compiled, this data gives an average intracellular pH for the delivered oligonucleotide.  
CDPimid displays strong buffering activity while CDP does not. 
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6.4.3 Exclusion of intercalating dye by CDP and CDPimid polyplexes 
 PicoGreen experiences significant fluorescence enhancement upon intercalation 
in nucleic acids, such that its exclusion indicates inaccessibility of the nucleic acids to 
intercalation [23].  This characteristic was used to evaluate different types of polyplexes 
for the relative accessibility of pDNA.  Polyplexes were subjected to disruption by 
increasing concentrations of NaCl, then combined with solutions of PicoGreen and 
evaluated for fluorescence intensity.  Unlike 25-kD branched polyethylenimine (PEI), 
which showed near complete dye exclusion without added NaCl, CDP and CDPimid 
gave only moderate exclusion of PicoGreen without NaCl and minimal dye exclusion at 
higher salt concentration (Figure 6.4a).  A further study explored the reliability of 
observed differences between CDP and CDPimid at low NaCl concentrations; dye 
exclusion was less with CDP for the NaCl concentrations investigated (Figure 6.4b). 
 
 
a      b 
  
Figure 6.4  PicoGreen exclusion as a measure of salt-induced complex dissociation 
The exclusion of the DNA-intercalating dye PicoGreen was used as a measure of 
polyplex stability against salt-induced dissocation [23].  (a) CDP and CDPimid did not 
exclude PicoGreen to the same extent as 25-kD branched polyethylenimine (PEI).  (b) 
Examination of lower salt concentrations revealed that dye exclusion by CDP was 
consistently less than with CDPimid. 
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 Inclusion complex formation between the PicoGreen dye and the cyclodextrin 
cups of CDP or CDPimid would likely impart some fluorescence to these materials.  
Significant fluorescence of this type would give a false impression of reduced dye 
exclusion, consistent with the observations of CDP and CDPimid polyplexes in the 
PicoGreen salt-dissociation assay.  To investigate this possibility, CDP and CDPimid 
were incubated with PicoGreen in the absence of any DNA.  The fluorescence generated 
by these combinations represents only 0.05% of the fluorescence enhancement seen with 
PicoGreen interactions with uncomplexed pDNA.  Thus, the incomplete dye exclusion 
(measurable fluorescence) observed with CDP and CDPimid polyplexes is unlikely to be 
a result of PicoGreen-cyclodextrin or PicoGreen-polycation interactions. 
 
 
 
 
 
Figure 6.5  PicoGreen fluorescence with individual polyplex components 
To investigate if the incomplete dye exclusion observed for CDP and CDPimid 
polyplexes results from PicoGreen interactions with the polycation, the dye was 
incubated with either pDNA alone or polycation alone.  The fluorescence enhancement 
resulting from PicoGreen-pDNA interactions is ~2000 times the enhancement that is seen 
with PicoGreen-CDP or PicoGreen-CDPimid interactions. 
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6.4.4 CDPimid polyplexes are more resistant to heparan sulfate than CDP polyplexes 
 Heparan sulfate was employed to evaluate the ability of a polyanion to cause CDP 
or CDPimid to displace from DNA.  Polyplexes were formulated, incubated with various 
amounts of heparan sulfate for 5 min at room temperature, and then loaded to an agarose 
gel and electrophoresed.  Polycation-bound DNA will not migrate in the gel.  At higher 
heparan sulfate concentrations, “free” nucleic acids could be observed due to their 
movement in the gel.  For polyplexes formulated with a DNA oligonucleotide (Figure 
6.6) or with plasmid DNA (Figure 6.7), an equivalent dose of heparan sulfate generated 
greater displacement with CDP than with CDPimid. 
 
 
 
 
 
 
 
Figure 6.6  Heparan sulfate release of oligonucleotide from polyplexes 
Polyplexes were prepared with a 25-mer DNA oligonucleotide (FITC-oligo) and either 
CDP (lanes 2-8) or CDPimid (lanes 9-15).  The resulting polyplexes were incubated with 
increasing amounts of heparan sulfate (hep. su.) to induce oligonucleotide release.  
Samples were then loaded to an agarose gel and electrophoresed.  With equivalent 
heparan sulfate loading, CDP polyplexes showed more extensive oligonucleotide release 
than CDPimid polyplexes. 
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 Polyplexes are exposed to acidification when trafficking in the endocytic 
pathway; to test whether acidic conditions alter the relative susceptibility of CDP and 
CDPimid to heparan sulfate, polyplexes were acidified to pH 3 by addition of 0.1 N HCl 
prior to heparan sulfate incubation.  Acidified polyplexes displayed an equal response to 
heparan sulfate as their as-formulated counterparts (Figure 6.7b). 
 
 
 
 a      b 
 
          as-formulated  acidified 
Figure 6.7  Heparan sulfate release of pDNA from polyplexes 
CDP/pDNA (top row) and CDPimid/pDNA (bottom row) polyplexes (Poly.) were 
incubated with increasing amounts of heparan sulfate (hep. su.) to induce pDNA release.  
Samples were then loaded to an agarose gel and electrophoresed.  (a) With equivalent 
heparan sulfate loading, CDP polyplexes showed more extensive pDNA release than 
CDPimid polyplexes.  (b) Equivalent results were obtained for polyplexes incubated with 
heparan sulfate (left) or polyplexes acidified to pH 3 and then incubated with heparan 
sulfate (right). 
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6.4.5 Transmission electron microscopy shows CDPimid gives enhanced unpackaging 
and accessibility of delivered DNA relative to CDP 
 CDP or CDPimid polyplexes were delivered to cultured cells and visualized using 
transmission electron microscopy (Figures 6.8, 6.9).  Intact polyplexes were easily 
identifiable, appearing as irregular aggregates roughly 300-500 nm in diameter.  Some 
aggregates are composed of smaller rounded components (likely the as-formulated 
polyplexes readily observable by light scattering in water [10,12,16]). 
 Most intracellular vesicles containing CDP polyplexes conformed to the 
aggregates’ shape and contained little to no void space or other material (Figures 6.8d-i).  
In contrast, vesicles containing CDPimid polyplexes occasionally enclosed portions of 
void space (Figures 6.9c-d) or large amounts of material separate from the aggregates 
(Figures 6.9b-c,e-i).  It is unclear if this accompanying material is derived from or is 
independent of the polyplex aggregates. 
 As the time between the initial exposure to CDP polyplexes and the cells’ fixation 
was increased from 0.5 to 24 h, aggregates of CDP polyplexes increasingly appeared in 
the vicinity of the cell nucleus (Figure 6.8).  The larger size of aggregates closer to the 
nucleus suggested an aggregation of polyplex aggregates was occurring.  Only a small 
minority of CDP polyplexes appeared to be disassembling (6.8q-r).  These degrading 
polyplexes, with less distinct and defined borders than most aggregates, were found more 
commonly within vesicles than free in cytoplasm. 
 In contrast, CDPimid polyplexes were observed undergoing significant unraveling 
in intracellular vesicles at 4 or 8 h after initial transfection (Figure 6.9).  Various loops 
and swirls extend from the central mass of some CDPimid polyplexes (Figure 6.9g-i).  
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Also, some cells contain swirls or ring structures in the absence of larger aggregates; 
these features may be found either within larger vesicles (Figure 6.9g,j) or filling vesicles 
entirely (Figure 6.9k-l).  A fuzzy or hairy surface characterizes many aggregates (Figure 
6.9c-d,f) and many of the loops, swirls, and rings (Figure 6.9g-l). 
 Both CDP and CDPimid polyplexes could be observed in the absence of 
surrounding membranes.  Aggregates were observed either in direct contact with the 
surrounding cytoplasm (Figures 6.8k-m, 6.9f,j) or bordering void spaces (Figures 6.8j-
k,n).  Intact polyplexes or their aggregates were not observed within any cell nucleus. 
 In order to visualize unpackaged intracellular pDNA, CDP or CDPimid was used 
to deliver biotin-labeled pDNA to cells.  Subsequently, TEM samples were prepared 
using anti-biotin immunolabeling with colloidal gold.  Intracellular CDP and CDPimid 
polyplexes are both labeled by this method, but the numbers and density of gold particles 
per polyplex or aggregate are generally less with CDP than with CDPimid (6.10a, 6.11a-
g).  The CDPimid polyplexes can be seen in cells as large, heavily gold-labeled entities. 
 Immunolabeling of unpackaged pDNA within cells generates clusters of colloidal 
gold separate from polyplexes.  For both CDP and CDPimid, these clusters are found 
both in the cytoplasm (Figures 6.10c-e, 6.11h) and in the cell nucleus (6.10f-h, 6.11i).  
Qualitative differences were not apparent among the colloidal gold clusters for the two 
types of polyplexes, either in their intracellular distribution or overall prevalence. 
 Cells transfected with unlabeled pDNA and subjected to equivalent preparation 
and immunolabeling do not reveal colloidal gold labeling of polyplexes or colloidal gold 
clustering (not shown).   
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Figure 6.8  TEMs of CDP polyplexes 
BHK-21 cells were exposed to CDP polyplexes and prepared for TEM imaging. The 
polyplexes appear as large aggregates and are seen associated with cell membranes, often 
directly with invaginations of these cell membranes (a-c).  The aggregates proceed into 
cells in large vesicles that conform to the shape of the aggregates (d-i).  Some polyplexes 
are not completely surrounded by membranes (h-i).  Bars for (a-i), 200 nm.
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(Figure 6.8, continued) At later times, many polyplexes are observed in the cytoplasm 
without surrounding membranes (j-n).  The cytoplasm appears to contact the polyplexes 
in some cases, whereas in others there is a void space between the polyplexes and the 
surrounding cytoplasm.  Later timepoints show an accumulation of polyplexes in a 
perinuclear region (o-p).  Some CDP polyplexes appear to be undergoing degradation (q-
r).  Bars for (j-r), 500 nm.  Cell nucleus, nu. 
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Figure 6.9  TEMs of CDPimid polyplexes 
BHK-21 cells were exposed to CDPimid polyplexes and prepared for TEM imaging.  As 
with CDP, intracellular CDPimid polyplexes appear as large aggregates within vesicles 
(a-b).  The vesicles containing these aggregates do not necessarily conform to the 
aggregates’ shape (b-d).  Vesicles containing polyplex aggregates also appear to have a 
variety of other contents (b-c,e-i).  Some aggregates have a fuzzy exterior (c-d,f) and not 
all aggregates are contained within vesicles (f).  Bars for (a-f), 200 nm.
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(Figure 6.9, continued) To a much greater extent than CDP polyplexes, CDPimid 
polyplexes appear to be degrading within vesicles.  Various loops and swirls are observed 
emanating from the aggregates (g-i).  In other cases, circular or oval ring structures or 
swirls are observed in the absence of larger aggregates, either contained within larger 
vesicles (g,j) or filling vesicles entirely (k-l).  As with the aggregates, many of the loops, 
swirls, and rings appear fuzzy or hairy (g-l).  Bars for (g-l), 200 nm. 
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Figure 6.10  Immunolabeling to detect intracellular DNA delivered by CDP 
Biotin-labeled pDNA was delivered to cells in CDP polyplexes, and TEM samples were 
prepared using anti-biotin immunolabeling with colloidal gold.  Clusters of colloidal gold 
(arrows) can be found outside of polyplexes (c-h), an indication of unpackaged 
intracellular pDNA.  Some of the intracellular gold clusters are within a cell nucleus (f-
h).  When CDP is used to transfect cells with unlabeled pDNA and samples are 
equivalently prepared and immunolabeled, there is no colloidal gold labeling of 
polyplexes or colloidal gold clustering (not shown).  Bars, 200 nm.  Cell nucleus, nu. 
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Figure 6.11  Immunolabeling to detect intracellular DNA delivered by CDPimid 
Biotin-labeled pDNA was delivered to cells in CDPimid polyplexes, and TEM samples 
were prepared using anti-biotin immunolabeling with colloidal gold.  Large, heavily 
gold-labeled entities (polyplexes or their aggregates) are readily observed (a-g), and the 
intensity of polyplex labeling (numbers of gold particles) for CDPimid polyplexes 
generally exceeds that observed with CDP.  As with CDP polyplexes, clusters of 
colloidal gold (arrows) outside of polyplexes (h-i) reveal intracellular pDNA that has 
unpackaged from polyplexes.  Such gold clusters are found in cytoplasm (h) or the cell 
nucleus (i).  Bars, 200 nm.  Cell nucleus, nu. 
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6.4.6 CDPimid produces more unpackaged intracellular DNA than CDP 
 The comet assay is a standard method of evaluating DNA damage [24,25].  In this 
assay, cells are gently lysed, embedded in an agarose gel on a glass slide or coverslip, and 
exposed to electrophoresis.  Only damaged cellular DNA is reduced to a size that permits 
migration within the gel, and this damaged DNA will generate a characteristic “comet” 
pattern upon subsequent intra-gel labeling of nucleic acids by a fluorescent marker.  The 
intensity of the comet reflects the extent of DNA damage.  By this method, individual 
cells may be visually evaluated for DNA damage. 
 We have modified this assay to produce an aggregate separation and visualization 
of delivered and unpackaged nucleic acids.  Rather than evaluating samples on an 
individual-cell basis, cells are collected by centrifugation, lysed, embedded in an agarose 
gel, and subjected to electrophoresis in order to generate a relative measure of DNA 
unpackaging for a particular sample.  Also, rather than adding a fluorescent label after 
electrophoresis, we transfect cells using nucleic acids that have been covalently modified 
with a fluorescent marker.  Thus, we are able to distinguish exogenous (delivered) 
nucleic acids from cellular DNA.  The “unpackaged” oligonucleotide measured by this 
assay is that which migrates through the agarose gel to the same extent as in the case of 
direct gel loading of the oligonucleotide.  Polyplexes suspended in 1X lysis buffer alone 
do not generate this migrating DNA, suggesting that the DNA unpackaging that allows 
for electrophoretic migration has occurred within cells. 
 As measured by this assay, CDPimid consistently generates greater amounts of 
unpackaged nucleic acids (Figures 6.12-6.14).  This is true for a variety of timepoints 
ranging from 6 to 44 h after the initial transfection, and is true whether the polycations 
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are used to deliver a DNA oligonucleotide (Figures 6.12, 6.14) or siRNA (Figure 6.13).  
PEGylation of polyplexes does not alter this effect, as PEGylated CDPimid particles 
generate greater levels of migrating DNA than CDP polyplexes or their PEGylated 
variant (Figure 6.14).  PEI was also examined in siRNA delivery and did not produce a 
signal representing unpackaged nucleic acid (Figure 6.13). 
 
 
 
 
 
Figure 6.12 Unpackaging of DNA delivered to HeLa cells by CDP or CDPimid 
CDP or CDPimid was used to transfect HeLa cells, which were evaluated after 6, 12, or 
18 h for unpackaged, FITC-labeled DNA oligonucleotide.  At all timepoints examined, 
CDPimid samples showed more unpackaged DNA than CDP samples. 
 
 
 
Figure 6.13 Unpackaging of siRNA delivered to HeLa cells by CDP, CDPimid, or PEI 
CDP, CDPimid, or 25-kD branched polyethylenimine (PEI) was used to transfect HeLa 
cells, which were evaluated after 16 h for the levels of unpackaged, FITC-labeled siRNA.  
CDPimid samples showed more unpackaged nucleic acid than CDP samples.  The PEI 
samples did not generate an unpackaged siRNA signal. 
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Figure 6.14 Unpackaging of DNA oligo delivered to HeLa cells by CDP or CDPimid or 
their PEGylated variants 
CDP, CDPimid, or their PEGylated variants were used to transfect HeLa cells, which 
were evaluated after 14, 20, or 44 h for the levels of unpackaged, FITC-labeled DNA 
oligonucleotide.  At all timepoints examined, the greatest amount of unpackaged DNA 
was seen with CDPimid samples, followed by samples transfected with PEGylated 
CDPimid particles.  CDP and PEGylated CDP particles also show unpackaged DNA, but 
in lesser amounts. 
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6.4.7 Uptake of CDP and CDPimid polyplexes is similar but not equivalent 
 Rather than indicating differences in intracellular processing, differences in the 
amounts of unpackaged intracellular DNA with CDP and CDPimid could simply reflect 
differences in the total amount of DNA delivered to cells.  Flow cytometry was used to 
evaluate the cellular uptake and retention of a FITC-labeled DNA oligo delivered to 
HeLa cells with CDP or CDPimid polyplexes or with their PEGylated variants (Table 
6.1).  All particles showed strong uptake to cells, with over 98% of cells registering 
positive at both examined timepoints.  CDPimid samples generated greater fluorescence 
than CDP samples.  However, CDPimid buffers the pH experienced by delivered nucleic 
acids whereas CDP does not (Figure 6.3), irrespective of PEGylation [16], and the 
fluorescence of FITC is quenched at lower pH.  Thus, the observed differences in the  
flow cytometry data do not necessarily represent enhanced uptake with CDPimid. 
 
 
 
 
 
 
20 h 44  h 
Nucleic 
acid 
Delivery 
vector 
% cells 
FITC-
positive 
Mean 
fluorescence
% cells 
FITC-
positive 
Mean 
fluorescence
- - 0.50 3.41 0.05 2.83 
FITC-oligo CDP 99.33 3109.80 99.11 1291.04 
FITC-oligo CDP+Ad-PEG 99.56 1398.83 98.12 579.79 
FITC-oligo CDPimid 99.67 6920.65 99.41 4465.41 
FITC-oligo CDPimid+Ad-PEG 99.79 6770.88 99.87 3829.96 
 
Table 6.1 Summary of flow cytometry analysis 
A FITC-labeled oligonucleotide (FITC-oligo) was used to formulate CDP, PEGylated 
CDP, CDPimid, or PEGylated CDPimid particles.  HeLa cells were transfected with the 
particles and evaluated after 20 h or 44 h for FITC fluorescence by flow cytometry.  All 
types of particles gave rise to strong fluorescence at the timepoints examined, although 
CDP particles did not generate as much fluorescence as CDPimid particles.  Data 
represent the mean of duplicate samples. 
 164
6.4.8 CDP and CDPimid transfection are not equally affected by chloroquine analogues 
 HeLa cells were transfected with CDP/pDNA or CDPimid/pDNA polyplexes in 
the presence or absence of selected analogues of chloroquine (CQ).  The trends in the 
expression levels were consistent in that CQ and (to a greater extent) CQ7a conferred 
marked improvements in transfection efficiency, while CQO and CP were not as 
beneficial (Figure 6.15).  However, improvements in transfection efficiency with CQ and 
CQ7a were noticeably greater for CDP polyplexes than for CDPimid polyplexes, and 
strong effects with CDPimid were seen only with 0.2 mM CQ or CQ7a. 
 
 
Figure 6.15  Effect of chloroquine analogues on transfection by CDP and CDPimid 
HeLa cells were transfected with CDP or CDPimid polyplexes in the presence of various 
analogues of chloroquine (CQ).  Luciferase activity was used as a measure of transfection 
efficiency.  CQ and CQ7a gave the greatest increases in transfection efficiency, and such 
increases were greater with CDP polyplexes than with CDPimid polyplexes. 
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6.4.9 Dye exclusion with CDP and CDPimid polyplexes is similarly affected by 
chloroquine analogues 
 While CQ and CQ7a contribute significantly to the transfection efficiency of both 
CDP and CDPimid, greater enhancements in the case of CDP raise CDP-mediated 
expression to levels beyond CDPimid-mediated expression in the presence of CQ and 
CQ7a.  Dye exclusion was used to compare the relative accessibility to chloroquine 
analogues of DNA in CDP and CDPimid polyplexes (Figure 6.16).  As-formulated CDP 
and CDPimid polyplexes do not exhibit full exclusion of the DNA intercalating dye 
PicoGreen, but increasing concentrations of strong DNA-binding chloroquine analogues 
can restrict this access and generate increased dye exclusion.  Here, trends in dye 
exclusion were similar for each polyplex type, reflecting similar accessibility of DNA to 
chloroquine analogues. 
 
 
 
 
Figure 6.16  Polyplex exclusion of PicoGreen in the presence of chloroquine analogues 
The exclusion of the DNA-intercalating dye PicoGreen was used to indicate the relative 
accessibility of pDNA in CDP or CDPimid polyplexes to chloroquine analogues. 
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6.5 Discussion 
 Modification of CDP with terminal imidazole groups successfully introduces 
intracellular pH-buffering activity to this non-viral gene delivery vector (Figure 6.3).  The 
new polycation, CDPimid, displays improved transfection efficiency in a variety of 
cultured cell lines (Figure 6.2).  It is found that CDP and CDPimid give similarly strong 
DNA uptake (Table 6.1) and that CDPimid also gives improved performance in cells with 
a cytoplasmic expression system (Figure 6.2), indicating that the improvements in 
transfection efficiency with CDPimid result from phenomena within cells but prior to 
delivery to the cell nucleus.  These results are consistent with the hypothesis that the 
improved performance of the pH-buffering CDPimid results from enhanced escape from 
endocytic vesicles. 
 CDP has a relatively low degree of polymerization (~6), such that end-group 
modification may affect its chemical and biological properties and the properties of its 
polyplexes.  Direct quantification of the polycation-DNA binding strength for CDP and 
CDPimid by isothermal titration calorimetry is not possible due to the nature of the 
polycations’ amidine charge centers.  Thus, indirect methods are applied to evaluate the 
relative binding strength of these two vectors with nucleic acids.  In cell-free assays, CDP 
appears bound more weakly to nucleic acids than CDPimid.  CDP polyplexes display 
weaker dye exclusion than CDPimid polyplexes (Figure 6.4) and are more susceptible to 
induction of DNA release by heparan sulfate (Figures 6.6, 6.7). 
 Despite these observations, CDPimid appears to facilitate greater intracellular 
release of delivered nucleic acids than CDP.  CDP polyplexes within cells generally 
appear in transmission electron microscopy (TEM) as large, well-defined aggregates that 
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grow larger (due to collection or aggregation of existing aggregates) over the initial 24 
hours after transfection (Figure 6.8).  In contrast, extensive unraveling and disassembly 
of intracellular CDPimid polyplexes is observed only 4 or 8 hours after initial 
transfection (Figure 6.9).  Immunolabeling of delivered DNA shows that CDP and 
CDPimid both produce unpackaged DNA, but the intensity with which CDPimid 
polyplexes are labeled (under equivalent conditions) suggests that the DNA within these 
polyplexes may be more accessible than that of CDP polyplexes (Figure 6.10-6.11).  
Further, a novel modification of the comet assay shows that CDPimid generates greater 
amounts of unpackaged nucleic acids than CDP, irrespective of the polyplexes’ 
PEGylation (Figures 6.12-6.14). 
 The mechanism behind the enhanced intracellular unpackaging observed with 
CDPimid is unclear.  Dye exclusion indicates that the terminal imidazole groups do not 
inhibit polycation-DNA interactions (Figure 6.4).  Polyplexes may undergo changes in 
the binding between polycation and nucleic acid as they traffic in the endocytic pathway, 
particularly as the imidazole groups carry out their pH-buffering function and become 
protonated.  The observed disassembly of CDPimid polyplexes in intracellular vesicles 
would support this hypothesis.  Although no changes in DNA release were observed for 
polyplexes acidified prior to heparan sulfate treatment (Figure 6.7b), immersion in the 
electrophoresis buffer would mask differences if the DNA release with heparan sulfate is 
reversible.  Efforts to conduct the gel electrophoresis at acidified pH were not successful. 
 As implied by the experiments with heparan sulfate, intracellular factors may be 
responsible for polyplex disassembly.  If so, the response of CDP and CDPimid 
polyplexes to heparan sulfate treatment may not reflect their susceptibility to the relevant 
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intracellular factors.  A further possibility is that differences in the intracellular 
distribution of polyplexes and polyplex-disrupting factors are related to the differences in 
unpackaging.  If the pH-buffering of CDPimid facilitates its escape from the endocytic 
pathway and polyplex disruption occurs primarily in the cytoplasm, CDPimid should 
generate more unpackaged DNA.  This hypothesis is undermined by numerous TEM 
observations of CDPimid polyplexes disassembling within intracellular vesicles. 
 Additional information on the intracellular behavior of CDP and CDPimid 
polyplexes arises from their differing responses to treatment with chloroquine analogues.  
Chloroquine (CQ) and (to a greater extent) its analogue CQ7a contribute significantly to 
the transfection efficiency of non-viral vectors, although they show stronger effects on 
CDP than on CDPimid (Figure 6.15).  The enhancements likely result from the ability of 
CQ and CQ7a to facilitate unpackaging of delivered DNA, buffer the pH of the endocytic 
pathway, and bind to unpackaged DNA within cells (see Chapter 5). 
 CDPimid, CQ, and CQ7a independently display similar intracellular pH-buffering 
activity [16], so it is likely that CQ and CQ7a contribute to transfection efficiency of 
CDPimid by improving unpackaging and/or by binding the released DNA.  In this case, it 
is not immediately clear why the transfection efficiency of CDP would surpass that of 
CDPimid in the presence of CQ or CQ7a.  CDP polyplexes with CQ, CDP polyplexes 
with CQ7a, or CDPimid polyplexes (with or without CQ or CQ7a) should be similarly 
pH-buffered.  CDPimid produces more unpackaged intracellular DNA than CDP, and CQ 
or CQ7a would not necessarily reverse this situation (such that CDP polyplexes with CQ 
or CQ7a give greater unpackaging than CDPimid polyplexes with CQ or CQ7a). 
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 One possibility is that CQ gives greater displacement and is better able to bind 
unpackaged DNA with CDP than with CDPimid due to the spatiotemporal intracellular 
distribution of CQ and of the polyplexes.  Protonation of CQ is believed to drive its 
accumulation in endocytic vesicles [26], where it can interact with endocytosed 
polyplexes.  CQ-mediated polyplex disruption and CQ binding of unpackaged nucleic 
acids may very well occur within these vesicles.  If the pH-buffering by CDPimid limits 
the supply of protons necessary to drive accumulation of CQ in endocytic vesicles, or if 
CDPimid polyplexes more readily escape the endocytic pathway and release their DNA 
cargo, there may be reduced opportunity for interactions between CQ and the polyplexes 
and/or between CQ and the delivered DNA.  Thus, CQ (and also CQ7a) would not 
produce the same enhancements in transfection efficiency with CDPimid that are 
observed with CDP. 
 In conclusion, we have used a range of methods to investigate differences in the 
gene delivery behavior of CDP and its imidazole-terminated variant, CDPimid.  As 
hypothesized, the imidazole modification of CDP confers intracellular pH-buffering 
activity that is correlated with an increase in transfection efficiency.  The pH-buffering 
activity is hypothesized to facilitate escape from the endocytic pathway.  It was also 
observed that CDPimid generates greater amounts of unpackaged intracellular nucleic 
acids than CDP, making the mechanism of CDPimid’s increased transfection efficiency 
less clear.  The increased unpackaged intracellular DNA with CDPimid was not 
consistent with measures indicating that CDPimid binds nucleic acids more strongly than 
CDP, emphasizing the need to evaluate the behavior of non-viral gene delivery vectors in 
their functional environments.  The characterization of gene delivery behavior with CDP 
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and CDPimid reinforces the notion that non-viral gene delivery involves complex 
systems, where simple modifications can have unanticipated consequences. 
 
6.6 Acknowledgment 
 I am grateful to Patrick Midoux for kindly supplying the 293-T7 cells and the 
plasmid pT7-Luc, to Rajan Kulkarni for carrying out the measures of intracellular pH-
buffering activity, and to Ryan Zeidan for synthesizing the chloroquine analogues used in 
this study. 
 
6.7 References 
1. Bieber T, Meissner W, Kostin S, Niemann A, Elsasser HP. (2002) Intracellular 
route and transcriptional competence of polyethylenimine-DNA complexes. J. 
Control. Release 82:441-454. 
2. Remy-Kristensen A, Clamme JP, Vuilleumier C, Kuhry JG, Mely Y (2001) Role 
of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA 
complexes. Biochim. Biophys. Acta 1514:21-32. 
3. Hwang SJ, Davis ME (2001) Cationic polymers for gene delivery: designs for 
overcoming barriers to systemic administration. Curr. Opin. Mol. Ther. 3:183-
191. 
4. Forrest ML, Pack DW (2002) On the kinetics of polyplex endocytic trafficking: 
implications for gene delivery vector design. Mol. Ther. 6:57-66. 
5. Sonawane ND, Szoka FC, Verkman AS (2003) Chloride accumulation and 
swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. 
Biol. Chem. 278:44826-44831. 
6. Akinc A, Lynn DM, Anderson DG, Langer R (2003) Parallel synthesis and 
biophysical characterization of a degradable polymer library for gene delivery. J. 
Am. Chem. Soc. 125:5316-5323. 
7. Funhoff AM, van Nostrum CF, Koning GA, Schuurmans-Nieuwenbroek NM, 
Crommelin DJ, Hennink WE (2004) Endosomal escape of polymeric gene 
delivery complexes is not always enhanced by polymers buffering at low pH. 
Biomacromolecules 5:32-39.  
8. Choi JS, MacKay JA, Szoka FC (2003) Low-pH-sensitive PEG-stabilized 
plasmid-lipid nanoparticles: preparation and characterization. Bioconjug. Chem. 
14:420-429.  
9. Behr JP (1997) The proton sponge: A trick to enter cells the viruses did not 
exploit. Chimia 51:34-36. 
 171
10. Gonzalez H, Hwang SJ, Davis ME (1999) New class of polymers for the delivery 
of macromolecular therapeutics. Bioconjug. Chem. 10:1068-1074. 
11. Midoux P, Monsigny M (1999) Efficient gene transfer by histidylated 
polylysine/pDNA complexes. Bioconjug. Chem. 10:406-11. 
12. Davis ME, Pun SH, Bellocq NC, Reineke TM, Popielarski SR, Mishra S, Heidel 
JD (2004) Self-assembling nucleic acid delivery vehicles via linear, water-
soluble, cyclodextrin-containing polymers. Curr. Med. Chem. 11:179-97. 
13. Midoux P, LeCam E, Coulaud D, Delain E, Pichon C (2002) Histidine containing 
peptides and polypeptides as nucleic acid vectors. Somat. Cell. Mol. Genet. 
27:27-47. 
14. Singh RS, Goncalves C, Sandrin P, Pichon C, Midoux P, Chaudhuri A (2004) On 
the gene delivery efficacies of pH-sensitive cationic lipids via endosomal 
protonation: a chemical biology investigation. Chem. Biol. 11:713-23.   
15. Fukushima S, Miyata K, Nishiyama N, Kanayama N, Yamasaki Y, Kataoka K 
(2005) PEGylated polyplex micelles from triblock catiomers with spatially 
ordered layering of condensed pDNA and buffering units for enhanced 
intracellular gene delivery. J Am Chem Soc. 127:2810-1. 
16. Kulkarni RP, Mishra S, Fraser SE, Davis ME (2005) Single cell kinetics of 
intracellular, nonviral, nucleic acid delivery vehicle acidification and trafficking. 
Bioconjug. Chem. 16:986. 
17. Forrest ML, Meister GE, Koerber JT, Pack DW (2004) Partial acetylation of 
polyethylenimine enhances in vitro gene delivery. Pharm. Res. 21:365. 
18. Dubruel P, Christiaens B, Rosseneu M, Vandekerckhove J, Grooten J, Goossens 
V, Schacht E (2004) Buffering properties of cationic polymethacrylates are not 
the only key to successful gene delivery. Biomacromolecules 5:379. 
19. Funhoff AM, van Nostrum CF, Koning GA, Schuurmans-Nieuwenbroek NME, 
Crommelin DJA, Hennink WE (2004) Endosomal escape of polymeric gene 
delivery complexes is not always enhanced by polymers buffering at low pH. 
Biomacromolecules 5:32. 
20. Pun SH, Davis ME (2002) Development of a nonviral gene delivery vehicle for 
systemic application.  Bioconjug. Chem. 13:630-639. 
21. Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E (1998): The 
size of DNA/transferrin-PEI complexes is an important factor for gene expression 
in cultured cells.  Gene Therapy 5:1425-1433. 
22. Brisson M, Tseng WC, Almonte C, Watkins S, Huang L (1999) Subcellular 
trafficking of the cytoplasmic expression system. Hum Gene Ther. 10:2601-13.   
23. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring 
polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. 
J. Gene Med. 7:657–63. 
24. Ostling O, Johanson KJ (1984) Microelectrophoretic study of radiation-induced 
DNA damages in individual mammalian cells. Biochem. Biophys. Res. Comm. 
25. Singh NP, McCoy M, Tice RR, Schneider E (1988) A simple technique for 
quantitation of low levels of DNA damage in single cells. Exp. Cell Res. 175:184-
91. 
26. Poole B, Ohkuma S (1981) Effect of weak bases on the intralysosomal pH in 
mouse peritoneal macrophages. J. Cell Biol. 90:665-9. 
 
 
172
CHAPTER 7:  DESIGN OF NON-VIRAL GENE DELIVERY VECTORS TO 
OVERCOME INTRACELLULAR BARRIERS 
 
7.1 Introduction 
 The intracellular barriers to efficient, non-viral gene delivery include aspects of 
trafficking within and escape from the endocytic pathway, unpackaging of nucleic acids 
from the delivery vector, mobility and persistence within cytoplasm, and delivery to the 
cell nucleus.  By exploiting the synthetic nature of molecular conjugates, many chemical 
modifications have been made in an effort to address these perceived barriers.  Examples 
include enhancement of endosomal escape with buffering components, of vector 
unpackaging with selectively labile vectors, of nuclease resistance with modified nucleic 
acids, and of nuclear delivery using targeting sequences.  One area that has not been 
effectively addressed is the poor cytoplasmic mobility of cationic polymer-nucleic acid 
complexes (polyplexes) and of larger unpackaged nucleic acids.  This chapter reviews 
recent literature on the intracellular delivery of nucleic acids by non-viral systems. 
 
7.2 Trafficking within and escape from endocytic vesicles 
 A net positive surface charge facilitates facile entry of polycation-nucleic acid 
particles to cultured cells.  Electron microscopy has been used to visualize the apparent 
endocytosis of pDNA complexed with cationic lipids [1] or with cationic polymers [2].  
Both reports show images of gene delivery particles contained within invaginations of the 
cell membrane.  Using polylysine-pDNA complexes, Mislick and Baldeschwieler 
demonstrated that this uptake occurs through binding of cationic particles to anionic cell-
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surface proteoglycans [3].  The recent model of Kopatz et al. further implicates 
syndecans, a class of proteoglycans common to adherent cells [4].  Noting that pathogens 
are able to divert syndecan binding to enter cells, this model suggests that the clustering 
of syndecan molecules on the cell surface and their intracellular binding of actin can 
induce particle engulfment and cell entry.  Goncalves and coworkers recently suggested 
that transfection efficiency is greatest when the means of uptake is clathrin-dependent 
endocytosis [5]; this mode of entry places limits on particle size to about 200 nm [6]. 
Active in all cells, nonspecific uptake through binding of proteoglycans is not 
useful for targeted delivery in mammals.  Particles for in vivo gene delivery should 
incorporate ligands to target specific cell types and allow particles to enter cells through 
receptor-mediated endocytosis.  Following uptake, the particles are delivered to the 
endocytic pathway.  For many delivery vectors, cells transfected with fluorescently-
labeled polycations and/or nucleic acids display punctate cytoplasmic staining indicative 
of sequestration in the endocytic pathway.  Using transmission electron microscopy of 
cells transfected in vitro, we have observed vesicles containing intracellular polyplexes 
and their aggregates [2].  Vesicles of the endocytic pathway undergo active transport 
along intracellular microtubules.  Consistent with the hypothesis of polyplex entrapment 
by these vesicles, Suh et al. have shown that the movement of polyethylenimine (PEI)-
plasmid DNA (pDNA) complexes within cells includes an active mode that can be 
impaired by depolymerization of microtubules [7]. 
 The vesicles comprising the endocytic pathway become progressively more acidic 
as endocytosed materials proceed towards lysosomes.  There is strong evidence that 
endocytosed polyplexes experience this reduction in pH as they move through the 
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endocytic pathway.  Multiple researchers have used changes in fluorescence or used 
confocal or electron microscopy to show polyplex components in acidic and/or endocytic 
compartments [2,5,8-11].  Two groups have used bulk ratiometric fluorescence assays to 
quanitify the acidification experienced by intracellular polyplexes.  By conjugating both a 
pH-sensitive and a pH-insensitive label to pDNA [12] or to polycationic delivery vectors 
[13], these investigators were able to calculate the average pH environment of 
intracellular complexes made with PEI or polylysine and to show that these pH values are 
reduced over time.  More recently, we have used a single pH-sensitive fluorophore to 
explored the range of pH values experienced by intracellular nucleic acids as a function 
of time and delivery vector [14]. 
 These studies collectively show that many types of polyplexes proceed through 
the endocytic pathway and accumulate in the perinuclear region in lysosomes, where 
nucleases and other degradative enzymes present an undesirable environment for the 
delivered nucleic acids.  It has been generally assumed that avoidance of lysosomes can 
give rise to improved gene delivery with polyplexes.  This hypothesis has been supported 
in part by enhancements in reporter gene expression observed for transfections of many 
types of polyplexes in the presence of the endosomotropic agent chloroquine [15-19]. 
 The influenza virus exploits the increasingly acidic pH of endocytic vesicles to 
trigger reorganization of its hemagglutinin protein and escape from the endocytic 
pathway.  In an effort to engineer endosomal escape in non-viral gene delivery by a 
similar method, Kyriakides et al. developed pH-sensitive membrane-disrupting polymers 
[20].  Observing the strong in vitro hemolytic performance of poly(propylacrylic acid) at 
pH values less than 6.5, these investigators incorporated the polymer in non-viral 
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formulations and measured increases in reporter gene expression both in vitro and in 
vivo. 
 PEI (polyethylenimine) is one delivery vector that gives high transfection 
efficiencies that are unaffected by the presence of chloroquine.  This observation gave 
rise to the “proton sponge” hypothesis, wherein PEI is naturally endosomotropic due to 
its numerous amine residues with pKa values in the physiological range [21].  In this 
hypothesis, the amine residues of PEI are able to buffer the acidification of the endosome, 
thereby impeding its progression on the endocytic pathway and/or facilitating its rupture.  
Kichler et al. demonstrated that acidification plays a role in PEI-mediated transfection in 
vitro; inhibition of endosome acidification with bafilomycin A1 led to a sharp drop in 
reporter gene expression [22].  Akinc et al. showed that N-quaternized (and therefore 
non-buffering) derivatives of PEI are inferior delivery vectors [23].  The “proton sponge” 
hypothesis is also supported by the recent results of Sonawane and coworkers, who 
observed that, relative to poorly-buffering polylysine-pDNA complexes, polyplexes 
prepared with strongly-buffering PEI or polyamidoamine gave reduced acidification, 
increased swelling, improved buffering capacity, and heightened osmotic fragility of 
endosomes [24]. 
  The aforementioned ratiometric fluorescence assays, however, did not fully 
support the “proton sponge” hypothesis for PEI.  In the experiments utilizing labeled 
nucleic acids, PEI showed apparent buffering relative to polylysine [12, 14]; for the case 
of dual-labeled delivery vectors, however, the apparent buffering with PEI was restricted 
to only one of the three cell lines examined [13].  It was also shown recently that 
acetylation of PEI improved its transfection efficiency despite a concomitant reduction in 
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buffering capacity [25].  We have observed intact polyplexes in cytoplasm with both PEI 
and a non-buffering β-cyclodextrin-containing polymer, demonstrating that a buffering 
delivery vector is not a necessary requirement for endosomal escape of intact polyplexes 
[2].  Dubruel et al. have found that polymethacrylates with buffering capacity similar to 
polyethylenimine generate far inferior transfection, attributing this to inferior endosomal 
escape [26].  Funhoff et al. questioned the general applicability of the “proton sponge” 
hypothesis upon observing poor transfection efficiency of a new polymer with a pKa that 
should supply buffering capacity [27].  Erbacher et al. further showed that chloroquine 
can dissociate polycations from pDNA [15]; along with preceding chapters of this report, 
these results suggest that vector displacement is another means by which chloroquine 
enhances transfection efficiency in vitro. 
 Despite questions about the “proton sponge” hypothesis, buffering moieties have 
been added to many vectors in an effort to mimic the purported endosomotropic activity 
of chloroquine and PEI.  One such moiety is histidine, a natural amino acid whose side 
chain becomes protonated at pH ~6.  Midoux et al. prepared a histidine-substituted 
polylysine that generated much greater in vitro reporter gene expression than unmodified-
polylysine transfection and even unmodified-polylysine transfection in conjunction with 
chloroquine treatment [28].  Transfection efficiency in vitro was markedly improved with 
a low extent of histidine substitution and continued to improve slightly with additional 
histidine substitution.  As with PEI-pDNA transfection, reporter gene expression in an in 
vitro histidylated polylysine-pDNA transfection was reduced when endosome 
acidification was inhibited with bafilomycin A1.  While Midoux et al. used histidine 
substitution throughout the polylysine backbone, Davis et al. pursued an alternate 
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strategy of histidine substitution only at the termini of a β-cyclodextrin containing 
polymer [29].  Davis et al. observed that histidine substitution produced increases in in 
vitro reporter gene expression for the same level of pDNA delivery to cells, supporting 
the hypothesis that buffering moieties somehow contribute to the defeat of intracellular 
barriers. 
 Rather than applying direct histidine conjugation, some researchers have pursued 
buffering through incorporation of polyhistidine.  Pack et al. found that the transfection 
efficiency of ternary complexes of pDNA, polylysine, and glycosylated polyhistidine was 
not significantly improved relative to simple pDNA-polylysine complexes [30].  Noting 
that polyhistidine had been shown to have fusogenic properties at mildly acidic pH [31], 
Benns and coworkers prepared a polyhistidine-graft-polylysine copolymer as a gene 
delivery vector.  The β-galactosidase expression resulting from transfection with the 
copolymer was superior to that of simple polylysine [32].  The purported fusogenic 
contribution was limited, however, as chloroquine treatment produced further increases in 
transfection efficiency for both the copolymer and umodified polylysine.  Although the 
importance of buffering thus remains in question relative to factors such as vector 
displacement, it is likely that buffering components offer contributions to enhanced gene 
delivery. 
 The engineering of endosomal escape processes with molecular conjugates should 
account for both the nature and morphology of the intravesicular polyplexes.  We have 
used transmission electron microscopy to show that unmodified polycation-pDNA 
complexes enter cells as large aggregates of 3-5 times the as-formulated diameter [2].  
Still-larger aggregates were observed as aggregate-containing vesicles appeared closer to 
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the nucleus.  The membranes of these vesicles conformed to the contorted, bulbous shape 
of the aggregates therein.  When PEI-pDNA complexes were coated with polyethylene 
glycol (PEG) to confer extracellular salt stability, the particles’ intracellular morphology 
was also seen to be affected.  Intracellular PEGylated particles were observed as discrete 
entities contained in smooth, circular vesicles, and the particles retained their as-
formulated size (Fig. 7.1).  The observation of unmodified polyplexes as large aggregates 
in intracellular vesicles may be related to the superior transfection efficiency seen with 
those polyplexes relative to their PEGylated variants.  Only a slight swelling of the large 
aggregates could lead to vesicle rupture, while such is not the case with the PEGylated 
particles.  Further studies will be needed to address these issues. 
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Figure 7.1  Stabilization of polyplexes affects uptake and trafficking 
Unstabilized complexes aggregate in the transfection medium; these enter cells and 
traffic through them as large clumps.  In contrast, PEGylation of non-viral complexes 
allows for uptake of discrete entities that remain distinct throughout the endocytic 
pathway.  The intracellular complexes can be observed in the transmission electron 
microscope.  Scale bars, 200 nm. 
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7.3 Vector unpackaging 
 The unpackaging of nucleic acids from delivery vectors is essential to the gene 
delivery process.  Nucleic acids function through interactions with cellular components 
such as proteins and other nucleic acids, and these cellular components may remain 
inaccessible to nucleic acids that remain bound to delivery vectors.  Reduced 
transcriptional activity has been observed for pDNA bound to cationic dendrimers [33] or 
to polylysine [34].  Prolonged binding of pDNA and more severe inhibition of its 
transcriptional activity are together correlated to an increase in polylysine length [34].  
Koping-Hoggard et al. used chitosan to demonstrate a correlation between ease of 
polyplex dissociation and increases in transfection efficiency [35].  As described above, 
our results and those of Erbacher et al. [15] indicate that the endosomotropic agent 
chloroquine produces enhancements in transfection efficiency in vitro in part by 
dissociating the polycations from pDNA in the delivered polyplexes. 
 A proposed mechanism for vector unpackaging is displacement of nucleic acids 
by intracellular polyanions.  The kinetics and ease of this unpackaging are related to the 
chemical structure of the delivery vector.  A series of β-cyclodextrin-containing polymers 
prepared by Hwang et al. demonstrated a clear relationship between the polymer-pDNA 
binding strength and the number of methylene units separating charge centers on the 
polymer [36].  Itaka et al. observed that linear and branched PEI are displaced from 
pDNA with similar kinetics, but showed using fluorescence resonance energy transfer 
(FRET) that, in cells, linear PEI is displaced from pDNA far more readily than the 
branched variant [10].  Based on these studies, it is unlikely that polycations and/or lipid 
delivery systems that bind nucleic acids with sufficient strength to afford stability in vivo 
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will spontaneously release the nucleic acid to any great extent once inside cells.  Thus, 
these systems should be designed so that the transition from extracellular to intracellular 
compartments triggers a reduction in the binding strength of the delivery vector. 
 Degradable delivery vectors have been designed in an effort to facilitate vector 
unpackaging.  Various researchers have sought to construct vectors that will fall apart 
within cells and render the polyplexes unstable.  Unfortunately, the optimal kinetics and 
intracellular location of this degradation are unknown, and it is difficult to predict where 
and how quickly a new vector will exhibit degradation.  For example, Forrest et al. 
prepared highly cross-linked mimics of 25-kDa branched PEI by reacting 800-Da PEI 
with short, linear diacrylates [37].  The resulting conjugates were sensitive to hydrolysis 
at both near-neutral and mildly acidic pH.  An intercalating-dye exclusion assay, 
however, showed that polyplexes produced with these conjugates did not exhibit pDNA 
release in vitro even after 24 h in hydrolyzing conditions.  The increasingly acidic pH of 
endocytic vesicles can also be exploited to induce vector unpackaging.  Choi et al. 
demonstrated that polycation-pDNA particles could be prepared with an acid-labile lipid 
at pH 8.5 and would rapidly degrade at pH 5.3 [38].  The pH-sensitive lipid-pDNA 
particles showed sharp increases in transfection efficiency relative to similar, pH-
insensitive particles. 
 Other designs have sought to exploit the reducing environment found within cells.  
In an effort to provide extracellular particle stabilization that would be discarded after 
cellular uptake, Carlisle et al. coated PEI-pDNA polyplexes with poly[N-(2-
hydroxypropyl)methacrylamide] through a reducible disulfide linkage [39].  The coating 
could be removed by reduction with dithiothreitol, and transfections with coated particles 
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showed that the resultant reporter gene expression could be modulated by the extent of 
degradable coating and the strength of the intracellular reducing environment.  Rather 
than using disulfide bond reduction to remove a stabilizing coating, Saito and coworkers 
designed polyplexes to become endosomolytically active in a reducing environment [40].  
The cationic DNA-binding peptide protamine and the endosomolytic protein listeriolysin 
O were conjugated through a disulfide bond, rendering listeiolysin O inactive.  This 
protamine-lysteriolysin O copolymer was designed to degrade in acidic vesicles and 
release active listeriolysin O to facilitate the endosomal escape of the remaining polyplex.  
In fact, an optimized loading of listeriolysin O to the polyplexes produced pronounced 
enhancements in reporter gene expression. 
 The internal polyplex structure can also be rendered sensitive to a reducing 
environment.  A modified polylysine vector prepared by Pichon et al. has its amine 
charge centers connected to the polymer backbone by disulfide bonds [41].  Polyplexes 
prepared with this modified polylysine can be disrupted by reduction with dithiothreitol 
or glutathione and exhibit improvements in transfection efficiency relative to unmodified 
polylysine.  Miyata et al. prepared polyplexes using a thiolated PEG-polylysine 
copolymer, then transferred the polyplexes to an oxidative solution to crosslink the 
copolymers within the polyplexes [42].  Their results indicated that the extent of 
intrapolyplex crosslinking and the density of the polymers’ cationic charge both 
contribute to pDNA release upon reduction of the disulfide cross-links. 
Similarly, McKenzie and coworkers prepared a series of synthetic peptides as 
delivery vectors and observed that inclusion of cysteine residues allowed for spontaneous 
disulfide bond formation upon pDNA condensation [43,44].  The disulfide bond 
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formation conferred a reduction in particle size and stability against shear stress, and the 
authors ascribed increases in transfection efficiency to enhanced pDNA release upon 
intracellular reduction of the disulfide bonds.  For these materials, variation in the 
number of cysteine residues can be used to control the extent of disulfide crosslinking 
and the resulting stability. 
The reversible polymerization of liposomes presents another opportunity for 
preparation of degradable complexes, and polymerized lipoplexes have been designed 
with susceptibility to degradation by reducing conditions.  Balakirev et al. used lipoic 
acid, a molecule containing an unstable dithiolane ring, to prepare reactive amphiphiles 
that polymerized under oxidative conditions to condense pDNA into small particles [45].  
The researchers implicated intracellular reduction by glutathione and NAD(P)H in the 
improved transfection efficiency of the reducible lipoplexes. 
 
7.4 Cytoplasmic persistence and mobility 
 For certain applications, it may be sufficient to ensure the nucleic acids escape 
from the endocytic pathway and are released from delivery vectors.  RNA interference 
approaches, for example, are designed to function in the cytoplasm and often rely on 
small oligonucleotides that can readily diffuse through the cytoplasm [46].  
Unfortunately, delivery to the cytoplasm is inadequate for complete genes or plasmids 
that must access the cell’s transcriptional machinery; these materials must traverse the 
cytoplasm and reach the cell nucleus. 
 Barring direct association of polyplexes and intracellular microtubules, 
observations of active, microtubule-dependent intracellular transport of PEI-pDNA 
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complexes [7] suggest that polyplex motion in cytoplasm occurs in the context of 
entrapment in endocytic vesicles.  Intact polyplexes are typically dense and dozens or 
hundreds of nanometers in diameter, and those that escape endocytic vesicles cannot be 
assumed to exhibit significant movement in cytoplasm or to traffic to the cell nucleus.  
Diffusion in the cytoplasm is restricted by the structure of the cytoskeleton and the severe 
crowding presented by proteins, organelles, and other macromolecules [47,48].  The 
apparent immobility of intact polyplexes in cytoplasm suggests that these particles can 
only access the cell nucleus during cell division, when there is cytoplasmic mixing and 
degradation of the nuclear membrane.  Reports of intact polyplexes visualized in the cell 
nucleus are uncommon in the literature.  One hypothesis describing the intracellular 
trafficking of polyplexes suggests that the cytoplasm presents a “dead end” for intact 
polyplexes due to their large size and lack of active transport mechanisms.  It is 
reasonable to assume that current systems will undergo vector unpackaging and/or 
degradation before or upon deposition in the cytoplasm. 
 Although vector unpackaging is necessary for the eventual function of the 
delivered nucleic acids, its consequence in the endocytic pathway or in the cytoplasm is 
exposure of nucleic acids to a destructive environment.  Lechardeur et al. found that 
cytoplasmic nucleases limit pDNA to a half-life in cytoplasm of only 50-90 min [49].  
Pollard et al. confirmed these observations, finding a pDNA half-life in cytoplasm of 2 h, 
and suggested various means of confronting this hazard, including saturation or inhibition 
of cytoplasmic nucleases or the use of artificial nucleic acids that would not be 
susceptible to the nucleases [50].  Ribeiro et al. took a parallel approach to demonstrate 
that replacement of specific labile sites in pDNA can confer some resistance to nuclease 
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degradation without sacrificing the in vitro expression levels obtained from that pDNA 
[51].  Similarly, Layzer and coworkers discovered chemical modifications to siRNAs that 
greatly enhance the half-life in plasma without compromised efficacy in vivo [52]. 
 The size of the nucleic acid cargo affects its intracellular mobility.  Polyplexes are 
typically used to deliver pDNA of 5,000 or more base pairs (bp).  Unpackaged pDNA of 
this size is unlikely to escape degradation by traversing the cytoplasm.  Lukacs et al. used 
fluorescence recovery after photobleaching (FRAP) to measure the size-dependent 
diffusion of nucleic acids in cells [46].  The diffusion coefficient of linear DNA 
fragments in cytoplasm dropped severely as the DNA length increased from 100 to 500 
bp, and fragments longer than 2000 bp exhibited little to no diffusion.  More recently, it 
has been demonstrated that the actin cytoskeleton is largely responsible for this restricted 
diffusion [53].  These results suggest that, for most plasmids, diffusion alone cannot 
facilitate transport of unpackaged pDNA from cytoplasm into the cell nucleus. 
 
7.5 Nuclear delivery 
 While the precise mechanism of intracellular trafficking remains unknown, 
polyplexes are able to deliver some pDNA to the cell nucleus; however, the amount is 
likely only a small fraction of that delivered to cells [54].  Without incorporation of 
components to enhance nuclear delivery, significant pDNA delivery to the cell nucleus 
has rarely been visualized by microscopy.  In their multiple particle tracking experiments, 
Suh and coworkers ascribed the absence of fluorescently-labeled PEI in cell nucleus to 
their use of non-dividing cells [7].  Fluorescence in situ hybridization (FISH) by Langle-
Rouault et al. showed unpackaged pDNA only in cytoplasm, not in the nucleus, even 
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though a hundredfold increase in luciferase expression had indicated the authors had 
successfully designed a system for improved nuclear delivery [55]. 
 Indirect confirmation of nuclear delivery from simple polycation-pDNA particles 
is provided by the numerous reports of non-zero expression levels from exogenous 
pDNA.  The expression of reporter genes indicates that some pDNA has reached the cell 
nucleus and been transcribed.  Despite efforts at direct visualization, it remains unclear 
whether this pDNA reaches the nucleus in the form of polyplexes, polyplex fragments, or 
unpackaged pDNA.  Using in vitro transfection with PEI, Godbey et al. observed 
fluorescently-labeled PEI and pDNA in the cell nucleus [56].  The observations were 
made 4 h post-transfection, and the PEI and pDNA appeared to be associated. 
Using transmission electron microscopy of cells transfected in vitro, we explored 
the intracellular fate of polyplexes prepared with PEI or with a β-cyclodextrin-containing 
polymer [2].  These efforts did not reveal intact polyplexes in the cell nucleus.  However, 
by using immunolabeling of cells transfected with biotin-labeled pDNA, we were able to 
visualize unpackaged pDNA in both cytoplasm and nucleus of transfected cells (Figure 
7.2).  In contrast to the results of Godbey et al., these observations are consistent with a 
hypothesis of cytoplasmic vector unpackaging followed by nuclear import of unpackaged 
pDNA, either intact or as digested fragments.  In experiments using flow cytometry of 
cells transfected with fluorescently-labeled pDNA, James and Giorgio noted but 
discounted the possible impact of degraded pDNA [57].  It is unknown if pDNA 
fragments can enter the nucleus more easily than intact pDNA (a possibility supported by 
the aforementioned results of Lukacs and coworkers [46]) or contribute measurably to 
observed transfection efficiencies. 
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Figure 7.2  Observation of unpackaged intracellular pDNA through immunolabeling 
Unpackaged intracellular nucleic acids can be visualized in the transmission electron 
microscope.  Here, polyethylenimine was used to deliver biotin-labeled pDNA to BHK-
21 cells in vitro.  Cells were fixed and prepared in thin sections, and an anti-biotin 
antibody was used to label intracellular pDNA with colloidal gold.  Clusters of gold 
particles (arrows) in the cytoplasm (left) or cell nucleus (right) indicate the presence of 
pDNA outside of intact polyplexes.  Scale bars, 200 nm. 
 
 Although the mechanism of nuclear delivery is not clear, cell division appears to 
play a significant role.  Brunner et al. and Mannisto et al. have shown that the 
transfection efficiencies of branched PEI and polylysine exhibit dependence on cell cycle 
[58, 59].  Similarly, multiple investigators have seen that mitosis produces an increase in 
transfection efficiency with liposomes [60-62].  Using microinjection of pDNA to 
cytoplasm and examining a range of pDNA doses, Ludtke et al. showed that compared to 
non-dividing cells, roughly twice as many dividing cells expressed a reporter gene [63].  
A widely-accepted explanation for the positive correlation between transfection 
efficiency and cell division is that cytoplasmic pDNA can access the nucleus more easily 
upon the breakdown of the nuclear envelope in mitosis.  As the intact actin cytoskeleton 
causes poor diffusivity of pDNA in cytoplasm [53], pDNA introduction to the cell 
nucleus may also be facilitated by cytoskeletal degradation and intracellular 
reorganization during cytokinesis. 
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 In marked contrast to their work with other delivery agents, Brunner and 
coworkers observed that transfection with linear PEI was not affected by the cell cycle 
[58,64].  Consistent with this result, confocal microscopy by Wightman et al. showed 
pDNA association with the nucleus for linear PEI but not branched PEI [65].  Linear PEI 
shares its unusual cell-cycle independence with viral vectors, which can exploit viral 
mechanisms for nuclear delivery, and electroporation.  A molecular-level explanation of 
how linear PEI and electroporation achieve cell-cycle independence could provide 
valuable insight for improving nuclear delivery of non-viral vectors. 
 In the design of synthetic gene delivery systems, reliance on cell division for 
nuclear delivery should be avoided because of the desire to target non-dividing cells in 
vivo.  As transfection efficiency is not abolished entirely in non-dividing cells, existing 
systems likely achieve some nuclear delivery through one or more alternative 
mechanisms.  Although the numerous nuclear pore complexes allow small solutes and 
proteins to pass freely through the nuclear envelope, pDNA (but not complexes, unless 
they are very small [66]) may be able to be transported into the cell nucleus through these 
pores via a passive or active transport mechanism. Too large to diffuse through the 
nuclear pore complexes by passive diffusion, karyophilic proteins are directed to the 
nucleus by a class of peptides known as nuclear localization signals (NLSs) [67-70].  
NLS-containing proteins are carried to the cell nucleus through a nuclear pore complex in 
a stepwise, energy-dependent fashion.  Efforts to incorporate a nuclear targeting 
component in a synthetic gene delivery system have focused on exploiting this natural 
pathway for nuclear delivery [71]. 
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Conjugation to an NLS has been shown to enhance the nuclear delivery of 
carboplatin, a small molecule anticancer agent [72].  Analogously, some investigators 
have attempted to enhance nuclear delivery of delivered nucleic acids by direct labeling 
with NLSs.  Sebestyen et al. utilized covalent attachment of an NLS to a linearized 
pDNA construct with a functional reporter gene [73].  When the construct was applied to 
digitonin-permeabilized cells, the NLS did not affect the resulting expression levels.  
These authors subsequently showed that an NLS markedly enhanced nuclear delivery of 
linear pDNA in microinjected cells for only DNA under 1500 bp [74].  Consistent with 
this result, a microinjected 900-bp linear expression cassette produced greater reporter 
gene expression when conjugated to the NLS. Moving beyond this size limit, Zanta et al. 
prepared a 3500-bp linear DNA fragment capped by a single terminal NLS [75].  When 
administered to cultured cells with a cationic lipid or with PEI, the NLS-labeled construct 
produced greater luciferase expression than an unlabeled construct or pDNA.  However, 
the effect of the NLS was less pronounced in non-dividing cells or with increasing DNA 
doses. 
 The aforementioned reports all incorporated the NLS of the SV40 large T antigen.  
Early identification of this NLS has left it well-characterized in the literature, but there is 
no guarantee that this classical NLS is the most suitable option for non-viral delivery of 
nucleic acids.  The wide variety of NLSs is accompanied by many independent import 
pathways.  Although proteins directed for nuclear import are not necessarily restricted to 
a single pathway [68], the simultaneous function of independent pathways may indicate 
that certain cargoes are best suited for specific pathways [76].  Cellular nucleic acids 
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enter the nucleus on a distinct pathway from many proteins, as evidenced by the nuclear 
import of RNA-containing small nuclear ribonucleoprotein particles [77]. 
Rather than using the SV40 large T antigen NLS, Subramanian et al. conjugated 
the M9 NLS to a DNA-binding peptide and used cationic lipids to deliver the conjugate-
pDNA complexes to cultured cells [78].  These M9-containing lipoplexes exhibited 
significant improvements in transfection efficiency relative to simple pDNA-lipid 
transfection, but formulations that excluded the peptide conjugate in favor of one or both 
of its unconjugated components also produced increases in reporter gene expression.  
Further, the number of peptides necessary to elicit these effects was enormous.  As such, 
it is difficult to assess the extent to which the M9 NLS contributed to nuclear delivery 
through the expected mechanism.  Using peptide nucleic acid (PNA) clamps to bind NLS 
peptides to linearized 5000-bp pDNA, Bremner et al. observed little enhancement in 
transfection efficiency with any of 4 NLSs: the SV40 large T antigen NLS, an extended 
version of this NLS, the M9 NLS, and the NLS of the human T cell leukemia virus type 1 
Rex protein [79].  Only the minor increase with the extended SV40 large T antigen NLS 
was statistically significant. 
The variable performance of NLSs in non-viral delivery could stem from multiple 
factors, including inhibitory interactions between NLSs and nucleic acids.  The NLSs 
studied by Bremner et al. displayed electrostatic interactions with nucleic acids, and 
conjugation to pDNA impeded NLS binding to transport receptors [79].  Further, it is not 
clear that NLSs, whose natural function is in protein transport, can contribute to the 
transport of large pDNA.  Another concern is a dearth of knowledge on the optimal NLS 
loading number and density.  In their experiments with microinjected or digitonin-
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permeabilized cells, Ludtke et al. observed a positive correlation between enhanced 
nuclear delivery and a greater number of NLSs per linear DNA construct [74].  An 
excessive NLS loading, however, may cause different regions of a single DNA construct 
to be directed simultaneously through multiple nuclear pore complexes, leaving the 
nucleic acid unable to enter the nucleus efficiently or entirely.  Zanta et al. emphasized 
this point, designing their gene construct with a single, effectual NLS and estimating that 
the likelihood of simultaneous entry through multiple nuclear pore complexes was 
significantly enhanced for nucleic acids above 1000 bp [75]. 
 Rather than incorporating an NLS, some investigators have sought to exploit the 
nuclear import machinery in an indirect manner.  As shown by Kaneda et al., delivery of 
nuclear proteins concurrent with lipofection of pDNA enhances the pDNA nuclear 
delivery and gene expression [80].  These authors suspected that complexes of pDNA and 
nuclear proteins could protect pDNA from nucleases and facilitate pDNA transfer to the 
nucleus.  Under the assumption that endogenous, newly-synthesized nuclear proteins can 
function in the same way, a number of investigators have proposed a “piggybacking” 
mechanism for pDNA delivery to the nucleus [76,81].  As newly-synthesized nuclear 
proteins will be in the cytoplasm and many will contain both a DNA-binding element and 
an NLS, this hypothesis suggests that DNA-binding elements of the nuclear proteins bind 
to unpackaged pDNA in the cytoplasm and carry this pDNA into the nucleus as they are 
carried there by the nuclear import machinery. 
Dean and coworkers lent credence to the piggybacking hypothesis by 
demonstrating that the sequence of pDNA could affect its nuclear import, and that this 
import, requiring certain cytoplasmic factors, could be inhibited by restricting transport 
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through the nuclear pore complex [81,82]. Langle-Rouault et al. demonstrated a 
sequence-dependent effect using a plasmid containing the Epstein-Barr origin of 
replication, oriP [55].  The researchers used lipofection or microinjection to transfect a 
cell line that stably expressed Epstein-Barr nuclear antigen 1.  Consistent with a 
hypothesis of enhanced nuclear delivery through interaction beween oriP and Epstein-
Barr nuclear antigen 1, the oriP-containing plasmid showed a 100-fold transfection 
efficiency enhancement in the stably-expressing cell line.  Similarly, Vacik et al. showed 
that expression of pDNA containing portions of the smooth muscle gamma actin 
promoter was markedly enhanced in cultured cells that express transcription factors 
specific to smooth muscle cells (SMCs) [83].  The enhanced expression was observed 
both in SMCs and in epithelial cells stably transfected to express an SMC serum response 
factor. Mesika et al. used the transcription factor NF-κB to develop a controllable method 
of nuclear delivery through piggybacking [84].  NF-κB is found predominantly in the 
cytoplasm unless its nuclear localization is activated by a particular stimulus.  These 
investigators prepared pDNA with a repeating sequence of NF-κB binding sites, used a 
cationic dendrimer to transfect cells in vitro, and monitored luciferase reporter gene 
expression as a function of NF-κB stimulation.  In the four cell lines investigated, an 
order of magnitude enhancement in gene expression was observed for transfection with 
the modified pDNA in conjunction with activation of NF-κB.  Confocal microscopy 
verified that NF-κB activation improved nuclear delivery of the modified pDNA, leading 
the authors to conclude that the modified pDNA was binding NF-κB in the cytoplasm 
and accompanying it to the nucleus upon NF-κB activation. 
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For all systems, the morphology of the nucleic acids may have an impact on 
nuclear delivery efficiency.  Studies in non-viral gene delivery tend to focus on closed 
circular pDNA, which is resistant to exonucleases and gives higher transfection 
efficiency than its linearized variant [79].  However, the best results to date with NLSs 
have utilized linearized nucleic acids [74,75,79].  In part, the disparate performance of 
circular and linearized pDNA may be due to differences in cytoplasmic mobility. 
 Existing non-viral delivery systems do not traverse the nuclear membrane with 
ease.  NLSs act naturally to deliver cellular proteins to the nucleus, but the NLS function 
may not be transferable to larger entities such as pDNA thousands of bp in length.  
Further, the methods currently under study for nuclear delivery, including NLSs and 
piggybacking, may be severely undermined by the relative immobility of pDNA in 
cytoplasm if this immobility impedes the delivered nucleic acids from encountering the 
relevant proteins.  The development of an efficient nuclear delivery method remains an 
area of opportunity. 
 
7.6 Future directions 
 A variety of means are under development to address the intracellular barriers 
experienced by nucleic acids that are delivered by molecular conjugates.  For example, 
the acidity of the endocytic pathway presents an opportunity for the engineering of 
endosomotropic mechanisms, and one approach to induce dissociation of polyplexes 
utilizes the reducing environment of the cell.  Such modifications may become more 
effective with elucidation of the preferred time and location of endosomal escape and 
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vector unpackaging.  Efforts to engineer improved persistence and nuclear delivery are 
also underway. 
To date, non-viral approaches have not produced a full rival to the superior 
transfection efficiency of viral vectors.  A particular intracellular barrier that remains to 
be addressed is the poor cytoplasmic mobility of larger nucleic acids.  pDNA that is 
unpackaged from delivery vectors in the cytoplasm is likely to be degraded before it can 
diffuse to its place of function or to bind proteins that can confer nuclease protection and 
nuclear delivery. A mechanism for promoting cytoplasmic mobility, perhaps in 
conjunction with nuclear delivery, likely presents an opportunity for further 
improvements in transfection efficiency.  As non-viral systems are commonly 
characterized by transient expression, opportunities also remain in prolonging expression.  
A successful approach by Nakai et al. achieved integration of exogenous pDNA by 
linearization; integration was further enhanced with incorporation of virally-derived 
inverted terminal repeats [85]. 
 Recent research demonstrates that the intracellular trafficking of non-viral 
formulations is affected by the particles’ morphology, size, and cellular uptake 
mechanism [2,5].  For example, Goncalves et al. recently demonstrated that the size of 
polylysine-pDNA complexes dictates whether they enter cells through clathrin-dependent 
or -independent pathways [5].  These authors used a variety of methods to present 
detailed characterizations of the materials’ intracellular destination(s) and observed that 
clathrin-dependent internalization was more conducive to enhanced transfection.  
Because the physiochemical nature of the delivery formulation affects both its cellular 
uptake and its intracellular trafficking, progress in intracellular gene delivery requires 
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such elucidation of mechanisms for physiologically-relevant systems that are salt- and 
serum-stabilized, appropriately-sized, and targeted to specific cell types. 
 
7.7 Conclusion: A systems approach 
 Among the numerous challenges of creating a non-viral delivery system exists a 
daunting one: the integration of the components into a workable system that combines the 
attributes of the components without suffering losses because of the integration. 
Examples of the detrimental effects of integration already exist: as shown in Chapter 3, 
PEGylation of polyplexes can endow them with serum stability but also greatly inhibit 
gene expression.  The key issue is to develop delivery systems that provide the 
appropriate spatio-temporal functions, i.e., the system must perform particular functions 
in the right places at the right times to provide for effective transport of the nucleic acid 
to the desired site of action in mammals.  This is likely to require an adaptive system, one 
that can sense its surroundings and respond dynamically to spatio-temporal, 
environmental changes.  Early examples of these systems do exist [29], but much further 
progress employing this approach will be necessary to bring these entities from 
laboratory systems to practical “bedside” medicines. 
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CHAPTER 8: RECOMMENDATIONS FOR FUTURE WORK 
 
 This thesis has described the importance of a systems approach in the 
development of non-viral gene delivery vectors.  The gene delivery particles studied here 
have consisted of simple complexes between nucleic acids and polycations, or such 
complexes modified after formulation by addition of a poly(ethylene glycol) coat.  
Analysis of these particles’ behavior in vitro provides information about their relative 
performance and possible shortcomings.  However, particles developed for systemic 
administration should be targeted to specific cell types.  In many cases, therapeutic 
performance will require expression (with plasmid DNA) or repression (with small 
interfering RNA) of particular genes in certain cells of the body.  Further, targeted 
particles will likely require lower doses than nonspecific particles to achieve the desired 
function.  The necessity of a systems approach, as indicated by this thesis, suggests that 
further studies (both in vitro and in vivo) be undertaken with particles targeted to specific 
cells, either through addition of cell-specific ligands or through use of genes which are 
expressed only in certain cell types.  For particles targeted using a surface ligand, the 
ligand itself may very well influence the gene delivery behavior and performance of the 
gene delivery particles.   Studies characterizing the behavior of targeted, salt-stabilized, 
and fully-assembled particles are necessary for improved, therapeutically-relevant 
understanding of non-viral gene delivery. 
 With the difficulty in developing synthetic materials that generate therapeutically-
relevant gene expression, the fate and consequences of non-viral gene delivery vectors 
have not been extensively investigated.  The toxicity of polycationic vectors has been 
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addressed through development of novel materials, including the cyclodextrin-containing 
polycations studied in this thesis.  The data presented in Chapter 2 show that the chemical 
structure of the delivery vector is directly related to its toxicity, offering means of 
developing materials with an optimized balance between gene transfer and toxicity.  Such 
efforts would benefit from an improved understanding of the source and nature of 
polycation toxicity.  With reduced toxicity, non-viral gene delivery systems can be 
applied in larger doses, allowing for improved gene transfer. 
 A significant impediment to non-viral gene delivery is likely the metabolic 
instability and poor cytoplasmic mobility of larger nucleic acids.  Nucleic acids that are 
unpackaged from delivery vectors in the cytoplasm are likely to be sequestered or 
degraded before having an opportunity to carry out their function.  Further improvements 
in transfection efficiency will likely result from improved cytoplasmic mobility and/or 
persistence.  As vector unpackaging is required for delivered nucleic acids to function, 
and appears to occur prior to nuclear delivery with some of the systems examined in this 
thesis, these aims may best be pursued by a design which assumes (and exploits) vector 
unpackaging in the endocytic pathway or cytoplasm and includes additional 
modifications for cytoplasmic mobility and/or persistence.  Sample strategies include the 
use of peptides or ligands to target particular intracellular destinations or the use of 
modified nucleic acids to inhibit degradation.  Thus, there is impetus for the design of 
non-viral gene delivery systems that can both self-assemble upon formulation and 
partially unpackage after cellular uptake, allowing for polycation unpackaging from 
nucleic acids while maintaining intracellular targeting or protective features. 
 
